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To Andrew and our parents
....man knows partly but conceives beside, 
Creeps ever on from fancies to the fact.
And in this striving, this converting air 
Into a solid he may grasp and use,
Finds progress, Man's distinctive mark alone, 
Not Gods's and not the beast's:
God is; they are;
Man partly is, and wholly hopes to be.
(G.M. Hopkins)
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Abstract
Experimental diets containing either 4.8 or 9.6% wheat bran, 
8.5% beef suet, and a stock diet were fed to rats for long and 
short periods in order to determine their effects on hepatic drug 
metabolizing enzymes in comparison to a fibre-free control diet. 
The only dietary related changes observed were with the stock diet 
(41B), in the rats fed for either 12 wk or 18 months, which 
consistently induced 7-ethoxyresorufin-O-deethylase, a
mixed-function oxidase enzyme known to be catalysed by cytochrome 
P448; at 12 wk this diet also induced cytochromes P450 (female 
rats only) and b_, and biphenyl-4-hydroxylase. At this time point
5
7-ethoxyresorufin-O-deethylase activity was also stimulated by both 
the bran diets.
Intestinal drug metabolizing enzymes were found to be 
unaffected by three dietary levels of wheat bran (4.8, 9.6 & 
28.8%), fed for 4 wk, compared to a fibre-free control diet. The 
effect of incorporation of safrole, an inducer of the a 
mixed-function oxidases and an hepatotoxic agent, into the 
fibrerfree and 9.6% bran diets, on the levels of intestinal 
mixed-function oxidases was similar in both dietary groups. This 
indicated that at the levels of safrole and wheat bran used , bran 
does not adsorb safrole in vivo or prevent its biological activity.
The effect of wheat bran fed at three dietary levels, for 
long and short periods, on mucus synthesis was investigated, and 
found to be without effect. The stock diet (41B) increased mucus
synthesis in the colon and duodenum, as determined by measurement 
of the rate of incorporation of (^fOn-acetylglucosamine into . mucus 
glycoproteins in mucosal homogenates. The effect of wheat bran,
8.5$ beef suet and the stock diet on the sialic acid content of 
gastro-intestinal glycoproteins was without effect, indicating that 
the character of the mucus was not altered by these dietary 
regimes.
Adverse effects of wheat bran on mineral status have been 
reported. A study was made using well-nourished rats , of the bone 
mineral stores, compared to the fibre-free diet. No adverse 
effects of either wheat bran (4.8 or 9.6%) or of wholemeal bread 
incorporated into the diet at 17 or 34% f or of the stock diet, were 
found in comparison to the fibre-free diet. The effect of wheat 
bran on the circulating levels of vitamin D, determined by 
radioassay, was similarly without effect.
Finally, a drug-nutrient interaction, that of anti-convulsant 
therapy and associated folate deficiency was further investigated. 
Rats maintained for periods of between 13 & 18 wk on a folate
deficient diet were dosed with inducing agents of the 
mixed-function oxidase enzyme system for periods of 4 days and 2 wk 
(phenobarbitone) and 7 days (3-methylcholanthrene), in order to 
determine whether folate deficiency prevented their inducing 
effects. The animals were judged to be folate deficient by 
determination of serum and red cell folate levels using a 
radioassay technique. The results conclusively showed that 
induction of cytochrome P450 and the mixed-function oxidase enzymes
was not affected by folate deficiency, indicating that the 
long-term anti-convulsant treatment is probably required to elicit 
this adverse reaction.
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Chapter One
Introduction
Dietary Fibre
Introduction - An item of the diet which has received much 
attention over the last decade because of its postulated role in 
protecting against certain diseases, is dietary fibre. Burkitt & 
Trowell (1975) suggested that low intakes of dietary fibre in 
Western countries may contribute to the occurrence of certain 
diseases and that increasing the consumption of fibrous foods, 
particularly bran, would decrease the incidence of diverticular 
disease, carcinoma of the colon, cardiovascular disease, diabetes 
mellitus and obesity. The upsurge of interest in the field of 
dietary fibre research, stimulated by reports of its preventive 
role in thé aetiology of these diseases, has led to a vast increase 
in knowledge of the nutritional, physiological and epidemiological 
functions of the fibrous components of plant foods in our diet.
Historical Background - It was known before the middle ages that 
part of our plant and cereal food was indigestible but it was not 
until the 19th century that attempts were made to measure this 
component. The impetus came from the developing world of animal
nutrition. An estimate of the indigestible fraction was required
in order to predict the nutritive value of animal feedstuff, for 
economical and nutritional reasons. The original method for 
measuring the crude fibre content was developed in Moglin, Germany, 
in 1806 by Einhof (Van Soest and McQueen,1975), and involved 
treating the sample sequentially with petroleum ether, hot
sulphuric acid, boiling water and hot alkali. The method became
well established and was incorporated into various statutory
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provisions, having practical value as an index of the indigestible 
matter in animal feeds. It was thought to measure the cellulose 
content of the diet.
As far as human nutrition is concerned a major advance in the 
field of dietary fibre research came from McCance and Lawrence 
(1929) who made a formal attempt to measure the carbohydrate 
content of the diet; it became apparent that a significant part of 
plant carbohydrates were not digested in the human alimentary 
tract. These were termed unavailable carbohydrates. From this 
initial concept ensuing research in this field over the past 50 
years has furthered our understanding of dietary fibre. The 
laxative effect of bran was demonstrated (Williams & 
Olsted,1955,1956), and it was used to treat constipation, irritable 
colon, haemorrhoids and chronic colitis (Dimmock,1936). Cleave 
(1956) related the existence of certain diseases to the excessive 
consumption of ref mat carbohydrate foods in particularly sugar. 
Burkitt recognised the rarity of diseases mentioned in Cleave's 
hypothesis among native Africans. He studied transit times and 
stool weights in relation to fibre intake (Burkitt et al,1972). 
His dietary fibre hypothesis, attributing some of the diseases of 
Western civilisation to an inadequate intake of this dietary 
component has stimulated an abundance of research in this field 
(Burkitt,1971).
Definition - Dietary fibre was defined in 1974 (Trowell,1974) as 
'the remnants of the plant cell wall that are not hydrolysed by the 
alimentary enzymes of man', and redefined in 1976 (Trowell _et
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al_, 1976) as 'the plant polysaccharides and lignin which are 
resistant to hydrolysis by the digestive enzymes of man*.
Classification - Dietary fibre consists of a diverse group of 
substances of plant origin, found mostly in the plant cell wall, 
which vary in chemical composition and physiological effect. There 
is no generally accepted classification of the components of 
dietary fibre (Cummings,1976). The best classification would be 
one based on the molecular structure of its component members but 
such information is not known for all the possible constituents of 
fibre. Much of the analysis of cell wall substances has been done 
on wood, cereals and grasses, with little analytical work on the 
common dietary constituents of fruits and vegetables. Existing 
classifications show two major classes of fibre - polysaccharides 
and lignin. This nomenclature is based on the classical schemes of 
fractionation, the definitions relating to the methods of isolation 
rather than the chemical structure.
Polysa&harides
Cellulose - is the major structural polysaccharide in the cell 
wall. It is a single homopolysaccharide of D-glucose residues 
linked in j31-4 configuration in long unbranched chains and has a 
crystalline structure. The p-configuration provides resistance to 
the action of pancreatic amylase but cellulases are widely 
distributed in fungi and bacteria, so that they afe present in the 
rumen and colon (Yost,1972). X-Ray diffraction studies reveal 
areas of cellulose molecules which are disordered and 
non-crystalline and may represent areas where other sugars or 
uronic acids are incorporated into the molecule (Southgate,1976).
— 5 —
Such regions are accessible to many reagents, including cellulases, 
which may be due to the weaker hydrogen bond formation (Shafizadeh 
and McGinnis,1971)• These regions may also be where the sorption 
of water, for which cellulose has great affinity, takes place since 
the X-ray diffraction pattern is unchanged when cellulose fibres 
are wetted.
Hemicelluloses - This term refers to the non-cellulosic 
polysaccharides' and was introduced by Schulze in 1891 
(Aspinall,1959) to describe those polysaccharides extracted from 
the plant cell wall by dilute alkali. Together with pectin the 
hemicelluloses form the matrix of the plant cell wall in which are 
enmeshed the cellulose fibres. They are a complex series of 
heteroglycans based on three types of homopolymeric backbone chains 
- xylans, mannans and galactans, and one type of mixed chain, 
glucomannan. They are smaller than cellulose molecules and carry 
side chains containing arabinose, galactose, xylose, mannose, 
glucose, rhamnose, galacturonic and glucuronic acids. They are 
further classified into acidic or neutral forms based on the 
content of uronic acids (Aspinall,1970). The uronic acid groups 
are derived from oxidation of the terminal -CHpH to -C00H, and are 
important in determining the physical properties of hemicelluloses 
since when they are present as glycosides they behave as simple 
hydrocarboxylic acids, forming metal salts, amides and alkyl and 
methyl esters (Danishefsky et al,1970; Percival,1963)•
Pectic Substances - are present in smaller amounts than the other 
cell wall constituents and are biochemically less well defined. 
They act as inter-cell wall cementing substances. There are three 
groups - pectins, which have a high degree of méthylation of the
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carboxylic acid groups, pectinic acids, in which only some of the 
acidic groupings are methylated, and pectic acids, in which the 
polysaccharides are devoid of methyl groups. D-Galacturonic acid 
is the principal component and other monomers found are 
D-galactose, L-arabinose, D-xylose, L-rhamnose, L-fucose, 
2-0-methyl-B-xylose and 2-0-methylfucose. Two important properties 
of pectin are its ability to form gels and its ion-binding 
capacity. The latter is closely related to the free uronic acid 
content (Branch et al,1975).
Gums, Mucilages and Storage Polysaccharides - These fibre 
components of the diet are not cell wall constituents but are 
related biochemically and in their physical properties to these 
constituents (Aspinall,1970a). Gums are produced at the site of 
injury to plants. They are a complex group of branched uronic 
acid-containing polymers composed of glucuronic and galacturonic 
acids, xylose, arabinose and mannose. Examples are gum arabic and 
gum tragacanth. Mucilages are present in plant seeds where they 
prevent desiccation (Aspinall,1970). They are mostly neutral 
polysaccharides. The best known example is guar gum, a
galactomannan. Mucilages from cereals are characteristically
highly branched with a backbone of 1-4p-D-Xylose with L-arabinose 
side chains. An example of a storage polysaccharide not digested 
by man is inulin which is found in Jerusalem artichokes. 
Non-polysaccharides
Lignin - is a complex cross-linked polymer formed of substituted 
phenylpropane molecules derived from coumaryl, coniferyl and 
sinapyl alcohols, and it is a small polymer of molecular weight
1000-4500. The units are joined by C-C bonds in a variety of
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linkages. Lignin is extremely inert and highly resistant to 
chemical degradation and enzymic digestion. It has a strengthening 
function in the cell wall (Pearl,1967)• Its spatial configuration 
is difficult to determine and it is hest viewed as infiltrating 
around the cellulose fibrils in a 3-D system (Southgate,1976). 
There is no structure for the lignin molecule and its biosynthetic 
pathway is thought to produce a random type of polymer 
(Freudenberg,1965).
Minor Components of the Plant Cell Wall
Certain components associated with dietary fibre in the cell wall, 
though not themselves of a fibrous nature, are recognised to have 
some effect on the behaviour of dietary fibre (Cummings,1976). 
Such components include protein, • inorganic constituents, cutin, 
suberin, waxes, phytic acid, glycosides e.g. saponin, and 
polyhydroxyphenols e.g. tannins.
Wheat Bran - The dietary fibre used in the work reported in this 
thesis is wheat bran. Bran is a product of flour milling and 
ideally comprises the outer layers of the wheat grain i.e. the 
pericarp, consisting of the epidermis, cuticle, cross-cell layer, 
and tube-cell layer ; the seed coat consisting of the testa, 
tegumen and pigment cells ; the hyaline layer and the aleurone 
layer. Together these layers represent 11-16% of whole wheat. The 
composition of bran is - cellulose 21%, pentosan 20 - 26%, starch 
7.5 - 9%» sugar 5%, protein 11 - 15%, fat 5 - 10%, ash 5 - 9% and
water 14%. The fatty acids are 84% unsaturated (mostly linoleic 
and oleic acid) and 16% saturated. The minerals are potassium, 
phosphorus, and magnesium. Other substances included are phytic
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acid and some vitamins.
Analysis - To date there is no one single procedure for measuring 
accurately and completely the dietary fibre content of mixed diets. 
Limitations of the crude fibre method are realised and it is 
gradually being replaced by more informative analytical procedures. 
The limitations presented by this method are due in part to its 
highly ' empirical nature, its poor reproducibility and the 
time-consuming procedure. A portion of the cellulose is known to 
be solubilised during the acid and alkali treatment and removal of 
some of the lignin during the preliminary solvent extraction is 
known to occur (Hallab and Epps,1963)• It has been estimated that 
the method gives recoveries of 50 - 80% of the cellulose, 10 - 50%
of the lignin, and 2.0% of the hemicelluloses.
Since the late 1930’s two main streams concerned with dietary 
fibre analysis have developed - the fibre school, concerned with 
animal nutrition and the cell wall constituent school, concerned 
with human nutrition. A third major area of interest, the 
chemistry of the plant cell wall has improved our knowledge of the 
structural components of the plant cell wall.
From the fibre school the methods of Van Soest have developed 
for acid detergent fibre (ADF), which is determined by refluxing 
samples with 2% cetyl trimethyl ammonium bromide in sulphuric acid, 
filtering, drying and weighing, and neutral detergent fibre (NDF), 
which is determined by refluxing samples with a 5% solution of hot 
detergent, filtering, drying and weighing. ADF gives an accurate
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measure of the cellulose and lignin content - in forage, and NDF 
gives a measure of the total cell wall materials (Van Soest,1963? 
Van Soest,1963a). Problems are encountered when these methods are 
applied to human diets since the fibre content is considerably 
smaller than in animal feeds and makes precision difficult. The 
high level of lipid in a mixed diet causes problems with foaming 
and filtration, and insolubility of some starch in the hot 
detergent, and loss of some water-soluble polysaccharides.
The method developed from the cell wall-constituent school is 
that of Southgate (1969,1969a) which measures the various 
components of the unavailable carbohydrate fraction by a series of 
extraction and hydrolysis stages to separate cellulose from 
non-cellulosic polysaccharides, followed by splitting of the 
components into constituent sugars which are then determined by 
quantitative chromatography, ion-exchange chromatography, or 
gas-liquid chromatography. This gives values for the 
non-cellulosic polysaccharides in two fractions - those that are 
water-soluble and hydrolysable with dilute acid, and the others are 
the cellulose and associated non-cellulosic pentosans and lignins. 
Measurement of the component sugars gives some indications of the 
types of polysaccharide present.
Procedures developed from concern with plant-cell-wall 
chemistry are research-oriented, lengthy and not applicable to 
routine analysis. However, they are the most detailed methods 
available (Southgate,1976).
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Much current research in the field of dietary fibre has led 
to the general conclusion that more detailed knowledge is required 
of the composition of dietary fibre in order to explain its 
specific physiological effects. Hence as much information as 
possible is required at the stage of analysis, although these tend 
to be the more lengthy and complex procedures.
Physical Properties
Water Holding Capacity - This is determined by the chemical and 
physical composition of fibre and the surrounding medium. The 
presence of polar groups on the polysaccharides increases the 
hydration capacity and intermolecular bonding. Generally 
hemicelluloses have a greater capacity to hold water than 
cellulose, and lignin has even less. Particle size is an important 
determining factor. More moisture is retained in the interstitial 
spaces of large particles than small particles (Kirwan et al,1974)» 
The part of the plant from which the fibre material comes also 
influences the ability to hydrate, leaves and roots having a 
greater water holding capacity than seeds and tubers. Bran is one 
of the most hydratable materials and is effective in retaining 
water in physiological conditions (McConnell et al,1974)»
Adsorption - Some types of dietary fibre adsorb organic materials 
such as bile acids, bile salts and bacteria. Eastwood and Hamilton 
(1968) found sterol adsorption to be pH dependent and possibly to 
•occur by hydrophobic bonding between lignin and sterol molecules. 
Pectins (Kay and Truswell,1977) and guar gum have also been shown 
to bind bile acids. ■ Such binding leads to increased excretion. 
Bile acid adsorption is dependent upon the physical and chemical
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form of the fibre, the pH and osmolality of the intestinal 
contents, and thé type of bile acid (Eastwood and Mowbray,1976). 
Cellulose is less effective at adsorbing bile acids than the 
mucilaginous and gel-forming fibres, but lignin has the greatest 
capacity, particularly in acidic conditions, when conjugation of 
the hydroxyl groups is suppressed (Eastwood and Mowbray,1976). 
Free bile acids are more readily bound than conjugates and the 
dihydroxy-bile acids more readily than the trihydroxy-bile acids. 
The presence of short chain, unsaturated fatty acids in bile acid 
micelles decreases their adsorption (Eastwood and Mowbray,1976). 
Cation Exchange Properties - Most plant fibres act as weak 
monofunctional ion-exchange resins, although those of cereals and 
tubers may behave as polyfunctional exchange resins. This action 
is related to the number of free carboxyl groups on the sugar 
residues (McConnell et al,1974). For example, binding of
calcium by dietary fibre is related to the presence of 
unsubstituted uronic acid groupings (Branch et al,1975)* Such in 
vitro studies suggest that mineral adsorption may be altered by the 
ingestion of dietary fibres.
Physiological Effects of Dietary Fibre
Digestibility - Although by definition dietary fibre is resistant 
to digestion by the alimentary enzymes in humans, it is susceptible 
to degradation by bacterial action in the colon. There is 
variation between individuals and the components of dietary fibre 
are affected to differing extents - 29-82$ of cellulose, 56-87$ of 
hemicellulose (Southgate et al,1976; Southgate â Durnin,1970; 
Milton-Thompson & Lewis,1971), and 90$ of pectin (Cummings et
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al,1979) are lost in the gut. Lignin is highly resistant to 
bacterial enzymic action and is completely recovered in the stool 
(Southgate et al,1976; Southgate and Durnin,1970). The extent of 
breakdown is dependent upon the colonic transit time, the colonic 
bacterial flora and the composition of the fibre. Vegetable cell 
walls are generally more easily fermented than cereal brans which 
are thicker and more highly lignified. Wheat bran is one of the 
most resistant of the dietary components (Van Soest and 
Robertson,1976), with faecal recovery greater than 70#. Methane, 
carbon dioxide, hydrogen,water and short chain fatty acids (acetic, 
lactic, propionic and butyric acids) are produced as a result of 
fermentation. Hence in vitro actions of fibre may be eliminated as 
a result of degradation of fibre and the products of fermentation 
may be responsible for some of the effects of dietary fibre.
Transit Time - The most immediate results of a higher intake of
dietary fibre are an increase in faecal weight with a decrease in
transit time, which shows logarithmic correlation of transit time 
to faecal weight (Burkitt et al,1974). Above a certain weight, the 
critical faecal weight, further increases do not affect the transit 
time significantly (Spiller et al,1978), which may partly account 
for conflicting reports of increased fibre intakes and their effect 
on transit time (Hill,1974)•
The mechanism by which fibre increases faecal weight; was
generally believed to be due to its water holding properties
(McConnell et al,1974)* However Stephen and Cummings (1979) showed 
the relationship between in vitro water holding and in vivo faecal 
bulking to be an inverse one. They found, for those fibres that
— 13 —
are digested in the colon, an increase in "bacterial mass to cause 
the increase in faecal weight (Stephen,1981).
Bacteria - Dietary fibre*’ can affect the metabolic activity of the 
gut flora by three mechanisms. The first is the effect of fibre on 
substrate concentration which depends on the sequestering ability, 
extent of gel-formation and to what extent the fibre is fermented. 
The second is the effect on enzyme action which relates to its 
effect on transit time so that when transit time is shortened, 
little metabolism can take place. The third is the effect of 
breakdown products of fibre on enzyme activity. When dietary fibre 
is rapidly fermented the local concentration of short chain fatty 
acids will increase sufficiently to cause a fall in pH. Bacterial 
enzymes which metabolise steroids have pH optima close to 7» 
Intestinal Absorption - Higher intakes of dietary fibre have been 
shown to slow gastric filling (McCance et__al_, 1953; Haber et 
al,1977), which may result in slower intestinal absorption; 
subsequent glucose and insulin responses will also be slower. 
Various studies have shown higher intakes of dietary fibre to 
prolong gastric transit time (Holt et al,1979; Wilmshurst and 
Crawley,1980). The rate and extent of small intestinal absorption 
is determined by the rate of passage of contents and the degree of 
mixing. It is only possible to use indirect methods of study in 
man. Measurement of hydrogen in the breath, from caecal flora 
metabolism, can be used as a marker of the arrival of the front of 
a meal at the terminal ileum (Jenkins et al,1978). Using this 
technique it has been demonstrated that guar gum delays small 
intestinal transit time, pectin and methylcellulose have no effect, 
and gum tragacanth and wheat bran have an intermediate effect
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(Jenkins et al,1978).
In vitro studies have shown glucose, . maltose and 
oligosaccharides to be released more slowly from cooked ground soya
beans than from wholemeal bread, and lentils to have an
intermediate effect (Jenkins et al,1980). This may be partly due 
to different rates of enzymic action, but mostly to trapping of 
products in the interstices of the food. These results were 
consistent with blood glucose reponses when fed to healthy 
volunteers, indicating different rates of digestion depending on 
the type of food. An in vitro study of the rate of hydrolysis of 
starch in cereal foods has shown that stoneground wholemeal flour 
is hydrolysed more slowly 'than white flour; cooking made the 
starch more readily available for enzyme hydrolysis and fibre
exerted an inhibitory effect by forming a physical barrier to limit 
access of the hydrolytic enzymes to the starch (Snow and 
0‘Dea,1981).
An increase in the proportion of goblet cells in the duodenum 
and colon of rats fed 20$ wheat bran has been reported (Schneeman
et al,1982), indicating a higher production of mucus. Mucus is 
believed to contribute to the thickness of the unstirred layer in 
the intestine (Nimmerfall and Rosenthaler,1980) which in greater 
quantities may reduce the absorption rate, especially of 
lipid-soluble compounds (Thompson,1978).
Bioavailability - Reports of decreased bioavailability of minerals 
resulting in negative mineral balances by increased intakes of 
dietary fibre are numerous. Reviews of the effect of fibre on
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iron, zinc and copper balances (Kelsay,1981), and on calcium, 
magnesium and phosphor us balances in humans (Kelsay,1982) have 
recently been published. Important considerations when assessing 
the effect, of fibre on mineral balance are the type and level of 
dietary fibre, the level of mineral intake, the time of feeding and 
the presence of mineral binding agents other than dietary fibre 
e.g. phytic acid.
Carotene appears to be bound by the plant cell wall fraction, 
decreasing its bioavailability in human subjects (Kelsay,1982). 
Gregory (1980) found low bioavailability of vitamin in cereals 
compared to non-fat dried milk. Vitamin B ^  bioavailabilty appears 
to be decreased by those dietary fibres that are digested by 
intestinal bacteria (Cullen and 0ace,1980). A study in rats of the 
effect of 10$ dietary pectin on plasma and red cell vitamin E 
concentrations, and tissue contents of vitamin E, showed that 
pectin reduced the bioavailability of vitamin E (De Lumen et 
al,1982).
A study of the effect of wheat and rice bran supplements (fed 
for 26 days, 20g/day), on protein utilisation in human female 
adults suggested a trend towards lowered protein utilisation when 
bran was incorporated into white bread; this was indicated by 
decreased urinary and increased faecal nitrogen excretion, although 
other parameters were not altered (Jank et al,1981). An animal 
study (Wojcik and Delorme,1982) showed a decreased efficiency of 
protein utilisation in rats consuming marginal protein and high 
cellulose (28.6$), compared to rats fed a cellulose-free control
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diet.
Hence it seems that interactions occur between all types of 
fibres and nutrients such as mineral salts, vitamins, and protein. 
In Western Society food intake is high and fibre intake 
comparatively low so that any potential adverse effects are not 
generally manifested. However these interactions could be of 
importance in developing countries, where traditional high fibre 
staple diets are associated with malnutrition, or in certain 
population groups of the Western countries.
Pancreatic Enzymes - Examination of the effects of dietary fibre on 
the upper gastro-intestinal tract has revealed that dietary fibre 
can alter metabolic parameters. Schneemann et al (1982) found that 
a 20$ wheat bran diet fed to rats for 2 wk increased amylase and 
trypsin activities in the pancreas compared with a fibre-free diet; 
in the intestinal contents only lipase activity was elevated. 
Isaksson et al (1982), using an in vitro buffer system or human 
duodenal juice, determined the effects of various fibres on the 
pancreatic enzymes. They found that pectin, guar gum, and wheat 
bran caused a marked decrease in amylase and lipase activities, 
that pectins and wheat bran reduced trypsin activity and that 
pectins reduced phospholipase activity. The effects of fibre on 
enzyme activities were greater in the duodenal juice than in the 
buffer solutions. These studies are not directly comparable, since 
they use different species, but . the results are not necessarily 
contradictory, as Schneeman et al (1982) measured the enzymes at 
their site of production and Isaksson et al (1982) were measuring 
enzyme activity after production.
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Fibre in Human Disease
Colorectal Cancer - "Epidemiological data indicates that the 
incidence of colon cancer is determined by environmental rather 
than genetic factors. The aetiology of the disease is thought to 
be multi-factorial and diet to be of major importance in its 
causation (Burkitt, 1978; Sherlock et al,1980). Colorectal cancer 
has been shown to correlate positively with meat and fat 
consumption and negatively with dietary fibre consumption 
(Burkitt,1978). However no single dietary component has been 
identified as causing colon cancer ao that the relationship is 
complex.
None of the preformed carcinogens present in the diet has 
been shown to be related to colon cancer (Hill,1982). Bacterial 
metabolism in the colon was postulated as a mechanism of production 
of the carcinogenic molecule (Aries et al,1969; Hill et al,1971)« 
The composition of the diet would determine the amount of substrate 
available. Numerous substrates have been investigated (Hill,1977) 
and the bile acids have been implicated to be possible 
precarcinogens. Their faecal concentration correlates with dietary 
fat (Cummings et al,1978), and inversely with dietary cereal fibre 
(Cummings et al,1976), and they are structurally related to the 
cyclopenta(c<)phenanthrenes, a known group of carcinogens (Coombs 
and Croft,1973).
The two major hypotheses af colon cancer are based on dietary 
fibre deficiency (Burkitt,1971) and high dietary fat consumption
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(Hill,1975)• The role of dietary fibre in reducing colon cancer is 
related to a more rapid transit of gut contents decreasing the 
opportunity for bacteria to produce carcinogenic metabolites, and 
for any such metabolites to act on the colon wall. However the 
correlation between colon cancer and dietary fibre intake from 
epidemiological data is poor (Irving and Drasar,1973; Hill,1974). 
The dietary fat hypothesis is related to facilitated growth of 
intestinal bacteria (when a high fat diet is consumed), which are 
capable of converting dihydroxy bile acids to carcinogenic 
polynuclear hydrocarbons (Hill,1975).
A decrease in colonic mucosal exposure is a necessary outcome 
of the dietary fibre hypothesis for protecting against colon 
cancer. This could occur by dilution due to chemical binding, 
water-holding and stool-bulking, shortened colonic transit time, 
modification of bile acid and of faecal flora metabolisms 
(Gori,1979). The addition of 32g of dietary wheat bran per day 
increased the total faecal bile acid excretion, but when expressed 
as a concentration, bile acid was lower than in the control period 
(Cummings et al,1976). Studies of the influence of dietary fibre 
on bile acid excretion show conflicting results (Story and 
Kritchevsky,1980). However, dietary fibre can affect the bile salt 
pools in the colon, ileum and jejunum (Story and Kritchevsky,1978). 
Ullrich et al (1981) found high fibre diets to produce no change in 
human neutral faecal steroids (cholesterol and coprostanol) and 
total steroids, with a marked increase in primary bile acids 
(chenodeoxycholic and cholic acids) and a decrease in secondary 
bile acids (lithocholic and deoxycholic acids). These results were
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in agreement with suggestions of other workers (Kritchevsky et 
al,1974) that binding of bile acids to fibre decreases their 
conversion to primary and secondary forms and increases faecal 
steroid excretion.
A positive correlation of colorectal cancer incidence and 
faecal deoxycholic acid levels has been reported (Hill,1979; Mower 
et al,1979)« This secondary bile acid is produced by the action of 
bacterial 7#-dehydroxylase on cholic acid and the faecal activity 
of this enzyme was found to be higher in colorectal cancer patients 
than controls (Mastromarino et al,1976).
The influence of dietary manipulations on the faecal 
micro-flora shows that diet does not alter the composition of the 
faecal micro-flora (Finegold and Sutter,1978). Neither fibre-free 
or fibre-supplemented diets were found to alter the major groups of 
bacteria (Bornside,1978). However, diet has been shown to alter 
the metabolic activity of the faecal micro-flora.
Studies using animal models have shown that dietary fibre 
protects against the effects of administration of known chemical 
carcinogens (Freeman et al, 1.978, Reddy and Mori, 1981). Citrus pulp 
and wheat bran have been shown to bind dimethylhydrazine (DMH; a 
known chemical carcinogen which requires metabolic activation) at 
the pH of the stomach and small intestine and to increase faecal 
bulk (Smith-Barbaro et al,1981a). This decreases the amount of 
carcinogen coming into contact with the colonic mucosa, which may 
account for the decreased number of tumours observed in these
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groups. These authors have also shown that certain dietary fibres 
can affect the levels of hepatic, small and large intestinal 
cytochromes P450 and b^, which may partly account for the decreased 
number of tumours observed. Such an approach is useful for 
investigating mechanisms of carcinogenesis and interactions of 
carcinogens with dietary fibres, but their relevance to human 
studies is not clear.
The fundamental question of whether dietary fibre protects 
against human colon cancer is debatable. Much investigation of the 
hypothesis of Burkitt (1971) has produced greater understanding of 
effects of dietary fibre, but conclusive proof of the hypothesis is 
still awaited. However, the hypothesis has not been disproved and 
neither has it been superseded.
Coronary Heart Disease - The protective role of dietary fibre 
against this disease is possibly related to the effect of some 
types of dietary fibre in lowering serum cholesterol and blood 
lipid levels. Clinical studies in human subjects have shown 
various legumes (Luyken et al,1962), oats (de Groot et al,19^5; 
Judd and Truswell,1981), and vegetables (Grande et al,1965) to be 
effective in decreasing serum cholesterol levels, whereas wheat 
bran has been found to be ineffective (Truswell and Kay,1975; Kay 
and Truswell,1977a). The mucilaginous and gel-forming 
polysaccharides appear to be the most effective in decreasing serum
cholesterol levels. Jenkins et al_ (1975a) found guar gum and
pectin to decrease serum cholesterol and wheat fibre to slightly 
increase it. Other studies have shown conflicting results 
(Durrington et al,1976), but it is now generally agreed that bran
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has no hypolipidaemic effect whereas pectin lowers serum 
cholesterol concentrations.
The major mechanism thought to be responsible for the 
hypocholesterolaemic effect of some dietary fibres is the binding 
of bile acids in the intestine, with interruption of their 
enterohepatic cycle leading to increased faecal excretion. The 
adsorption of bile salts and acids by dietary fibres may result in 
decreased micellar formation, thus affecting cholesterol 
absorption. An increase in bile acid excretion would cause 
increased synthesis to make up this loss. Both events would 
deplete cholesterol pools (Story and Kritchevsky,1976).
Diverticular Disease - This concerns the presence of saccular 
outpouchings of the sigmoid colonic wall often with a thickened 
corrugated bowel wall. Uncomplicated diverticulosis may be
symptomless, but when inflammatory reactions develop this results 
in abdominal pain and vomiting. Epidemiological data correlates 
low-fibre diets with an increased prevalence of the disease, 
although its aetiology is unknown. Prolonged transit times, low 
stool weights and increased colonic pressures are thought to be the 
relevant associated factors. Painter and Burkitt (1971) suggested 
that fibre supplements!; in the form of bran should alleviate the 
symptoms, rather than low fibre diets which were the treatment at 
that time. Some studies have shown this to be the case 
(Kelsay,1978) although other studies have reported no effect on 
transit time (Brodribb and Humphreys,1976). Results of studies 
aimed at demonstrating a causal relationship between disturbances
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of colonic motility and the development of diverticulosis are 
inconclusive (Eastwood et al,1978). As treatment of the disease 
with high fibre diets has progressed the number of operations for 
uncomplicated diverticular disease has markedly decreased 
(Anon.,1978).
Diabetes - The effects of delayed gastric emptying and slowed 
intestinal absorption manifested by some types of fibre have been 
demonstrated to be effective treatments in the management of some 
diabetics (Jenkins et_al,1976).
Obesity - Heaton (1973) has suggested that high fibre intakes may 
be helpful in the management of obesity by decreasing food intake 
of the . absorption of nutrients. Titcomb (1976) found a reducing 
diet containing large amounts of high fibre bread to promote 
satiety and to facilitate weight loss. The extent to which fibre 
may decrease energy availability is unclear. A supplementation of 
38g/day of bran in the form of biscuits was found to increase the 
daily faecal energy loss by 20-95 calories per day (Southgate et 
al,1976).
The Metabolism of Drugs and Environmental Chemicals
Introduction - The effect of foreign compounds on the body and on 
the defence mechanisms of an organism is also the subject of much 
scientific research with a view to establishing the causation of 
cancer and other diseases. Organisms have lived for millions of 
years in a hostile environment. In our present industrial society 
hostility is increased by exposure to a vast array of man-made
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Chemical pollutants such as pesticides, food additives, drugs, 
detergents and plastics which may become distributed into the air, 
water and soil, may damage plant and animal life, and may have 
direct effects on the health of man. Foreign compounds are neither 
utilised for energy production or maintenance of tissues or body 
functions and are potentially dangerous to the body, which has a 
biochemical defence mechanism to protect against their harmful 
effects. The metabolism of such compounds is generally directed 
towards detoxication and excretion which is achieved by two series 
of reactions (Williams,1971)• Phase I reactions
(biotransformations) are asynthetic and introduce or unmask 
functional groups. Phase II reactions (conjugations) are energy 
requiring and synthetic, coupling the existing or newly introduced 
functional groups.to polar molecules and forming more polar, easily 
excretable compounds.
Phase I Metabolism - Phase I reactions are catalysed primarily by 
the mixed-function oxidase enzyme system located in the endoplasmic 
reticulum of certain tissues. The liver is the major site and 
exhibits high activity; lung, skin, gastro-intestinal mucosa, 
colonic mucosa, kidneys and adrenals are the other sites of 
activity. The enzyme system is multi-component, comprising a 
phospholipid - phosphatidylcholine, a flavoprotein reductase - 
NADPH cytochrome P450 reductase, and a haemoprotein - cytochrome 
P450 (Lu and Coon,1968). The occurrence of cytochrome P450, a 
pigment producing a Soret peak at 450nm when complexed in reduced 
form with carbon monoxide, was reported independently by Klingberg 
(1958), and Garfinkel (1958). The studies of Omura and Sato
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(1964,1964a) revealed its haemoprotein nature and its "basic 
properties. Its role as the site of oxygen .activation and as the 
terminal oxidase for steroid hydroxylation (Estabrook et al,1960) 
and drug oxidation (Cooper et al,1965) was soon determined. The 
unknown significance of NADPH cytochrome C reductase, discovered in 
1950 (Hogeboom and Schneider,1950) was elucidated when steroid and 
drug oxidations were shown to be NADPH dependent. Its role in 
reduction of cytochrome P450 was finally shown after purification 
of the enzyme system (Lu and Coon,1968).
Cytochrome P450 is widespread throughout the plant and animal 
kingdom. In addition to its role in xenobiotic and steroid 
metabolism it hydroxylates many endogenous substrates in 
intermediary metabolism: biosynthesis of prostaglandins,
thromboxanes and prostacyclins, synthesis of cholesterol and its 
degradation to bile acids, corticosteroid and sex hormone 
metabolism, «-hydroxylation of fatty acids, and regulation of 
carbohydrate metabolism. Cytochrome P450 has a molecular weight of 
45-6OK and belongs to the b class of cytochromes containing 
protohaem, the iron complex of protoporphyrin, as its prosthetic 
group (Omura and Sato,1964). This lies centrally in the porphyrin 
nucleus with the nitrogen atoms occupying four of the co-ordination 
valencies in a plane and separating the fifth and sixth ligands 
which are available for binding two axial ligands of either the 
apoprotein or of other molecules e.g. oxygen or carbon monoxide. 
The fifth ligand is currently thought to be a form of sulphur, 
possibly a cysteine residue from the apoprotein (Mason et al,1965  ^
Jefcoate and Gaylor,1969? Ojaki et al,1978). The nature of the
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sixth ligand and co-ordination site where molecular oxygen binds 
and is activated is uncertain.
In its oxidised form in vitro the haemoprotein binds with 
substrates to give two different types of spectra. Many lipophilic 
compounds produce a spectral change with a peak at 385nm and a 
trough at 420nm (type I spectra). Several lipophilic 
nitrogen-containing species e.g. aniline, produce a spectra with a 
peak at 430nm and a trough at 595nm (type II spectra). Reverse 
type I spectra have a peak at 415-420nm and a trough at 390nm. 
These spectral changes indicate different interactions between 
substrate and haemoprotein, and modification of the spin state of 
the haem iron. Cytochromes exist in either a low spin or a high 
spin state, determined by the position of the five 3d electrons in
the ferric ion. Maximal pairing gives a low-spin state and maximal 
separation a high-spin state. In the microsomal membrane about 50$
of cytochrome P450 exists in the high spin form. Type I spectral
changes are produced by a hydrophobic interaction with a
hydrocarbon residue of the apoprotein (Yoshida and Kumaoka,1975), 
with a change from a low spin state of the haem iron with loss of 
the endogenous sixth ligand. Type II compounds interact directly 
with the haem iron at the sixth ligand (Yoshida and Kumaoka,1975) 
and cause conversion from the high to the low spin state of the 
haem iron. The interaction is by hydrophobic forces and requires 
provision of an atom with a free electron pair for the sixth 
co-ordination site so that it remains in a low spin state.
The enzyme cycle of cytochrome P450 is shown in Fig.1. The
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substrate sterically binds to the oxidised form of cytochrome P450 
and the change in spin state and associated increase in redox 
potential facilitates the following reduction of the haem iron by 
an electron from NADPH cytochrome P450 reductase. Dioxygen 
combines with this complex and a second electron is inserted, 
resulting in an unstable intermediate which decomposes and loses 
water and allows insertion of active oxygen into the substrate 
resulting in the monooxygenated product and oxidised low-spin 
ferric haemoprotein.
There are two theories of the mechanism of oxygen insertion. 
It may be via an oxene intermediate, which directly inserts oxygen 
into the C-C bond, or via an acylated ferrous-oxy intermediate such 
that the ultimate hydroxyDating species is a peracid. The reducing 
equivalents are both provided by reduced pyridine nucleotides 
(NADPH and NADH). Flavoproteins transduce the electron flow so 
that one electron at a time is inserted. NADPH is the preferred 
source of reducing equivalents (Sato et_al_, 1965) • Addition of NADH 
to a drug oxidation system supported by NADPH often results in 
"NADH synergism" i.e. a more than additive increase. 
NADH-Cytochrome b5 reductase and cytochrome be are thought to be 
involved in transfer of the second electron (West et al,1974î 
Cohen and Estabrook,1971i Cohen and Estabrook,1971a).
The first electron reduction step is rate-limiting in the 
overall cycle for most substrates (Holtzman et al,1968; Davies e_t 
al,1969). The operation of the cycle is generally tightly coupled 
to oxygenation of the substrate, although a small degree of
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uncoupling occurs with some relatively good substrates (Hildebrandt 
et al,1975)«
This enzyme system is the most versatile known as it can 
accept as substrates organic chemicals of exogenous and endogenous 
origin and of widely differing molecular weight and chemical 
structure. The reactions catalysed vary considerably and include 
aromatic and aliphatic hydroxylation, oxidative deamination, N-, S- 
and O-dealkylation, arene oxide formation, desulphuration, 
N-hydroxylation, N- and 8-oxidation and dechlorination. Compounds 
thus metabolized may be excreted in urine or bile, or further 
metabolized.
Phase II Metabolism - Foreign compounds with polar groups and 
products of phase I metabolism may be conjugated with glutathione, 
glycine, acetate (acetyl CoA), glucuronic acid (uridine 
diphosphoglucuronic acid), sulphate (3 '-phosphoadenosine
5 '-phosphosulphate) and methyl (Ç-adenosyl-methionine). The 
endogenous component is usually activated but in some cases the 
foreign compound/phase I metabolite may possess the energy. Each 
compound with a polar group may be conjugated with one or more of 
the endogenous substances. This occurs by the action of 
transferase enzymes located in the microsomes, mitochondria or 
soluble fraction of the cell. There is often a multiplicity of 
transferases for each endogenous substance, each with its own 
substrate specificity. A diversity of metabolites for a given 
compound is thus possible.
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Formation of Reactive Intermediates - In addition to detoxication 
reactions both phase I and phase II reactions participate in the 
formation of reactive intermediates which can covalently bind to 
the tissue macromolecules and lead to toxicity, mutagenicity and/or 
carcinogenicity. Biotransformations which result in activated 
metabolites generally involve hydroxylation at sterically hindered 
positions (bay regions) resulting in unacceptable compounds for 
further enzymic detoxication (Parke and loannides,1982). Such 
intermediates may exist as free radicals or interact with 
endogenous molecules or function as radical generators by 
interacting with molecular oxygen and other small molecules 
(Parke,1981). Metabolism with cytochrome P450 may result in the 
formation of carbenes which form stable ligand complexes with 
cytochrome P450 e.g. methylenedioxyaryl compounds such as safrole. 
Hence, metabolism by microsomal mixed-function oxidases may result 
in detoxication, activation and formation of carbene complexes with 
cytochrome P450 following activation (Parke,1981).
Enzyme Induction - Pretreatment of experimental animals with 
certain compounds was shown to induce liver microsomal enzyme 
activity (Brown et al,1954). A variety of stRicturally unrelated 
compounds are now known to induce the activity of mixed-function 
oxidases. The most potent inducers are barbiturate drugs, 
chlorinated hydrocarbons, insecticides and carcinogenic polycyclic 
hydrocarbons (Kupfer,1970). Their only common property is their 
degree of lipophilicity (Parke,1976). True enzyme induction 
results from de novo protein synthesis (Conney,1967)• Stimulation 
as distinct from induction may occur in vivo and in vitro, but only
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for certain enzyme activities. Examples are biphenyl 2-hydroxylase 
(McPherson et al,1974) and UDP-glucuronyltransferase (¥isnes,1971). 
The consequences of induction are accelerated biotransformations 
and increased turnover of endogenous substances. Recently it has
been demonstrated that both phenobarbitone and 3-methylcholanthrene
is
increaseidue to de novo protein synthesis of cytochrome P-450 
species. The total mRNA isolate from liver of a
phenobarbitone-treated rat, when translated in vitro contained more 
protein than was immuno-precipitable with antibodies to 
phenobarbitone induced P-450 than liver from control animals 
(Colbert et__al, 1979; Dubois & Waterman, 1979) • However in most 
cases the stimulation of a particular enzyme activity by
3-methylcholanthrene or phenobarbitone has not rigorously been 
shown to be de novo protein synthesis.
Multiple Enzyme Forms - Pretreatment of animals with various 
inducers is known to produce differential effects on mixed-function 
oxidase enzyme activities, indicating the presence of multiple 
forms of cytochrome P450. The isozymes are characteristic of the 
particular tissue and animal species. After pretreatment with an 
inducer the forms are isolated, solubilised, purified and 
characterised by their immunological and physicochemical 
properties, their enzyme specificities, kinetics, and amino-acid 
sequences (Guengerich,1979)• The isozymes have different but 
overlapping substrate specificities (Guengerich,1979)> such that 
different forms of cytochrome P450 may metabolise a given substrate 
at comparable rates, but metabolise other substrates at vastly 
different rates; the enzyme variants of P450 have essentially the
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same enzyme active site (Parke and loannides,1982 ; Dus,1982)# 
Although 11 forms of cytochrome P450 in untreated rabbit liver 
microsomes were recently reported, only 6-8 forms have been 
adequately isolated and characterized from rat and rabbit liver, to 
be defined as distinct forms (Lu and West,1978). However, it has 
been suggested that any individual mammal may have the capacity to 
produce thousands of unique cytochrome P450 haemoproteins (Nebert 
and Negishi,1982).
Comparison of the inducing effects of phenobarbitone and 
3-me thylcholan threne (Conney,1967) shows phenobarbitone to
stimulate a larger number of drug metabolizing pathways than
3-methylcholanthrene (Lu et al 1976). Where substrates e.g. 
biphenyl, can be oxidised in a variety of positions the ratio of 
different hydroxylated products is altered by pretreatment with 
either inducer (Creaven and Parke,1966). Phenobarbitone stimulates
4-hydroxylation of biphenyl, whereas 3-methylcholanthrene increases 
both 4- and 2-hydroxylation. Phenobarbitone does not cause an 
alteration in the wavelength of maximum absorption, whereas
3-me thy1cholan threne causes the absorption maximum to decrease to
448nm (Alvares et al,1967), for which reason the
3-methylcholanthrene form is known as cytochrome P448. This form 
is more distinct than other forms (Parke and loannides,1982), as it 
exists naturally in the high-spin state, is induced by chemical 
carcinogens and is found in malignant cells, foetal and neonatal 
tissues. It is able to insert oxygen into bay regions and is 
therefore associated with production of reactive intermediates.
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The physiological significance of multiple forms of 
cytochrome P450 lies in the potential for differing metabolisms. 
Differences in substrate specificity, regiospecificity and 
stereospecificity allow for activation or deactivation of a given 
chemical, which will determine the cytotoxic and carcinogenic 
action of a compound (Lu,1979). Their clinical significance is 
important in - polypharmacy and drug interactions; their 
significance in intermediary metabolism is in determining balances 
of the metabolic pathways; the differences in mixed-function 
oxidase activities between species, strains and individuals of 
different sex or age may be explained by multiple forms.
Physiological Factors Affecting Drug Metabolism
Species Differences - Differences in foreign compound metabolism 
occur between species due to genetic and environmental factors. 
Similarly different strains within a species, and individuals show 
genetically controlled differences (Evans et al,1960).
Age - Foetal and newborn animals have a decreased ability to 
metabolise foreign compounds (Pouts and Adamson,1959), and older 
rats show qualitative changes (Rikans and Motley,1981) and 
generally slower rates of foreign compound metabolism, which is 
thought to be related to changes in the fatty acid composition of 
microsomal phospholipids (Rikans and Motley,1981a).
Sex - Male rats generally have higher rates of foreign compound 
metabolism than female rats which is attributed to the anabolic 
action of androgens (Kato and Onoda,1970) and to the presence of 
different amounts of one or more of the major forms of cytochrome 
P450 in the liver microsomes of male and female rats (Kamataki et.
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al,1982). No sex difference is apparent for drug metabolizing 
enzymes, cytochrome P450 content and NADPH linked electron 
transport system of liver microsomes of rabbits, mice (although sex 
differences have been reported in certain strains), guinea pigs and 
hamsters (Kato,1974). The magnitude of sex difference in the rat 
depends on the substrate used (Kato and Gillette,1965). 
Hexobarbital hydroxylation, aminopyrine N-demethylation and 
pentobarbital oxidation are markedly sex dependent whereas aniline 
hydroxylation and zoxazolamine hydroxylation are less or are not 
sex dependent. N-Demethylation of N-methylaniline and 
p-nitroanisole are intermediate.
Nutritional Status - Foreign compound metabolism is sensitive to 
nutritional imbalances which are a major physiological factor in 
determining the body's metabolic reaction to a toxic compound. A 
brief review is now presented of the effect of the major nutrients 
on foreign compound metabolism.
Starvation - is frequently a prerequisite of chemotherapy or may 
ensue in pathological states. Kato and Gillette (1965) showed that 
starvation in male rats impairs only those enzymes that are largely 
sex-dependent, whilst in female rats these enzyme activities are 
increased by starvation. Subsequent work showed that starvation 
may interfere with the stimulatory effects of androgenic steroids 
in male rats whilst in female rats they may be due to slight 
increases in cytochrome P45Q content and activity of the 
NADPH-1inked electron transport system in liver microsomes (Kato 
and Onoda,1970). Similar sex differences in response to starvation 
were reported by Gram et al (1970)• Hepatic glucuronide 
conjugation of chloramphenicol was decreased in vivo by 1 8 - 2 4
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hours fasting in male rats (Alvin and Dixit,1974). Starvation 
markedly reduces the activity of mixed-function oxidases in the 
intestine (Wattenberg,1971 ), with decreased activity of 
glucuronyltransferase (Marselos and Laitinen,1975)•
Protein - microsomal oxidations are generally decreased by 
inadequate protein intakes (Mgbodile and Campbell,1972), with a 
concurrent decrease in hepatic microsomal protein and DMA 
concentrations. The liver cells tend to become larger and fewer in 
number (Campbell and Hayes,1976). Fractionation of the microsomes 
from weanling male rats maintained on a 5$ or 20% casein diet for 
10 days, followed by reconstitution of components from each group 
to allow an independent examination of each component to be made, 
revealed that there was no significant effect of protein depletion 
on the phosphatidylcholine. The reductase and cytochrome P450 
fractions obtained from the 5% casein group did not reconstitute 
equivalent control values indicating that the reaction between 
these two components could be the primary mechanism responsible for 
the effect of inadequate dietary protein (Nerurkar et al,1978). 
The arrangement of components within the membrane was found to be 
more rigid in the protein depleted animals which would decrease 
translational mobility of the components (Campbell et al,1979). 
Conflicting reports on the effect of dietary protein deficiency on 
conjugation reactions (Woodcock & Wood,1971; Smith et al,1973) 
indicate that the effect may be species related and dependent on 
the extent of protein depletion.
Lipid - contributes 30 - A0% by dry weight to the endoplasmic
reticulum, most of which is phospholipid (Glaumann and 
Dallner,1968). Deprivation of dietary lipid results in changes in
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the content of microsomal phospholipid fatty acids and is 
associated with decreased metabolism of hexobarbital, aniline and 
ethylmorphine, and decreased content of cytochrome. P450. A 
fat-free diet does not affect the activity of NADPH cytochrome C 
reductase so that the defect.is at some stage beyond the initial 
oxidation of NADPH (Norred and Wade,1972). Both the quantity and 
composition of dietary lipid is important in determining oxidative 
déméthylation activities and cytochrome P450 levels (Rowe and 
Wills,1976). Compared to a fat free diet, the rate of oxidative 
déméthylation was higher with the addition of corn oil. A 
similar finding (Century,1969) suggests that an insufficient supply 
of polyunsaturated fatty acids is rate limiting for drug 
metabolism. However the effect was shown not to be an essential 
fatty acid deficiency (Marshall and McClean, 1971). Induction of 
cytochrome P450 in rat liver by phenobarbitone was found to be 
enhanced with increasing dietary concentration of highly 
unsaturated fatty acids (Marshall and McClean,1971a). This was 
described as a 'permissive effect* since oils in the absence of 
phenobarbitone are only weak inducers. Fatty acid hydroperoxides 
or similar oxidation products were shown to play an essential role 
in induction of drug metabolizing enzymes in the liver (McClean and 
Marshall,1971). The authors concluded that maximal induction of 
cytochrome P450 by phenobarbitone requires dietary peroxidised 
lipids. The content of lipid peroxide in rat hepatic endoplasmic 
reticulum and the rate of NADPH linked lipid peroxidation were 
found to be higher in rats fed 10% corn oil than 10% lard or a fat 
free diet (Rowe and Wills,1976).
Carbohydrate - Sucrose feeding for 24-72 hours in place of a normal
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chow diet, was found to decrease the activities of various 
mixed-function oxidases in male and female rats, together with a 
decrease in content of cytochromes P450 and b^, and NADPH 
cytochrome C reductase activity (Kato and Gillette,1964)• 
Similarly, Dickerson et al (1971) found a 60% sucrose or glucose 
plus fructose diet when fed to rats, to decrease the activity of 
biphenyl-4-hydroxylase which correlated with lower levels of 
cytochrome P450. Xylitol feeding increases the hepatic 
amino-pyrine-N~d erne thyla s e activity, in mice, thought to be related 
to the concurrent increase in NADH (Smith,1982).
Vegetarian Diets - A comparison of feeding a vegetarian and a meat 
diet in the long-term to male and female rats, on hepatic, small 
intestine and colonic mucosal mixed-function oxidases showed that 
meat diets increased hepatic benzo(a)pyrene hydroxylase and 
aminopyrine N-demethylase activities in male rats and the 
vegetarian diets increased the enzyme activities in female rats, 
abolishing the sex differences normally apparent in rats. The 
vegetarian diets were more effective in promoting large and small 
intestinal mixed-function oxidase activity in female rats than male 
rats. Protein and fat content of both diets were also varied but 
the source of the diet and sex of the animal were found to be more 
important determinants of mixed-function oxidase activities than 
the relative composition of fat and protein in "the diets (Martin et 
al,1980).
Drug-Nutrient Interactions - Diet and nutritional status are 
important in determining the body's reaction to foreign compounds 
and protection against harmful substances which may eventually or
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immediately, and directly or indirectly be the cause of disease and 
illness. As drugs are classed as foreign compounds and are 
metabolized by this enzyme system, diet and nutritional status will 
equally affect the body's metabolism of a particular drug which 
will determine its bioavailability and the extent of its action. 
Anutrients present in the diet can induce the mixed-function 
oxidases particularly in the gut mucosa, which may alter the 
metabolism of some drugs and foreign compounds. The particular 
items of food eaten will affect the rate of absorption of drugs and 
other foreign compounds by altering the pH and motility of the gut, 
the ionic concentration, and the ratio of water and solid phases. 
Other food and drug interactions may occur: drugs may increase the
toxicity of naturally occurring food substances by blocking 
specific metabolic pathways; chemical interactions between drugs 
and food components may lead to the production of toxic compounds; 
drugs may affect the gut flora and normal gut function; there may 
be synergistic effects between food components and drugs; drugs, 
especially when chronically administered, may lead to altered 
nutritional status, which in turn may lead to altered drug 
metabolism. For example, pellagra-like symptoms have been observed 
in patients treated with isoniazid (for tuberculosis) which 
disappear following combined treatment with niacin and pyridoxine 
(Dilorenzo,1967)• Isoniazid is a pyridoxine antagonist and causes 
isoniazid-pyridoxine-hydrazone to be excreted in the urine in 
amounts sufficient to deplete body stores of pyridoxal phosphate, 
the active form of the vitamin (Vilter,1964)• The availability of 
pyridoxine for synthesis of niacin from tryptophan is decreased, 
causing a secondary vitamin deficiency, that of niacin.
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Low serum and red cell folate levels, and occasionally overt 
megaloblastic anaemia, occur in the majority of patients receiving 
long-term anticonvulsant therapy with diphenylhydantoin, 
phénobarbital and primidone (Reynolds,1974)• Phenothiazines and 
tricyclics also induce biochemical evidence of folic acid
deficiency (Labadarios et al,1978). It has been suggested that
folic acid may be involved both as a coenzyme for drug metabolizing 
enzymes and in the synthesis of the enzymes themselves (Labadarios 
et al,1978). Long term feeding to rats of anticonvulsant drugs in 
conjunction with a folate deficient diet was associated with 
impaired induction of cytochrome P450 (Labadarios,1975)• Hence 
chronic administration of any enzyme inducing drug would be 
increasingly likely to cause folate deficiency and consequently 
increased toxicity. The administration of folic acid to epileptics 
has been reported to aggravate their condition and disturb drug
control of seizures, so that administration of folic acid 
supplements.for therapeutic or prophylactic reasons remains
controversial. This interesting drug-nutrient interaction is 
further investigated in Chapter Six.
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AIMS
The aims of this study were:
1) To determine whether wheat hran is ahle to alter metabolic 
response, particularly of the mixed-function oxidase enzyme system 
of the liver and intestine, which may be related to its possible 
role in protecting the body from various diseases. Studies were 
designed to investigate more than one dietary level of bran and 
feeding periods were short-and long-term.
2) To determine the effect of bran on a physiological mechanism of 
protection against potential toxic insult i.e. the 
gas tro-intes tinal mucous barrier. Studies were designed to 
investigate more than one dietary level of bran and the effects of 
short- and long-term feeding.
3) To determine the effect of bran on the status of other nutrients 
: by measurement of the bone stores of minerals and circulating
levels of 25-hydroxyvitamin Dj.
4) To investigate the role of folic acid deficiency on drug-induced 
enzyme induction. Folic acid deficiency has been postulated as the 
cause of adverse reactions to anticonvulsant drugs after long-term 
therapy in epileptic patients. This interaction was further 
investigated.
-  4 U  -
Chapter Two
The Effect of Dietary Modification on the 
Hepatic Drug Metabolizing System in the Rat.
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Introduction
The primary importance of diet in the aetiology of colon 
cancer is implicated by epidemiological evidence which shows an 
association in areas of high incidence with consumption of a high 
fat and a low fibre diet (Burkitt,1971)• The possible protective 
role of fibre against colon cancer is partly attributable to its 
physical action in the gut. The demonstration of a decreased 
incidence of chemically induced colon cancer by certain dietary 
fibres and isolated components in animal models has given a more 
positive indication of its protective action (Wilson et al,1977; 
Wantabe et al,1978). Further experiments with rats and mice have 
shown that dietary fibre protects against the toxic action of 
certain foreign chemicals e.g. sodium cyclamate, amaranth and 
2,5-di-t-butylhydroquinone. When added to stock diets, which are 
high in cereal fibre, or semi-purified diets with an added fibrous 
component, there is a decreased incidence or absence of the toxic 
effects produced (slow weight gain, alopecia and diarrhoea) when 
the chemicals are added to a semi-purified diet (Kritchevsky, 
1977).
Dietary fibre is known to alter the absorption of 
triglycerides and sterols from the intestine (Cummings,1978).
Fatty acid composition ofingested fats influences the composition of fatty 
acyl groups of membrane phospholipids, which are able to regulate 
the substrate binding properties of the microsomal drug 
metabolizing enzyme system, thus affecting the * metabolism of
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foreign compounds. Dietary fibres may contain unidentified 
components, probably anutrients, which may have the capacity to 
induce the microsomal drug metabolizing enzymes. Alternatively, 
adsorption by dietary fibre of xenobiotics or anutrients in the 
diet, hence slowing their absorption, may prevent the action of 
potential microsomal enzyme inducers or slow the body's exposure to 
certain foreign compounds.
A study of the effects of wheat bran on hepatic drug
metabolism in the rat is now reported. The length of exposure
required for high fibre diets to produce any beneficial effects is
unknown. The optimal amount of dietary fibre that should be
ingested daily is also unquantified. The only criteria by which a
recommended daily intake for man has so far been assessed is
.©logical
related to the manifestation of its physir properties (Spiller et 
al,1977). It therefore seemed pertinent to examine the effect of 
two levels of wheat bran and also to study the effects of feeding 
diets in the short and long-term.
A diet containing a high level of saturated fat was included 
in some of the trials because of the association of high intakes of 
fat with cancer and atherosclerosis. Feeding a purified diet to 
rats results in lower activity of the mixed-function oxidase enzyme 
system in the liver (Brown et al,1954), intestinal mucosa 
(Wattenberg,1972a) and lung (Wattenberg,1972), when compared to 
rats fed a stock diet. Hence, a stock diet (41B) was also included 
in some of the trials to compare any effects with those of the 
experimental, semipurified diets.
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Experimental
Materials
The following chemicals were obtained from British Drug Houses Ltd
(BDH): biphenyl, aniline hydrochloride, formaldehyde,
p-aminophenol, bovine serum albumin and acetylacetone. Sigma was
the supplier of: cytochrome C, 1-naphthol, NADP (nicotinamide
dinucloetide phosphat^ 
adenine/n-Heptane, diethyl ether and chloroform, all of Analar
grade, were obtained from May and Baker, who very kindly donated
the ethylmorphine hydrochloride. Ethoxyresorufin and resorufin
were obtained from Pierce and Warrier. 2- and 4-Hydroxybiphenyl
and Tween-80 (polyoxyethylene sorbitan mono-oleate) were supplied
by Hopkins and Williams. 1-Naphthol-p-D-glucuronide was obtained
from Koch and Light. MADH (nicotinamide adenine
dinucleotide reduced) was purchased from Boehringer.
Copper reagent (protein determination) was prepared by the addition
of \% copper sulphate gH^O (0.5ml) and 2% trisodium citrate (0.5ml) .
to \% sodium carbonate in 0.1M NaOH (50ml).
Animals
Male, weanling, Wistar Albino rats of the Surrey University
breeding colony, were used for the short term feeding experiments
(4, 7 & 12 wk). They were kept in polypropylene .
hanging cages made by Worth Kent Plastic Cages. The rats used in
the long-term experiments' (males and females) and the female rats
maintained on the diets for 12 wk were supplied by the Flour
Milling and Baking Research Association. Weanling Wistar Albino
(COB) rats from Charles River, ..Mansion. Kent were housed five per
with wire mesh floors 
cage in plastic hanging cages / at the Flour Milling and Baking
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Research Association animal house until 3 wk prior to killing when 
they were transported to the animal house at Surrey University. 
Diet and water were available ad libitum to all rats. The 
temperature was kept at 37°C and the humidity at 50$. Lighting was 
on a 12 hr system.
Diets
The diets were formulated by the Flour Milling and Baking Research 
Association. The composition of the diets used is given in the 
Appendix to Chapter Two. The fibre-free diet was the experimental 
control. The concentrations of bran are equivalent to the amount 
of |wheat bran contained in wholemeal bread which constitutes 17 and 34$ 
a diet by weight. Two levels are the minimum required to show a dose 
response_ The stock diet, 41B was of vastly different
composition to the experimental diets and therefore could not be 
considered as a control. It was included in the experimental 
project at the Flour Milling and Baking Research Association as a 
control of animal husbandry. The composition of the diets by 
analysis, for which acknowledgements are due to the Flour Milling 
and Baking Research Assosiation, is also given in the Appendices.
The diets were stored in sealed buckets at 4°C.
Methods
Preparation of liver subfractions - The rats were killed by 
cervical dislocation between 9-10.30 a.m. and the livers excised 
and washed in ice-cold 1.15$ KC1 to remove excess blood. They were 
blotted dry with filter paper, weighed, minced with scissors and 
homogenised with a Potter Elvehjem mechanically driven homogeniser,
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in 0.1M Tris-HCl buffer pH?.4 to give a 25%w/v homogenate. The 
vessel was surrounded by an ice bath while three up and down 
strokes were made. Homogenates were transferred to 50ml 
polycarbonate centrifuge tubes and centrifuged in an MSB High Speed 
18 centrifuge at 1OOOOg(av) for 20 min at 4°C to sediment cell 
debris, mitochondria and lysosomes. An aliquot of the supernatant 
was further centrifuged at 105000g(av) at 4°C for 60 min in an 8x50 
ml fixed angle head rotor, Beckman 15-65 ultracentrifuge. This 
sedimented the microsomal pellet which, after removal of the 
soluble fraction (supernatant), was resuspended in 0.1M phosphate 
buffer pH?.4, to give a 25$w/v suspension. When storage was 
required, microsomes were frozen at -40°C as a pellet covered by a 
small volume of buffer (Tris-HCl 0.1M pH?.4), and resuspended the 
following day.
Cytochrome P450 - (Omura and Sato,1964)
The microsomal suspension was diluted 1:5 with 0.1M phosphate 
buffer pH?.4, the cytochrome P450 reduced with sodium dithionlte 
and the solution divided equally between 2 cuvettes (5ml per 
cuvette). Carbon monoxide was gently bubbled through the test 
cuvette for 50 seconds and a difference spectrum was obtained 
between 400-500nm using an Pye Unicam SP1800 double beam 
spectrophotometer. Cytochrome P450 content was expressed as the 
difference in optical density between 450-490nm, using an 
extinction coefficient of 91 mM knf1.
Cytochrome bg - (Ernste et al,1962)
The microsomal suspension, 25$w/v in 0.1M phosphate buffer pH 7.4 
was further diluted 1:5 with the same buffer, and divided equally 
between two cuvettes (5ml per cuvette). To the test cuvette, O.lmg
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of NADH was added and a difference spectrum was recorded between 
400-450nm using a Pye Unicam SP1800 double beam spectrophotometer. 
The difference in optical density between 410-426nm gave the 
concentration of cytochrome b^ using an extinction coefficient of 
ISÇmKT'cm"1.
NADPH Cytochrome C Reductase - (Williams and Kamin,1962).
Using a constant temperature cuvette, set at 37°C, in a Pye Unicam
SP1800 double beam spectrophotometer, Img of microsomal protein
(105000g fraction) in 0.05M phosphate buffer pH7.6 containing 1mM
KCN, was incubated with O.lymol cytochrome C for 2 min. Addition
of 5 pmol NADPH initiated the reaction. The initial velocity at
550nm was taken as a measure of reductase activity using an
—t _ i
extinction coefficient of 18.5mM cm*.
7-Ethoxyresorufin-0-Deethylase - (Burke and Mayer,1974)
Microsomal protein (1.Omg; 105000g fraction) in 0.1M phosphate
buffer pH7.8 was incubated at 57°C with 1pmol of ethoxyresorufin 
for 2 min in a constant temperature spectrofluorimeter cell. 
Addition of O.^umol NADPH initiated the reaction. Fluorescence was 
measured at excitation wavelength 510nm emission wavelength 586nm 
and slit widths of 3-5nm using a Perkin-Elmer MPF-3
spectrofluorimeter. The reaction was followed for 2 min. 
Resorufin was used as the standard (0.1nm).
Biphenyl Hydroxylases - (Creaven et al,1965)
The incubation system consisted of 3mg of microsomal protein 
(10000g fraction), 3»125pmol biphenyl, 10mg Tween-80, 1Opmol MgClg, 
1.5pmol NADP, 40pmol Tris-HCl buffer pH7.6, in a final volume of 
2ml.
After a preincubation period of 5 min at 37°C, the substrate was
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added to initiate the reaction. Termination at 10 min was achieved 
by the addition of 2N HC1 (0.5ml) and transfer of the tubes to an 
ice bath. Biphenyls were extracted into 10ml n-heptane for 10 min 
at room temperature followed by centrifugation using a Beckman J6 
centrifuge at 2500rpm for 10 min. Aliquots of the heptane layer 
(2.0ml) were further extracted into 0.1M NaOH (10ml) and 
centrifuged as before. The heptane layer was removed by vacuum 
pump. Fluorescence of an aliquot of the aqueous layer (2.0ml) 
adjusted to pH5«5 by addition of 0.25M succinic acid (0.5ml) was 
recorded using a Perkin-Elmer MPF-3 spectrofluorimeter at 
excitation wavelength 275nm emission wavelength 338nm for the 
determination of 4-hydroxybiphenyl, and wavelengths of 295nm and 
420nm respectively for determination of the 2-hydroxy isomer.. Slit 
widths were set at 6nm. Blanks and standards (25jug 4-hydroxy- and 
Gjig 2-hydroxy biphenyl ) were carried through the same procedure. 
Aniline Hydroxylase - (Guarino et al,1969)
The incubation system consisted of 3mg microsomal protein (10000g 
fraction) 20pmol aniline, 10pmol MgCl^ , 2|imol NADP, 20fimol 
glucose-6-phosphate and 150/umol Tris-HCl buffer pH 7.6, in a final 
volume of 2ml.
After a preincubation period of 5 min at 37°C, the reaction was 
initiated by addition of the substrate. Termination at 10 min was 
achieved by the addition of approximately 1 g solid NaCl and 
transfer of the tubes to an ice bath. p-Aminopheno1 was extracted 
into peroxide-free ether (10ml) at room temperature, centrifuged 
using a Beckman J6 centrifuge at 2500rpm for 10 min, further 
extracted into alkaline phenol (4ml) for 40 min and centrifuged as 
before. The absorbance was measured at 620nm in a Cecil 272
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spectrophotometer. Blanks and standards (0.05-0.25pmol
p-aminophenol) were carried through the same procedure. 
Ethylmorphine-N-Pemethylase - (Holtzman et al,1968)
The incubation system consisted of 3nig microsomal protein (10000g 
fraction) 15pmol ethylmorphine hydrochloride, 1Opmol
glucose-6-phosphate, 0.2mg semicarbazide hydrochloride solution 
(pH7.0) and 150pmol Tris-HCl buffer pH7.6, in a final volume of 
2.55ml.
After a 5 min preincubation period at 57 °C, the reaction was 
initiated by addition of the substrate and terminated at 10 min by 
addition of 15mg zinc sulphate and the tubes transferred to an ice 
bath. Addition of 1.0ml of a saturated mixture of solutions of 
barium hydroxide and sodium tetraborate (2:1, v/v), precipitated
all of the protein. After centrifugation, 2500rpm for 15 min 
(Beckman J6 centrifuge) an aliquot (2ml) of the supernatant was 
added to Nash reagent (2ml; Nash,1955) and incubated at 37°C for 
40min. The absorbance was measured at 412nm using a Cecil 272 
spectrophotometer. Blanks and standards (0.15-0.6pmol
formaldehyde) were carried through the same procedure.
1-Naphthol Glucuronyltransferase - (Bock,1974; Shirkey,1977)
The incubation system consisted of 0.5mg microsomal protein 
(105000g fraction), 0.2piol 1 -naphthol, 2.5|imol MgClz , 0.5mg
Brij-35, 5jimol UDPGA, and 0.05mmol Tris-HCl buffer pH7*6 in a final 
volume of 0.5ml.
After a 5 min pre-incubation period at 37 °C, the reaction was 
initiated by the addition of 1-naphthol and was terminated at 4 min 
by addition of 0.05M glycine-trichloroacetic acid buffer pH2.2 
(1.Oml), and the tubes were transferred to an ice bath. Unreacted
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1-naphthol was extracted into chloroform (6ml) at room temperature 
and after centrifugation at 2500rpm for 10 min, an aliquot of the 
aqueous layer (1.Oml) was added to 1.OM.glycine-NaOH buffer pH10.6 
(1.0ml). Fluorescence was measured using a Perkin-Elmer MPF-3 
Spectrofluorimeter at excitation wavelength 3>03nm, emission 
wavelength 334nm, with slit widths set at 6nm. Blanks and 
standards (5 - 20nmol) were carried through the same procedure. 
Protein Determination - (Lowry et al,1951)
Microsomal suspension 25%w/v was further diluted 1:20 with 0.5M
NaOH to give a concentration of 600mg microsomal protein/ml. An
aliquot (0.5ml) was added to an equal volume of 0.5M NaOH and
freshly made copper reagent (5ml) was added. After vortex mixing
the tubes were allowed to stand at room temperature for 10 min.
Folin-Ciocalteau's phenol reagent was diluted 1:2 with distilled
water and aliquots (0.5ml) added to the tubes and mixed within 1
at 720nm
second. The absorbance was recorded/after 30 min using a Cecil 272 
spectrophotometer. Bovine serum albumin (0-300pg) was used to 
construct a standard range of protein values.
Statistical Analyses
These were performed using Student's t_ test.
Results
No differences in food consumption or weight gain were 
observed between any of the groups of rats studied. All animals 
were healthy, and there were no obvious differences in behaviour or 
appearance between the groups.
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The rats maintained on the 4•8% and 9.6% hran diets for 4 wk 
showed no changes in levels of hepatic cytochromes P450 and tÿ or 
any of the mixedr-function oxidases studied compared to the 
fibre-free controls (Table 2.1). Microsomal protein values were 
similar in all groups. A longer feeding period (7 wk) was found to 
produce no changes in these enzyme levels. The diet containing 
Q.5% beef suet was also found to produce no changes in the animals 
maintained on this diet compared to the fibre^free controls. There 
were no significant differences in microsomal protein content 
between the groups (Table 2.2). Diet 41B, the stock diet, was 
associated with higher levels of cytochrome P450, cytochrome b^, 
biphenyl-4-hydroxylase, and 7-ethoxyresorufin-0-deethylase in male 
and female rats maintained for 12 wk on the diet,. compared to the
fibre-free controls (Tables 2.3 & 2.4)• 1-Naphthol
glucuronyltransferase activity was increased in the male rats in
the stock diet group compared to controls. The largest percentage
increase above controls was seen for 7-ethoxyresorufin-0-deethylase 
in both male and female rats (Tables 2.3 & 2.4)• This enzyme
activity is attributed to cytochrome P448, an enzyme thought to be 
associated with the activation of carcinogenic molecules (Burke and 
Mayer, 1975)• The male rats maintained on the 4.8% bran and 9»€>% 
bran diets and the female rats maintained on the 9.6$ bran diet had 
significantly ihigher 7-ethoxyreso rufin-O-deethylase activities. 
EthyImorphine-N-demethylase was significantly decreased in male 
rats maintained on the 9-6$ bran diet. However these changes did 
not follow any dose response effects.
In the male rats maintained for long-term (18 months) on the
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stock diet, no increase in levels of cytochromes P450, h^, or- of 
mixed-function oxidase enzymes was apparent in comparison to 
controls, apart from an increased activity of
7-ethoxyresorufin-0-deethylase (Table 2.5)» No changes were 
observed in the 9.6% bran and Q.5% beef suet groups compared to the 
fibre-free control group. Generally, all enzyme activities in the 
long-term study rats were lower than those observed in male rats at 
4, 7 and 12 wk (Fig. 2.1). However 7-ethoxyresorufin-0-deethylase 
was not observed to decrease in activity in groups of rats 
maintained on the control and 9.6% bran diets (Fig. 2.1).
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1 
2.1.
8
Drug metabolism parameters in mature (18 months) compared to 
young rats (12 weeks) for 1: cytochrome P450, 2: cytochrome bg,
3: NADPH cytochrome C reductase, 4: ethoxyresorufin-O-deethylase,
5: biphenyl-4-hydroxylase, 6: aniline hydroxylase, 7: ethylmorphine- 
N-demethylase, 8: microsomal protein.
Asterisks indicate values significantly different at 18 months 
compared to 12 weeks - * = p<0.05, ** = p<0.02, *** = p<0.01,
**** =p<0.005 (Student's t: test). (See Table 2.3. 0 2.5. for 
absolute values)
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Discussion
The lack of effect of wheat hran on hepatic cytochrome P450 
levels and mixed-function oxidases is in agreement with other 
workers (Smith-Barharo et al, 1981a; Proia et al,1981). An 11 
month exposure to a diet containing 15% wheat bran produced no 
changes in hepatic cytochrome P450 or cytochrome h' levels when 
compared to control rats maintained on a diet containing 5$ 
cellulose. Similar results were observed when 15$ citrus pulp 
replaced wheat bran in the experimental diet. Hepatic
3-hydroxy-5-methylglutaryl (HMG) CoA reductase activity, the key 
rate-limiting enzyme in cholesterol synthesis, was unaffected by 
either of the two high fibres regimes compared to the control, 
indicating that these dietary fibres do not influence hepatic 
cholesterogenesis (Smith-Barbaro et al,1981a).
The addition of 10.4$ cellulose to a purified diet was found 
to decrease hepatic cytochrome P450 levels and aniline hydroxylase 
and ethylmorphine-N-demethylase activities compared to the addition 
of 10.4$ pectin or a cereal based diet, and fed to rats for 5 wk 
(Proia et al,1981). Cytochrome b_ and'HMG CoA reductase levels
i
^were similar in rats maintained.on the cellulose and pectin diets 
and lower than rats maintained on the cereal-based diets. This 
work can be criticised for not including a correct control diet, 
i.e. the purified diet without any fibrous component added. The 
authors concluded that cellulose and pectin have substantially 
different effects on the cytochrome P450 system in rat liver and 
that dietary fibre does not affect this system and the HMG coA
- 59 -
reductase system in a parallel manner. However these conclusions 
are not in agreement with those of Smith-Barbaro et al (1981a). 
The experiments differed by the length of exposure to the diets and 
the use of fibre components by Proia et al (1981) compared to the 
use of natural fibres by Smith-Barbaro et al (1981 a).
In the reported experiment no dose response effects with 
dietary wheat bran content or consistent trends with the length of 
the feeding period were observed. It can be concluded from this 
work and other reports (Smith-Barbaro et al,1981a) that wheat bran 
does not affect the hepatic microsomal mixed-function oxidase 
enzyme system.
Similarly no changes were observed in the 8.5$ beef suet 
groups compared to the controls at any of the time points studied. 
Beef suet is composed of saturated and monounsaturated fat. This 
diet contained 2$ corn oil, such that the beef suet component 
contributed approximately 18$ and the corn oil approximately 4.2$ 
of the calories. The control and bran diets contained 2$ corn oil 
which contributed 5$ of the calorific intake. The results here are 
in agreement with other evidence (Marshall & McLean,1971a), 
indicating that the dietary level of saturated fat does not affect 
hepatic drug metabolizing enzyme activity when the dietary level of 
polyunsaturated fatty acids is adequate for maximal activity at 
both basal and induced, levels.
The increased levels of cytochrome P450 and cytochrome bg, 
and biphenyl-4-hydroxylase and 7-ethoxyresorufin-o-deethylase
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activities in the male and female rats maintained on the stock diet 
for 12 wk compared to the control, semipurified diet group is a 
well-reported phenomenon. This effect is due to foreign residues, 
vegetable components, anutrients and natural xenobiotics
(Wattenburg,1971)• A role of the hepatic drug metabolizing enzyme 
system is to eliminate naturally occuring xenobiotics, ingestion of 
which in large amounts would be expected to stimulate these
readily-inducible enzymes (Parke,1976). Feeding the stock diet 
over a longer period however results in an increased activity of 
7-ethoxyresorufin-o-deethylase, an enzymic activity attributed to 
cytochrome P448 (Burke and Mayer,1974). Kato and Takanakcv (1968) 
reported that induction of the cytochrome P450 system by
administration of phenobarbitone is less extensive in old than
mature rats. More recent studies examining the extent to which 
aging impairs induction have produced conflicting evidence 
(Schmucker and Wang,1980; McMartin et al, 1980; Gold and 
Widnell,1974; Kao and Hudson,1980). Inconsistent findings may be 
due to different strains, sex and age groups used for comparison, 
and the use of bedding and commercial diets which are known to 
alter levels of non-induced drug metabolizing enzymes.
More recent work (Rikans and Motley,1981) has shown that
qualitative changes in the microsomal enzyme system occur as the 
animals age, as well as modification of the induction process, 
supporting the evidence of Schmucker and Wang (1980) and McMartin 
et al (1980). Induction by methyltestosterone was found to be less 
in older animals (14-15 months) than in younger animals (3-5 
months), whereas induction by phenobarbitone or B-naphthoflavone
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was equivalent in both age groups. Benzphetamine-N-demethylase and 
aniline hydroxylase activities were decreased In older rats and 
nitroanisole-O-demethylation was enhanced (Rikans & Notley,1981).
The same authors (Rikans and Notley,1981a) found that aging 
from 5-14 months was accompanied by a decline in liver cytochromes 
P450 and bg, NADPH cytochrome C reductase and phospholipid content. 
The decline in microsomal monooxygenase activities was found to be 
substrate specific, indicating that the components which decline 
with age are not rate-limiting for the monooxygenation of all 
substrates. This may be explained by selective decreases in the 
activity of certain of the multiple forms of cytochrome P450. 
Evidence for a selective effect of aging on different forms of 
cytochrome P450 has been reported (McMartin et al,1980).
In the experiments now reported, a significant decline of 
enzyme activities was observed for rats maintained on all diets 
studied at- 18 months in comparison to rats fed for 4, 7 and 12 
wk. The exception is a small increase in the activity of 
7-ethoxyresorufin-O-deethylase in male control and 9-6% bran groups 
fed for 18 months compared to rats fed on these diets for 12 wk. A 
significant decline of activity of this enzyme was seen in the rats 
fed on the stock diet for 18 months in comparison to rats fed for 
12 wk (males), indicating a less marked induction response. The 
measurements were made on different days which may account for some 
of the variation. Schmucker and Wang (1980) reported no 
age-dependent differences in non-induced microsomal protein 
concentration indicating no loss of endoplasmic reticulum. In the
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reported experiment,'higher values for microsomal protein were 
found in. the fibre-free and stock diet groups of male rats 
maintained on the diets for 18 months.
The age-effects on 7-e tho xyre sorufin-0-dee thyla s e are 
interesting. The increased activity of this enzyme in rats 
maintained on the stock diet for 18 months, without an increased 
activity of any other enzymes may be due to a specific cytochrome 
P448 effect. This is supported by the maintenance of 
7-ethoxyresorufin-O-deethylase activity in the rats fed on the 
experimental diets for 18 months where all other enzyme activities 
have decreased. It has been suggested that cytochrome P448 is the 
form responsible for carcinogenic activation (Burke & Mayer,1975)•
The role of the mixed-function oxidase system as a survival 
mechanism against foreign compounds has been postulated 
(Wattenberg,1972), with the proviso that it is necessary to 
evaluate the overall balance of protective effects with potentially 
harmful ones. Exposure to naturally ocurring xenobiotics, 
promoting increased xenobiotic metabolism, leads to a general 
increase in turnover and detoxication, and increased incidence of 
acute toxicity due to some activation of compounds by this system 
may also occur. A loss of capacity for induction of drug 
metabolizing enzymes with aging may be indicative of decreased 
adaptation of the survival system by a loss of protection against 
tumour formation which may be of significance in the aetiology of 
aging and disease. Elderly human subjects show decreased induction 
response to dichloralphenazone compared to young subjects (Salem at
63 -
al,1978). A higher frequency of adverse drug reactions 
(Hurwitz,1969) and a higher incidence of cancer is seen in the 
elderly.
In conclusion it appears that any protection afforded by 
wheat bran against colon cancer and other diseases (Burkitt,1971) 
is not mediated through the hepatic mixed-function oxidase enzyme 
system. The association of aging with high incidence of cancers 
may be due to effects of aging on specific forms of cytochrome 
P450.
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Chapter Three
The Effect of Dietary Wheat Bran on Intestinal Drug Metabolism
and its Induction by Safrole in the Rat.
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Introduction
The small intestine has wide scope for xenobiotic metabolism. 
Whilst its capacity for metabolic transformation (phase I 
metabolism) is lower than the liver it has a greater capadty for 
synthetic reactions (phase II metabolism), of which glucuronidation 
is the most active. The intestine assumes importance as an organ 
of foreign compound metabolism since it is the first tissue to come 
into contact with orally ingested xenobiotics and the gut is the 
major route of exposure of the body to these compounds. The 
conversion of a proportion of these xenobiotics by the intestine, 
to excretable compounds offers protection to the rest of the animal 
body.
The mixed-function oxidase enzymes of the gastro-intestinal 
tract are highly inducible. It has been suggested that most aryl 
hydrocarbon hydroxylase (AHH) activity catalysed by the 
mixed-function oxidase enzymes in the intestine, one of the two 
major portals of entry, results from continuous exposure to 
endogenous dietary inducers (Wattenberg,1972a). Feeding rats a 
purified diet (casein, starch, c o m  oil, salt mix and vitamin 
supplement) compared to feeding purina rat chow results in 
substantially decreased benzo(a)pyrene hydroxylase activity in 
intestinal mucosa and lung (Billings and Wattenberg,1972). Crude 
diets have been shown to enhance the microsomal metabolism of this 
substrate in the liver (Brown et al,1954). The inducing activity 
of purina rat chow was traced to an inherent component, namely 
alfalfa grass (Wattenberg,1972). Other vegetables were
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subsequently shown to have inducing activity the most potent being 
members of the Brassicaceae family - Brussels sprouts, cabbage, 
broccoli, turnips and cauliflower; spinach, dill and celery were 
found to have similar effects. The potent compounds were 
identified as indole-3-acetonitrile, indole-3-carbinol and 
3,3 '-diindolylmethane, metabolites of indolylmethylglucosinolate 
(Loub et al,1975). Flavones (Wattenberg et al,1968) and isosafrole 
(Lake and Parke,1972) have been shown to induce mixed-function 
oxidases in the intestine. Numerous other chemicals to which we 
are exposed by dietary contamination and drugs are inducers of 
intestinal mixed-function oxidase enzymes (Sell and Davison,1973; 
Wattenberg and Leong,1965)*
Within the gastro-intestinal tract, xenobiotics are exposed 
to the same factors as dietary nutrients. Specific processes 
operating in the lumen and wall of the gastro-intestinal tract 
include secretion and cellular events; physicochemical conditions 
differ from the mouth to the rectum due to pH, micellar formation 
and ionic strength (Pekus,1980). These processes and conditions 
are in turn affected by the luminal contents. Dietary fibres are 
known to alter physicochemical conditions by their bulking action, 
adsorption of water and organic chemicals, their effect on transit 
time, gut motility, and ion-exchange capacity.
In the previous chapter wheat bran was found not to induce 
the mixed-function oxidases of the liver. Its effect on the more 
readily inducible intestinal mixed-function oxidases has therefore 
been investigated. A modified diet containing 28.8% bran, three
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times the amount present in the 9.6$ bran diet, was included in 
this experiment.
A proposed mechanism by which bran may protect against 
colorectal cancer is by the adsorption of carcinogens and 
precarcinogens in the intestinal tract (Burkitt,1971)» Safrole 
(4-allyl-1,2-methylenedioxybenzene) is a weak hepatocarcinogen 
(Homburger et al,1961) and an inducer of hepatic and extrahepatic 
mixed-function oxidases (Parke and Rahman,1970). It is the primary 
component of oil of sassafras and is a minor component of nutmeg, 
cinnamon, camphor and many other essential oils. The ability of 
wheat bran to adsorb safrole in vitro has been shown by Moore 
(1983), using wheat bran supplied by the Flour, Milling and Baking 
Research Association. There is approximately 60$ adsorption at 
pH3. The effect of feeding safrole in the presence or absence of 
bran on the induction of intestinal mixed-function oxidases and a 
glucuronyltransferase enzyme was therefore investigated in order to 
determine whether the in vitro adsorption of safrole by bran 
occurred in vivo and was of physiological significance i.e. by 
decreasing the extent of interaction between the carcinogen and the 
mixed-function oxidase enzyme system.
Many technical difficulties are encountered when 
investigating extrahepatic drug metabolism, mainly because of the 
excessive connective tissue contaminants and differences in enzyme 
stability and co-factor requirements. Techniques employed in the 
study of intestinal drug metabolism include histochemical 
techniques, isolated loops, mucosal scrapings and isolated cells.
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The latter two methods can be used for the preparation of 
sub-cellular structures. Difficulties arise because of 
contamination of the mucosal cells with cells of the brush border 
and terminal web, and with mucus. The rat especially produces 
copious quantities of mucus. Mucosal scraping preparations in the 
rat have been found to be unreliable for subfractionation 
(Shirkey,1977)• The use of isolated mucosal cells for 
sub-fractionation was found to be more consistent, giving reliable 
results (Shirkey,1977). Hence this technique was used in this 
study, with only slight modifications.
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Experimental
Materials
Safrole was purchased from Hopkins and Williams Ltd. Sucrose was
manufactured by Tate and Lyle. EDTA was purchased from BDH Ltd.
and glucose-6-phosphate dehydrogenase 
Glueose-6-phosphate, were purchased from 5Agma. All other
materials were obtained as described in Chapter Two.
Experimental Procedure
In the first experiment, rats (four per group) were maintained on 
the diets containing 4.8, 9.6 and 28.8% wheat bran for 4 wk. The 
latter level was achieved by addition of more of the same wheat 
bran to the 9.6% bran diet. The commencement of feeding was 
staggered such that two animals per group were killed on one day, 
and the final animal weights and feeding periods were the same for 
all animals. The results were pooled for analysis.
For the safrole study 0.25%(w/w) safrole was added to the 
fibre free and 9.6% bran diets. The unmodified fibre-free diet was 
the control. Four animals per group were used and each group was 
allowed a period of 5 days to adjust to the experimental diets 
before adding the safrole. The safrole-containing diets were 
introduced on day six. The animals were killed on day 13» thereby 
giving 8 days of feeding with safrole. All animals were killed on 
the same day.
Methods
Preparation of Intestinal Subfractions - (Modification of
Shirkey,1977)
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Between 9-30-10-30 a.m. the rats were killed by cervical 
dislocation, the abdomen opened and the small intestine, excised 
from the duodenum to the caecum, was flushed with ice-cold 
0.9$NaCl-20mM Tris pH7.4 buffer. The first 60cm of the proximal 
small intestine was cut into six 10cm lengths. Four rats were 
killed at one time and it was possible to deal with a total of 12 
rats on one day. Further work was conducted at 4 °C. The 
intestinal sections were everted onto six metal rods and vibrated 
vertically at 100Hz, 1.5nun (Vibromixer E1, A.G. Chemap, Zurich)
for 1 min in 0.14M NaCl-5mM EDTA pH7*4 buffer solution to dislodge 
the intact epithelial cells uncontaminated with lamina propria. 
This solution was poured into six pre-weighed MSE 50ml centrifuge 
tubes and the cells were precipitated by centrifugation at 1000g 
for 2 min in an MSE Minor centrifuge. The supernatant was 
discarded and the cells weighed and resuspended in 9ml 75mM sucrose 
buffer pH7.4. The cells were homogenised with a Potter Elvehjem 
mechanically driven homogeniser with ten up and down strokes. 
Before the final stroke 9ml 0.52M sucrose buffer pH7.4 and 7ml 0.3M 
sucrose pH7.4 were added to render the solution 0.3M. The 
homogenate was centrifuged for 4 min at 1OOOg (max) in an MSE Minor 
centrifuge, and the supernatant retained. The precipitate was 
washed twice with 0.3M sucrose pH7.4 and the supernatants combined. 
Mitochondria and lysosomes were precipitated by centrifugation at 
10000g(av) in an MSE High Speed 18 centrifuge. Microsomes were 
precipitated by centrifugation at 105000g(av) in a Beckman L5-65 
centrifuge. The pellet was resuspended in 0.1M Tris buffer pH7*4 
to give a concentration of 1 g wet cell weight in 2.5ml Tris-Hcl 
buffer.
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Biphenyl-hydroxyla ses - (Creaven et al,1965)
The incubation mixture consisted of 1.95]Miol NADP, 15jimol glucose
6-phosphate, 1 unit glucose 6-phosphate dehydrogenase, lOpaol 
MgClg, 1mg microsomal protein (105000g fraction), O.OSmMol Tris-HCl 
buffer pH 7*6, %. 0 pmol biphenyl and 0.08g Tween-80 in a final 
volume of 2ml.
The mixture was preincubated for 5 min in the absence of substrate 
which was added to start the reaction. Incubation was terminated 
at 7.5 min by addition of 2M HC1 (0.5ml) and the tubes plunged into 
an ice-bath. The extraction procedure consisted of the addition of 
n-heptane (7ml) containing 1.15$ isoamylalcohol and rotary 
extracting at room temperature for 10 min. After a 10 min 
centrifugation at 2500rpm in a Beckman J6 centrifuge, an aliquot of 
the heptane layer (2ml) was added to 0.1M NaOH (5ml) and similarly 
extracted and centrifuged. Fluorescence was measured in 2ml of the 
NaOH phase adjusted to pH5»5 by addition of 0.25M succinic acid 
(0.5ml) at excitation wavelength 275nm, emission wavelength 538nm 
for determination of 4-hydroxybiphenyl and excitation wavelength 
295nm, emission wavelength 420nm for determination of the 2-hydroxy 
isomer using Perkin—Elmer MPF-3 spectrofluorimeter. Blanks and 
standards (25|ig 4-hydroxy- and 6jig 2-hydroxybiphenyl ) were carried 
through the same procedure. The optimal substrate concentration 
for biphenyl hydroxylases was found to be 1pmol per incubation 
system, with an optimal incubation time of 7•5 min. Tween 80 was 
preferable to DMF (dimethyl formamide) for solubilising the 
biphenyl substrate as DMF was found to lead to precipitation, 
however small the volume added.
7-Ethoxyresorufin-O-Deethylase - (Burke and Mayer,1974)
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The procedure followed was identical to that described in Chapter 
Two except that 0.5mg microsomal protein (105000g fraction) was 
added.
1-Naphthol glucuronyltransf erase, ÏÏA3DPH cytochrome C 
reductase (using 0.5mg microsomal protein, 105OOOg fraction), and 
protein determinatons were carried out as described in Chapter Two. 
1-Naphthol glucuronyltransferase activity was linear up to 7.5 min; 
the incubation time of 4 min was chosen in agreement with other 
workers (Shirkey,1977; Dawson,1980).
NADPH cytochrome C reductase activity was linear within the range 
0.27 to 0.68 mg microsomal protein.
7-Ethoxyresorufin-0-deethylase activity was linear over the range 
0.27 to 0.54 mg microsomal protein.
Student's _t test.
Results
Growth of rats maintained on the diet containing 28.8% bran 
was similar to controls (Fig 3.1). These animals were healthy and 
identical to the other groups apart from the obvious increased 
quantity of faeces. Wheat bran at three dietary levels (4.8, 9.6 & 
28.8%) was without effect on NADPH cytochrome C reductase, 
biphenyl-4-hydroxylase, 7-ethoxyresorufin-O-deethylase or
1-naphthol glucuronyltransferase activities compared to control 
values . Protein concentrations and the weight of cells obtained
Statistical analyses
These were performed using
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were not significantly different between the groups (Table 3*1)•
The growth of rats maintained on the diets containing safrole 
was less than the control group, with slightly lower weights in the 
fibre-free 0.25%(w/w) safrole group than the 9.6% bran 0.25%(w/w) 
safrole group, despite equivalent food intakes in these two groups 
(Fig 3.2 and Table 3.2). Safrole intake was therefore the same in 
both groups (Table 3-2). The weight of cells recovered and protein 
contents were slightly higher in the safrole groups than in 
controls but these changes were not significant (Table 3*3)• 
Significant increases were found for NADPH cytochrome C reductase 
and 1-naphthol glucuronyltransferase activities in the safrole 
groups compared to controls, with a similar increase in activity 
for both groups (Table 3.3). Both the biphenyl 4-hydroxylase and 
7-ethoxyresorufin-O-deethylase enzyme activities were increased in 
both safrole groups compared to controls, although the changes were 
not statistically significant. Biphenyl-2-hydroxylase and
7-ethoxyresorufin-O-deethylase activities were lower in the 
fibre-free 0.25%(w/w) safrole group than in the 9.6% bran 
0.25%(w/w) safrole group, with the reverse being true for biphenyl
4-hydroxylase (Table 3.3).
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DURATION OF F EE DI N G  PERIOD (DAYS) 
Fibre Free control diet 
Fibre Free 0.25% saFrole diet 
9.6% Oran, 0.25% saFrole diet
Fig. 3.2.. GROWTH CURVE OF SAFROLE AND CONTROL RATS
Results are means of four rats per group. A period of 4 days 
on the respective diets without added safrole was allowed so that 
the animals were accustomed to the experimental diets; safrole 
feeding continued for a period of 8 days.
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Table 3,2. Food and Safrole Intakes and Final Bodyweights (Rats)
INTAKE
DIET GROUP
Fibre-Free Fibre-Free '+ 9.6% Bran + 
Control 0.25% Safrole 0.25% Safrole
Food Intake
g/1 0 0 g bodyweight/ 
day
12.6 ± 1.4 1 1 . 1  ± 1 . 6 11,0 ± 1.4
Safrole Intake
g/1 0 0 g bodyweight/ 
day
0.028 ± 0.004 0.028 ± 0.004
Total Safrole Intake 
in 8 days
g/1 0 0 g bodyweight 0.198 ± 0.01 0.196 ± 0.01
Final Bodyweight (g) 215 ± 2 198 ± 2 204 ± 3
Results are Mean ± SEM for four male animals. 
Safrole feeding period was 8 days.
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Discussion
The modifications of the method of Shirkey (1977) for the 
preparation of intestinal epithelial microsomes are those of Dawson 
(1980), in which the highest reported value of rat intestinal 
cytochrome P450 was found. The modifierions made were the omission 
of one washing at 1000g(max) and 1 washing at 10000g(av) which were 
thought to decrease the amount of non-microsomal protein 
sedimenting with the microsomes. A further modification was the 
use of six 10cm rods rather than three 20cm rods used by these 
workers (Shirkey,1977; Dawson,1980), for everting the gut 
sections. This enabled the volume of solution into which the cells 
were shaken and collected to be decreased and therefore enabled the 
first centrifugation procedure to be completed more quickly.
Short term (4 wk) feeding of wheat bran up to 28.8$(w/w) of
.small
the diet did not alter the [intestinal phase I or phase II drug 
metabolizing enzyme activities. Smith-Barbaro et al (1981 a) found 
that feeding rats a diet containing 15% wheat bran by weight for 11 
months did not alter cytochrome P450 concentration but decreased 
cytochrome bc levels by 50% compared to a control diet containing
b
5% cellulose. %iy protective effect of bran against colon cancer 
is not therefore mediated by a direct effect on liver or small 
intestinal mixed-function oxidase enzyme levels, producing the 
higher activities which are generally associated with lower tumour 
incidence (Wattenberg,1972a).
The presence of a mixed-function oxidase system in the colon,
— 80 —
capable of activating carcinogens to their proximate reactive form 
has been reported (Strobel et al,1980)» Smith-Barbaro et al 
(1981 a) found that feeding 15% wheat bran for 11 months decreased 
colonic cytochromes P450 and b_ by 55%, compared to controls (5%
b
cellulose). The exact role of this drug metabolizing system in 
colonic carcinogen detoxication is unknown, but it may be a major 
factor in determining the incidence of colorectal tumours.
These workers (Smith-Barbaro et al,1981a) also found 
decreased activity of intestinal and colonic
3-hydroxy-5-methylglutaryl co A reductase activity on both a 15% 
wheat bran and 15% citrus pulp diet in comparison to the control 
diet containing 5% cellulose and fed for 11 months. The diet 
containing 15% citrus pulp was found to lower intestinal and
colonic cytochromes P450 and bg. This indicates that dietary 
fibres may depress intestinal cholesterogenesis, the organ which 
under high fibre feeding may become most sensitive to dietary 
manipulation (Smith-Barbaro et al,1981a).| %ny protective effect of 
bran against colon cancer may be mediated through interaction with 
intestinal and colonic cholesterol metabolism which may influence 
the cytochrome P450 system, or it may be due to the physical
actions of fibre i.e. altering the availability of potential
carcinogenic molecules.
In rat liver, safrole and isosafrole have been shown to 
increase biphenyl 4- and 2-hydroxylases, glucuronyltransferase and 
cytochrome P450 levels (Parke and Rahman,1971). Safrole induces
benzo(a)pyrene hydroxylase activity in the rat small intestine and
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has been shown to be a less potent inducer of extrahepatic drug 
metabolism than isosafrole (Lake,1974). Safrole was found in the 
experiment now reported to increase rat intestinal NADPH cytochrome 
C reductase and 1-naphthol glucuronyltransferase activities and to 
increase biphenyl 4-hydroxylase and 7-ethoxyresorufin-O-deethylase 
activities, although these increases were not statistically 
significant. Biphenyl 2-hydroxylase activity was not increased. 
In the liver, both safrole and isosafrole enhance 4- and 
2—biphenylhydroxylase activities but in extrahepatic tissues 
isosafrole only stimulates 4-hydro xyla t i on. It appears that this 
is also true of safrole in the intestine.
The results indicate that 9*6%(w/w) wheat bran does not alter 
the capacity of intestinal drug metabolizing enzyme induction by 
safrole, a natural dietary component, after an 8-day feeding 
period. Hence the interaction between safrole and cytochrome P450 
is not reduced in the presence of bran, compared to a fibre-free
diet.
The increased activity of 7-ethoxyresorufin-O-deethylase,
though not significant, is interesting. Higher levels were found 
bran
in the<H7oWiuat/ 0.25%(w/w) saf role-fed group than in the
fibre-free ■0.25%(w/w) safrole group. This enzyme utilises 
cytochrome P448, which is thought to be involved in microsomal 
activation of carcinogens (Burke and Mayer,1975)•
Other workers have shown that diets containing some fibrous 
• components are protective against toxic substances and carcinogens
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(Ershoff,1972; Ershoff and Thurston,1974; Wilson et al,1977). 
They mostly conclude that the physical actions of fibre modify the 
toxicity of the substances. Binding studies in vitro have given 
support to this theory in some cases (Smith-Barbaro et al,1981), 
but not in others (Takeda and Kiriyama,1979)• However, in some of 
the in vivo experiments, workers have compared semi-purified diets 
to stock rations, which is not experimentally valid since stock 
diets are of completely different composition apart from containing 
a high level of fibre. The physical actions of dietary fibre which 
are thought to protect against carcinogens and toxic substances 
depend on a variety of factors. Those pertinent are the chemical 
structure of the toxic substance and how it is metabolised and 
absorbed in the gastro-intestinal tract, and the influence of 
gastro-intestinal events on the compound which in turn, are 
influenced by the type and amount of dietary fibre ingested. 
Interactions between the toxic substance and the particular type of 
dietary fibre are of major importance.
Thus wheat bran and citrus pulp have been reported to protect 
against dimethylhydrazine(DMH)-indueed colon tumourigenesis (Wilson 
et al,1977), probably by binding DMH (Smith-Barbaro et al,1981). 
However, the protective effect against amaranth toxicity by 
gobo-fibre, obtained from the roots of the edible burdock, which 
does not at/sorb amaranth (Takeda and Kiriyama,1979), is probably 
due to slowing the passage of chyme through the small intestine, 
thereby counteracting the inhibition of digestive enzymes caused by 
the amaranth (Takeda et al,1982). The protection afforded by 
dietary fibres is not uniform. The effects of toxic levels of
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amino acids (5$ glycine, methionine and 5% tyrosine) fed to rats 
are not counteracted by the presence of gobo-fibre, probably 
because these compounds are easily absorbed (Takeda et al,1979)»
Safrole is lipophilic and fat soluble and is absorbed rapidly 
from the intestine (Benedetti et al,1977)» It is a weak 
hepatocarcinogen and a weak inducer of extrahepatic mixed-function 
oxidase enzyme activities. The results now reported indicate that 
adsorption of the compound by dietary wheat bran (9*6%(w/w)) does 
not affect the ability of safrole to induce the intestinal 
drug-metabolizing enzymes in vivo.
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Chapter Four
The Effect of Dietary Modification on 
Gastro-intestinal Glycoprotein Biosynthesis.
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Introduction
Dietary fibre is associated with protection against certain 
gastro-intestinal diseases, including colorectal cancer and
diverticulosis (Burkitt,1971). The epithelial cells lining the 
gastro-intestinal tract have a very high rate of turnover and are 
continually being exfoliated and replaced (Croft et al,1977). The 
tract is completely covered with a blanket layer of mucus which is 
also continually renewed (Teague 1977). It is secreted by the
cells lining the mucosa and forms a viscous, tenacious layer about
1mm thick. It protects the delicate epithelium from mechanical and 
autolytic damage (Hollander,1954), facilitates the passage of 
contents along the gastro-intestinal tract by lubrication, and may 
help to control the osmotic movement of fluids across the
epithelial surface (Hafez,1977). The ability to perform these
functions resides in the chemical composition and structure which
renders mucus resistant to attack and able to form water-insoluble 
and viscous gels (Edward,1963) which act as a mesh, allowing 
retention of some substances whilst being permeable to others.
Mucus consists of water, glycoproteins, inorganic ions
(sodium, potassium, calcium and choride), proteins and DNA
(Clamp,1977)• Its gel structure, which is ill-defined, depends 
primarily on the large glycoprotein molecules (Cohen and 
Gold,1975), with molecular weights of several million (Clamp,1977). 
Glycoproteins consist of conjugated proteins covalently linked to 
carbohydrate oligosaccharide chains. In gastro-intestinal mucous 
glycoprotein the polypeptide chains contain a high content of
— 86 —
serine, threonine, and proline, and a low content of aromatic and 
sulphur-containing amino acids. There are many hundreds of 
oligosaccharide chains per molecule containing less than 25 
mono saccharides, usually about 8-10. The characteristic ones are 
L-fucose, D-galactose, N-acetylglucosamine, and
N-acetylgalactosamine and acyl neuraminic acids. Uronic acids are 
absent and mannose and glucose are found only in small quantities. 
Most.mucous glycoprotein of the gastro-intestinal tract contains 
over 50% carbohydrate (Clamp,1977)• The linkage of the 
carbohydrate to the polypeptide is an O-glycosidic linkage where 
N-acetyl glucosamine is joined from the carbon atom at position 1 
to the hydroxy group of serine or threonine and the linkage atom is 
oxygen (Anderson et al,1964).
The carbohydrate composition is of primary importance in 
determining the chemical and physical properties of mucus. The 
sugars are polar and tend to stabilise the glycoprotein in aqueous 
solutions; sialic acid residues impart a high negative charge to 
certain oligosaccharides ; the sugars tend to be heavier than the 
amino acids thus affecting the density of the molecules.
Sialic acids are important constituents of glycoproteins. 
They are built of nine-carbon sugars and are predominantly ÏÏ- and 
0- acyl derivatives of the a^-ketopolyhydroxyamino acid known as 
neuraminic acid, which -can be viewed as a condensation product of 
mannosamine and pyruvic acid. The most widely distributed sialic 
acid is N-acetyl-neuraminic acid
(5-acetamido-3,5-dideoxy-D-glycero-D-galactononulosaminic acid).
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Acyl neuraminic acids in glycoproteins are partly responsible for 
the high viscosity of mucilaginous secretions. They have low pK 
values and the carboxyl groups are fully dissociated at 
physiological pH values. The high density of the negatively 
charged carboxyl groups present on each mucin molecule impart to 
these molecules an extended rod— like charged polyelectrolyte 
structure, which is responsible for the very high viscosity of the 
aqueous solutions of the sialic-acid rich glycoproteins. If the 
sialic-acid groups are removed, the viscosity drops markedly. 
Hence any alteration in the terminal sialic acid moieties would 
produce mucus with considerably different properties. As sialic 
acids tend to occupy the terminal positions of oligosaccharide 
chains, they are also important in determining the half-life of 
glycoprotein molecules.
Cancers of the stomach and colon are associated with changes 
in mucus secretion (Clamp,1977)• Changes in the carbohydrate 
content of gastric mucus (Richmond et al,1955) &nd blood group 
activity (Schrager and Oates,1973) often occur with stomach cancer 
and there is often appearance of new (foetal) antigens in stomach 
and colon cancer (Clamp,1977). Certain disease states may show 
changes in glycoprotein concentration and composition and changes 
in other constituents of mucus e.g. inorganic ions (Findlay and 
O' Connor,1961).
The extent of intestinal glycosylation of glycoproteins is 
affected by age (Carlson et al,1973), the region of the intestinal 
tract (Kim et al,1975), administration of drugs (Forstner et
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al_, 1973 ? Lukie and Forstner, 1974), and by fasting and restraint 
stress (Dekanski et al,1975)»
The aim of the present work was to determine whether the 
experimental diets, fed for various periods, would alter the rates 
of mucus synthesis in the stomach, duodenum, and colon of the rat, 
by measuring the rate of incorporation of N-acetyl (5h )glucosamine 
into mucosal homogenates from these sites. This sugar appears in 
three locations in the oligosaccharide chain: the N-acetyl
glucosamine-aspargine linkage region, the core, and the terminal, 
non-reducing trisaccharides. Thus glucosamine incorporation occurs 
throughout the bio-synthetic process of glycoprotein molecules. In 
a previous study, N-acetylglucosamine was found to give the best 
incorporation rates of a series of labelled hexoses and amino 
sugars (Shillingford et al,1974) into gastro-intestinal mucosal 
homogenates.
The effect of wheat bran at levels of 4*8, 9.6 and 28.8$
(w/w) of the diet, 8.5$ beef suet (w/w) and a stock diet (41B) 
compared to a fibre-free control diet on N-acetyl(^N^glucosamine 
incorporation into mucosal homogenates was investigated in the rat 
fed for various periods of time on the diets. The incorporation of 
L-H)serine into gastric and colonic mucosal homogenates was also 
measured to determine whether any changes occurred in synthesis of 
the polypeptide backbone of glycoprotein molecules with changes in 
dietary composition. Measurement of terminal sialic acids was
undertaken to determine whether there were any changes in the type 
of mucus synthesised.
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Experimental
Materials
N-Acetyl-D-[1-^h ]glucosamine, (sp.act. 2.94Ci/mmol) and
L-[3-^H]serine, (sp.act. 280i/mmol), were purchased from Amersham 
International PLC. Dimilume-30 and Soluene-350 were obtained from
Packard Instrument Company. Periodic acid, butan-1-ol, 
2-thiobarbituric acid and sodium arsenite were obtained from BDH 
Ltd. Phosphotungstic acid was purchased from Sigma, and all salts 
from BDH Ltd. Other materials were obtained as previously 
described.
The periodate reagent consisted of 25mM periodic acid in 0.06M 
H£S04 pH 1.2 .
The sodium arsenite reagent consisted of 2$(w/v) sodium arsenite in 
0.5M HC1.
The thiobarbituric acid reagent consisted of 0.1M thiobarbituric 
acid, brought to pH 9-0 with sodium hydroxide.
Animals
The rats used in the long-term studies (18 months) were Wistar 
Albinos (COB), from Charles River, Mansion, Kent. They were housed 
at the Flour Milling and Baking Research Association animal unit 
until 2 wk before starting this experiment, when they were 
transferred to the University of Surrey animal unit. Female rats 
were used for the measurement of N-acetyl( H)glucosamine
incorporation, and male rats for the measurement of the terminal 
sialic acids. All other rats used were male Wistar Albinos of the 
Surrey University breeding colony, and were weanling rats at the 
commencement of feeding.
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Methods
3
Rate of Incorporation of N-acetylpH)glucosamine into glycoproteins 
- (Lukie and Forstner,1972; adapted by Okine et al,1982)
Animals were killed by cervical dislocation, the abdomen opened and 
stomach, colon and the first 5cm of the small intestine (duodenum) 
excised and placed in a beaker containing ice-cold 1.15$ KOI to 
remove the food residues of these tissues. The mucosae were gently 
scraped with a microscope slide and suspended in modified Krebs 
Ringer solution ( 15inl) and homogenised with a Potter Elvehjem 
mechanically driven homogeniser with ten up and down strokes. 
Aliquots of homogenates (5ml) were incubated with 1^ i0i of 
N-acetyl(^H)glucosamine or 2 pci of L-(^H)serine for 2hr at 57° 0, 
and gassed every 20 min with 95$ oxygen, 5$ carbon dioxide. At 2hr 
the reactions were terminated by addition of
20$(w/v)trichloroacetic acid containing 2$(w/v) phosphotungstic 
acid (5ml). The tubes were left to stand overnight to ensure 
maximum precipitation. Centrifugation at 5000rpm for 15min
deposited the precipitates which were washed twice with distilled 
water (5ml) and twice with chloroform:methanol, 1:1 (v/v;5ml). The
precipitate was transferred to scintillation vials, air dried and
weighed. Distilled water (0.2ml) and Soluene-550 (1.0ml) were 
added and the protein allowed to digest. The scintillant
(Dimilume) was added (10ml) and the radioactivity counted in an 
LKB-Wallac Ultrabeta 2002 scintillation counter. All estimations 
were performed in duplicate. Non-specific binding of the 
glucosamine was corrected using incubation systems in which the
trichloroacetic acid-phosphotungstic acid reagent was added
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immediately after the addition of the radio-labelled material and 
before incubation was commenced. Affinity chromatography on 
sephadex has shown the precipitated mucus fraction to contain the 
label only in mucus glycoprotein (Johnston,1977)•
The quench curve was determined by addition of chloroform 
(0.0 - 1.2ml) to Dimilume-30 (10ml), S'oluene-350 (1.0ml) water
(0.2ml) and ^H-hexadecane standard (1.64x10^ dpm), to enable 
conversion of cpm to dpm, by the external standard efficiency 
ratio.
Measurement of N-acetylneuraminic acid (NANA)
Sample preparation:
Mucosal scrapings of stomach, duodenum and colon, obtained as 
described above, were homogenised in 5mM EDTA (15ml) and 
glycoproteins precipitated by the addition of 10% trichloroacetic 
acid containing 1%(w/v) phosphotungstic acid (5ml). The 
precipitate was washed twice with distilled water (5ml) and twice 
with chloroform:methanol,1:1 (v/v;5ml), air dried and weighed. The 
precipitate was homogenised in distilled water (lOmg
precipitate/ml) and if storage was required this preparation was 
stored at -40°C.
Hydrolysis procedure :
Equal volumes of sample and 0.05M H2S04 were sealed under nitrogen 
in a glass ampoule and heated at 80°C in an oven for 1hr. The 
sample was filtered.
Estimation of N-Acetylneuraminic acid: (Aminoff,1961).
Aliquots of the sample (0.5ml) were treated with periodate reagent 
(0.25ml) for 30min. The excess periodate was reduced with sodium
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arsenite reagent (0.2ml), and the tubes left to stand until the
yellow colour of the liberated iodine had disappeared.
Thiobarbituric acid reagent (2ml) was added and the samples covered 
and heated in a boiling water bath for 7.5min. The solutions were 
cooled and extracted with butan-1-ol (5ml) containing 5%(v/v) 12M
HC1. Separation of the two phases was facilitated by a short
centrifugation at 3000rpm for 10 min, using a Beckman J6
centrifuge. The absorbance was read at 549nm using a Cecil 272 
spectrophotometer. Blanks and standards (5-40jig N-acetylneuraminic 
acid) were carried through the same procedure.
There is a second absorbance maximum at 552nm due to
deoxyribose (2-DR) for which a correction was made since it
interfered with absorption at 549nm. The correction factor was
obtained by determination of the molecular extinction coefficients
of NANA and 2-DR and substituting them into the following equation
pmol NANA ^3 ..... E4
 -- — x OD54g n m ----- ---------x ODgg^nm
E 2 E 3  r- E 2 E 4  E 2 E 3  —  E 1 E 4
where
E^ = mol, ext, coeff. of NANA at 532 nm x 10 3
E2 = mol. ext, coeff, of NANA at 549 nm x 10 3
E 3 = mol, ext. coeff, of 2DR at 532 nm x 10 3
E4 = mol. ext. coeff, of 2DR at 549 nm x lo"3
— 93 —
Statistical analyses
These were performed using student’s t^ test.
Results
The quench curve for tritium is shown in Fig 4.1• The 
rate of incorporation of radiolabelled N-acetylglucosamine and 
L-serine was found to be linear for incubation periods of up to 
3hr (Figs, 4-2 & 4,3,1,
After 4 wk exposure to the experimental diets the rats 
maintained on the 4.8$ and 9.6$ bran, and 8.5$ beef suet diets 
were found to have significantly higher incorporation of 
N-acetyl(^H)glucosamine in stomach mucosal glycoproteins in 
comparison to the fibre-free control group (Table 4.1). No 
changes were observed at 8 wk (Table 4.1). Duodenal mucus 
production was not affected by any of the diets after 4 or 8 wk 
of feeding (Table 4.2). Colonic mucus production was 
significantly increased in rats maintained on the 8.5$ beef 
suet diet for 4 wk, but no effect was observed after 8 wk of 
feeding. The 4.8$ and 9.6$ bran diets did not significantly 
alter colonic mucus production after 4 or 8 wk of exposure to 
the diets (Table 4.3).
The long-term study in female rats showed a significant 
increase of gastric mucosal incorporation of
U-(3:H)acetylglucosamine in those rats maintained on the 9.6$ 
bran diet (Table 4.1). The 8.5$ beef suet group had the same
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increase compared to the fibre-free control group but, because 
of the large animal variation, the result was not significant 
for this group (Table 4*1)• Similarly the increase observed in 
rats maintained on the stock diet- was found not to be 
significant. A significant increase in sugar incorporation in 
animals maintained on the stock diet was observed for duodenal 
mucus production (Table 4.2). In the colon the stock diet was 
again found to significantly increase the production of mucus 
(Table 4.3). The rats maintained on the 9*6% bran and 8.5$ 
beef suet diets had increased incorporations compared to the 
fibre-free controls, but these were not statistically 
significant.
The growth of the rats maintained on the 28.8% bran diet 
followed the same curve as the control group (fibre-free) over 
this time period (8 wk, Fig. 4- 4). This diet was found not to 
affect the incorporation of N-acetyl (3 H)glucosamine at any of 
the intestinal sites studied after an 8 wk feeding period 
(Table 4.4).
Incorporation of L-serine, which indicates the rate of 
polypeptide synthesis was not altered by dietary wheat bran at 
either level, or the stock diet, after 12 wk of feeding, in the 
stomach mucosa compared to the fibre-free control group. In 
the colon the 4.8% bran diet similarly did not alter the 
incorporation of L-<3 H)serine into the mucosal glycoproteins in 
comparison to the fibre-free control group (Table 4.5).
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The content of terminal sialic acid in the 
acid-precipitated glycoproteins was not affected by dietary 
wheat bran, dietary beef suet or the stock diet after 4 wk or 
18 months of exposure to the diets, in gastric or duodenal 
mucosal glycoproteins (Table 4.6 & 4*7). In colonic
glycoproteins, 4.8% bran was found to significantly increase 
the sialic acid content and 9.6% bran to increase it to the 
same extent, though not reaching levels of significance due to 
animal variation (Table 4.8).
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Fig. 4.2
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Table 4.1. Effect of Wheat Bran, Beef Suet and a Stock diet on the^
Incorporation of N^-acetyl^glucosamine in the Rat Gastric
Mucosal Glycoproteins.
Diet Group
Rate of (3H)N-acetylglucosamine incorporation 
(pmol/mg glycoprotein/hr)
Length of
feeding
period
4 weeks 
(males)
8 weeks 
(males)
18 months 
(females)
Fibre-free
Control
4.8% bran
9.6 % bran
8.5% beef suet
4IB Stock diet
0.13±0.11
* * *  
2.13±0.39
**
2.6710.64
1.2710.43
0.2710.14
0.2710.15 
0.2510.10 
0.1710.09(4)
0.5410.14 (3)
1.6310.32(4)
1.6710.58
1.5810.44
Results are mean 1 SEM for 5 rats per group unless otherwise indicated 
(numbers in parentheses).
Value significantly different from control:
*p<0.05, **p<0.01, ***p<0.005.
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Table 4.2. Effect of Wheat Bran, Beef Suet and Stock Diet on the
incorporation of N-acetylglucosamine in the Rat Duodenal 
Mucosal Glycoproteins.
Diet Group
Rate of (^H)N-acetylglucosamine incorporation 
(pmol/mg glycoprotein/hr)
Length of 4 weeks 8 weeks 18 months 
feeding (males) (males) (females) 
period
Fibre-free 0.7710,46 0.1310.05 0.2710.10(3)
Control
4.8% bran 1.4810.65 0.0610.008(4) —■
9,6% bran 0.2110.08 0.0410.007 0.4310.20(4)
8.5% beef suet 1.7110,71 0.1010.05 0.3910.10(4)
41B Stock diet - - 0.9110.27 *
Results are mean ± SEM for 5 rats per group unless otherwise indicated 
(numbers in parentheses)
Value significantly different from control: *p<0.02.
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Table 4.3. Effect of Wheat Bran, Beef Suet and a Stock Diet on the
Incorporation of N-acetylglucosamine into Rat Colonic
Mucosal Glycoproteins.
Diet Group
Fibre-free
Control
4.8 % bran
9.6 % bran
8.5% beef suet
4IB Stock diet
Length of
feeding
period
Rate of (3h )N-acetylglucosamine incorporation 
(pmol/mg glycoprotein/hr)
4 weeks 
(males)
0.6510.14
0,6510,22
0.5510.20
**
2.0410.58
8 weeks 
(males)
18 months 
(females)
1.0010.38
0.6610.17
0.6410.13
1.4710.19(4)
0.2710.08(3)
0.6210.35(3) 
0.6410.31 
0.9910.18*
Results are mean 1 SEM for 5 rats per group unless otherwise 
indicated (numbers in parentheses)
Values significantly different from control:
*p<0.05, **p<0.02.
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DURATION OF FEEDING PERIODS (WEEKS)'
 _ _ _ _  Fibre Free control diet
_ _ _ _ _ a-_ _ _ _  28.8 % bran diet
Fig. 4.4. GROWTH CURVE OF RATS FED ON 28.8% BRAN + CONTROL DIETS
Results are means of five rats per group.
- 103
Table 4.4. Effect of High Levels of Dietary Wheat Bran on the
I n c o r p o r a t i o n  o f  N - a c e t y l g l u c o s a m i n e  i n t o  H a t  G a s t r i c
D u o d e n a l  a n d  C o l o n i c  M u c o s a l  G l y c o p r o t e i n s .
Diet Group
Rate of (3H)N-acetylglucosamine incorporation 
Cpmol/mg glycoprotein/hr)
Tissue Stomach Duodenum Colon
Fibre-free 2.68±0.50 1.38±0.86 1.14±0.12
Control
28.8% bran 2.09±0.60 1.33±0.29 1.24+0.26
Results are mean ± SEM for 5 animals per group, Male rats were 
maintained on the diets for an 8-week period.
/
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Table 4.5, Effect of Wheat Bran and a Stock Diet on the Incorporation 
of L-serine into Rat Gastric and Colonic Mucosal 
Glycoproteins,
Diet Group
Rate of Incorporation of (^H)L-Serine 
(mol x lCr15/mg glycoprotein/hr)
Tissue Stomach Colon
Fibre-free 9.1±2.0 2 ,7±0. 6
Control
4,8 % bran 8.6+Î.9 3.3±0.9
9.6% bran 12,8±4.0 -
4 IB Stock 8 .2±0 . 6 -
Diet
Results are means ± SEM for 5 rats per group.
Male rats were maintained on the diets for 12 weeks.
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Table 4.6. Effect of Wheat Bran, Beef Suet and a Stock Diet 
on the Sialic Acid Content of Rat Gastric Mucosal 
Glycoproteins.
Diet Group
Sialic Acid Content (nmol/mg 
glycoprotein)
Length of
feeding
period
4 Weeks 
(males)
18 months 
(males)
Fibre-free
Control
4.8% bran
9.6 % bran
8 .5 % beef suet
4IB Stock 
Diet
0.39±0.09
0 .55±0. 1 2  
0.34±0.08 
0.35±0.07
0.4810.07(4)
0.4910.08(3)
0.3210.05
0.2710.03(4)
Results are mean 1 SEM for 5 rats per group unless otherwise 
indicated (numbers in parentheses).
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Table 4.7. Effect of Wheat Bran/ Beef Suet and a Stock Diet on the
Sialic Acid Content of Rat Duodenal Mucosal Glycoproteins,
Diet Group
Sialic Acid Content (nmol/mg 
glycoprotein
Length of
feeding
period
4 weeks 
(males)
18 months 
(males)
Fibre-free
Control
4.8% bran
9.6 % bran
8.5% beef suet
4IB Stock 
Diet
0.2410.04
0.1910.01 
0.3010.06 
0.2810.07
0.1810.03
0.1710.03
0.2010.03
0.2010.04(4)
Results are the mean 1 SEM for 5 rats per group unless otherwise 
indicated (numbers in parentheses).
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Table 4.8 . Effect of Wheat Bran, Beef Suet and a Stock Diet on the
• Sialic Acid Content of Rat Colonic Mucosal Glycoproteins.
Diet Group
Sialic Acid Content 
(nmol/mg glycoprotein) 
(Males)
Fibre-free
Control
0.77±0.02(4)
4.8% bran 1.83±0.03
9.6 % bran 1.84±0.05
8 .5 % beef
suet 0.80±0.02
Results are mean ± SEM for.5 animals per group unless 
otherwise indicated (numbers in parentheses).
Value significantly different from control:
*p<0.05.
The rats were maintained on the diets for 4 weeks.
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Discussion
The assay of incorporation of N-acetyl(3H)glucosamine into 
intestinal mucosal glycoproteins shows wide animal variation. 
Animals are not fasted before killing as this considerably 
depresses the rate of incorporation (Dekanski et al,1975)« At the 
time of killing the animals have variable contents of food residues 
in the stomach, duodenum and colon. It is not known what extent of 
variation in mucus production this produces. Mucosal contamination 
of the scraping is another variable parameter which may lead to 
discrepancies between samples.
The gastro-intestinal tract is a difficult organ to study 
because of such factors as extremes of pH, variable enzyme content, 
and microsomal contribution of intestinal matter (Hafez,1977)• 
Luminal fluids may contain secretions from various other organs 
which enter into the tract. The rate of incorporation into 
duodenal mucosal glycoproteins shows a low activity after 8 wk of 
feeding, which suggests that autolysis may have occurred due to the 
presence of digestive enzymes in the preparation. Microrganisms 
present in the colonic preparations may utilise the 
N-acetyl (^H)glucosamine, another source of variation between 
animals.
Wheat bran was found to significantly increase incorporation 
of N-acetylH)glucosamine into gastric mucosal glycoproteins only, 
after 4 wk and 18 months of feeding, The bran-containing diets are 
more bulky than the control diet and would be expected to require
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more secretion to achieve the same level of liquidisation, which 
occurs before the contents leave the stomach, as the fibre-free 
diet. Also, the bran may adsorb the secretions which would cause a 
greater requirement for mucus production. Similarly the high fat 
diet on entering the stomach would produce more viscous contents 
than the control diet requiring an increased volume of secretion 
from the stomach to achieve the same level of liquidisation. This 
may explain the significant increase seen after 4 wk, and the 
increase after 18 months of feeding. A significant increase in 
N-acetyl(H)glucosamine incorporation was seen in the colon mucosal 
homogenate after 4 wk and 18 months of feeding with the 8.5% beef 
suet diet.
The increased incorporation of N-acetyl( H)glucosamine in the 
rats maintained on the 8.5% beef suet diet is in contrast to 
results observed by Biol et al (1981). These authors found a high 
fat diet (10$ linoleic or oleic acid), fed to rats injected ip with 
I^Cglucosamine, to inhibit incorporation of ^Cglucosamine into 
microsomal pellets of gastro-intestinal tissue. No effect on 
incorporation of ip injected (^C)fucose or (1 )galactose, after 1
wk of feeding was observed. This feeding period is considerably 
shorter than the periods chosen in the experiment now.reported. 
Study of several of the glycosyltransferases indicated that high 
fat diets (10-50% fat) inhibited fucosyl-transferase activity in 
vitro after a 4 wk feeding period. The types of fat used to 
supplement the diet for the in vivo study were unsaturated, whereas 
beef suet, used in the experiment now reported, contains saturated 
fat. Biol et al (1981) found the corresponding saturated . fat
- 110 -
(stearic) to produce the same decrease in fucosyltransferase 
activity in vitro.
The stock diet (41B) was found to increase the incorporation 
of N-acetyl(^H)glucosamine at all sites studied, after 18 months of 
feeding in the female rats. These increases reached levels of 
significance in the colon and duodenum. The stock diet has a high 
dietary fibre content (17.6% NDF, Appendix l). As the bran diets 
only produced significant increases in the stomach it seemed 
pertinent to determine whether a higher dietary level of bran 
(28.8%,w/w) would produce similar results to those of the stock 
diet, thus elucidating the possible role of the higher dietary 
fibre content of the stock diet in increasing the rate of 
incorporation of the radiolabelled sugar into the mucosal 
homogenates. However the 28.8% bran diet, after 8wk of feeding, 
was observed not to produce an increase in the rate of 
incorporation of N-acetyT^H)glucosamine into mucosal homogenates 
at any of the intestinal sites studied, indicating that bran, even 
at this high level, does not increase the rate of glycosylation. 
The stock diet is of variable composition and the increased 
production of mucus caused by this diet may be due to an undefined 
component.
The incorporation of L-serine into mucosal glycoproteins is a 
measure of polypeptide synthesis. This was found to be unaffected 
by two levels of wheat bran and the stock diet in the stomach, and 
by the 4.8% bran diet in the colon, after a 12wk feeding period.
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Measurement of the terminal sialic acids in the rats
maintained on the 4*8 and 9.6% bran diets and 8.5% beef suet diet
for 4 wk (males), and the 9.6% bran, 8.5% beef suet and the stock
diets for 18 months (females) showed no significant changes in
comparison to the control fibre-free group in the stomach and
duodenum glycoproteins, indicating that the character of the mucus
is not altered at these sites by the diets. A significant increase
was observed in the colonic mucosal glycoproteins in the rats
a similar though not significant increase in rats maintained/ on the 
maintained on the 4.8% and\9•6% bran diets for 4 wk. Tnis suggests
that the mucus would be more viscous. A more viscous mucus may
give better protection to the underlying mucosa by forming a
thicker barrier.
Changes in mucus composition in disease states are 
well-reported. These changes may be quantitative affecting the 
volume of mucus secreted, quantitative changes in the concentration 
of constituents, increased loss of the mucus producing cells or 
abnormalities of the synthetic process (Clamp, 1977)• 
Histochemical studies have shown changes in intestinal mucus cells
in ulcerative colitis and Crohn's disease (Lev and Spicer,1965),
where hyperplastic goblet cells contain more sulpho-mucin than 
normal intestinal goblet cells. Greco et al (1967) found staining 
patterns of goblet cells at various stages of ulcerative colitis to 
differ. At early stages the goblet cells contained only neutral 
mucins, in advanced cases they contained weakly acidic mucins, 
which was indicative of a slower cell turnover. Filipe (1969) 
compared the distribution of mucins to ulcerative colitis and 
Crohn's disease to normal controls. The controls showed a
-  1 1 2  -
predominance of sulphated mucosubstances and absence of neutral 
mucins in the lower two-thirds of the crypts while the goblet cells 
of the upper third of the crypts contained a mixture of sulphated 
and non-sulphated acid mucopolysaccharides with a variable but 
small amount of neutral mucins. In severe cases of ulcerative
colitis a decrease of sulphated and acid.non-sulphated mucins was 
found. In patients with Crohn's disease the reduction of 
mucosubstances was found in only a few cases. An increased
production of mucus was reported by Goodman et al (1975) in
patients with Crohn's disease. These authors reported a 50% higher 
level of glucosamine synthetase in intestinal biopsies of patients 
with the disease compared to normal controls. Glucosamine
.synthetase catalyses the synthesis of glucosamine, the rate 
limiting reaction in gastro-intestinal glycoprotein biosynthesis
(Jerzy Glass & Slomiany,1977)• Lev et al (1969) reported less
cytoplasmic mucus in gastric cancer cells than in the normal 
gastric surface epithelium or goblet cells of the intestinal 
mucosa.
A reduction of the carbohydrate fraction of human colonic 
neoplasm compared to normal adjacent mucosa was reported by Kim et_ 
al (1974) which appeared to be directly related to the reduction of 
certain specific glycosyltransferases. Decreased activity of 
sialyltransferase for example reduces the cohesive properties of 
mucus. Amino acids in the protein core of glycoprotein of both 
malignant and normal specimens appear to be of similar composition 
whereas the glycoproteins from malignant colons have a wider 
monosaccharide variation than normal colons (Parke,1978).
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Many diseases of the gastro-intestinal tract are thought to 
he related to diet. Any quantitative or qualitative effect of 
dietary alteration on mucus biosynthesis would be of significance 
when considering causation of these diseases. Biol et al ( 1981) 
found high carbohydrate diets produced no effect on the in vivo 
incorporation of  ^^ C-glucosamine, ^Vc-fucose or^ ^  C-galactosamine 
into the microsomal pellet of intestinal mucosal cells. High 
protein diets were shown to increase the activity of several 
glycosyltransferase enzymes whereas high carbohydrate and high fat 
diets inhibited fucosyl-transferase. In the present study, bran 
appeared to increase mucus production in the stomach and to alter 
the sialic acid content in colonic mucosal glycoproteins. Beef 
suet (8.5%) appeared to increase mucus production in the stomach 
and the colon in the short-term, with no effect on the sialic acid 
content. The stock diet was associated with increased production 
of mucus at the three sites studied. The effects are only 
indications and no firm conclusions can be drawn from the results 
now presented.
Chapter Five
The Effect of Wheat Bran on Vitamin D Status 
and Bone Mineral stores in the Rat.
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•Introduction
Little research of the effect of dietary fibre on the 
absorption of vitamins and vitamin status has been conducted. 
Cummings (1978) has stated that since there is a general 
association of malnutrition and vitamin deficiency with staple 
diets, which are generally high in fibre content, and fibre has the 
capacity to adsorb organic components, this is an important area of 
research.
Vitamin Dg is a fat soluble vitamin and its absorption from 
the diet is similar to that of cholesterol, lipid soluble drugs and 
fatty acids (Hollander,1981). In the gastro-intestinal tract these 
compounds interact with bile acids which solubilise and convey them 
to the absorptive membrane where they become partitioned into the 
monomeric phase and penetrate the lipid cell membrane. Both lymph 
and portal blood transport vitamin D away from the intestine 
(Sitrin et al,1982). The primary area of absorption is unclear - 
Norman and Deluca (1963) proposed that it was the distal small 
intestine, whereas Schachter et al (1964) concluded the proximal 
small intestine to be the major site of absorption. Both 
endogenous and exogenous vitamin D undergo enterohepatic 
circulation (Hollander,1981).
The hypolipidemic effects of certain dietary fibres is 
thought to be due to binding of cholesterol and bile salts in the 
intestine thereby increasing faecal excretion of bile acids and 
salts, lowering blood cholesterol levels and draining hepatic
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cholesterol pools. In vitro work has substantiated this theory. 
Vitamin D is likely to be subject to the same interactions with 
dietary fibre. Its dietary concentration is considerably lower 
than the other sterols so that any loss could be of significance to 
the organism.
Vitamin D is the only vitamin known to act as a hormone. It 
induces the formation of specific messenger RNA's which code for 
proteins mediating its effects (Eisenstein and Passavay,1964). It 
is also endogenously synthesised in the skin from
7-dehydrocholesterol (Deluca,1978), by a photochemical reaction 
utilising ultraviolet light forming precholecalciferol which 
undergoes thermal isomérisation to cholecalciferol (Havinga,1973)• 
It circulates in the plasma bound to an dxT-globulin as 
25-hydroxyvitamin Dg. The hydroxylation reaction occurs in the 
liver (Horsting and Deluca,1969)• The kidney further hydroxylates 
this metabolite to 1,25-dihydroxyvitamin Dg, the active form of the 
vitamin (Deluca & Schnoes,1976). Measurement of plasma levels of 
25-hydroxyvitamin Dg is thus an indicator of bodily reserves of 
pro—hormone, since conversion to the active form is closely 
controlled to meet physiological requirements. The function of 
vitamin D in calcium and phosphorus homeostasis is to elevate serum 
concentrations of both ions by acting on the intestine to increase 
absorption, on bone to mobilise stores of these minerals and on 
kidney to improve renal reabsorption.
The effects of dietary fibre on mineral balance are complex 
and the relevance of adverse interactions on the health of
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populations is difficult to elucidate. Some fibres increase 
requirements for certain minerals depending on which type of fibre 
and which mineral is under consideration (Sandstead et al,1977; 
Ismail-Beigi et al,1977; Kelsay et al,1979). Mineral status is 
dependent upon other physiological parameters - vitamin D status, 
and protein and vitamin C intakes (Cummings,1981). The body is 
able to adapt to low intakes of some minerals (Malm,1958).
Calcium availability from foods of plant origin is inferior 
to its availability from milk (Ambrecht and Vasserman,1976; James 
et al,1978; Ranhotra et al,1980). Phytic acid
(Myo-inositol-1,2,3,4,5,6-hexakis-dihydrogen phosphate) is one of 
the factors shown to be responsible (Mellanby,1925 ; McCance and 
Viddowson, 1942). Phytic acid has been found to interfere with 
absorption of phosphorus (Taylor,1965), zinc (Reinhold,1975), and 
iron (Davies and Nightingale,1975). The presence of phytase 
(myo-inositol hexaphosphate phosphohydrolase) in human gut, which 
hydrolyses phytate esters and liberates bound metals, can prevent 
the potential loss of some minerals• Losses of phytate also occur 
during breadmaking since phytase is present in all sections of the 
wheat grain (Peers,1955)• In vitro studies have shown that fibre 
itself is able to bind calcium and zinc ( Reinhold et al,1975; 
James et al,1978). The uronic acid content has been found to 
correlate with mineral binding (James et al, 1978). The 
association of wholemeal bread with disturbances in mineral 
metabolism is important since wholemeal bread is a staple food in 
the diets of many populations. In many Western countries, white 
bread is fortified with iron and calcium, whereas wholemeal bread
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is not.
The experimental work now reported was designed to 
investigate the effect of wheat bran either as a separate item in 
the rat diet or included as wholemeal bread, on the circulating 
levels of 25-hydroxyvitamin and the bone mineral stores. This
experimental work was conducted at the Flour. Milling and Baking 
Research Association.
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Experimental
Materials
26(27)3H-hydroxycholecalciferol, specific activity 22.3ci/mmol was 
obtained from Amersham International PLC. It was stored in ethanol 
at -20°C at a concentration of 2jici/ml ethanol and diluted for use 
to a concentration of 80pg/l0yl. 25-hydroxyvitamin D was a gift 
from Dr. D.E.M. Lawson of the Dunn Nutritional Laboratory at 
Cambridge, but can be obtained commercially from Philips-Duphar, 
Research Dept, Weesp, Nr. Amsterdam, The Netherlands. It was 
diluted for use to a concentration of 64ng/ml ethanol and stored at 
-20°C. Charcoal (Norit G.S.X.) was obtained from Hopkin and 
Williams. Dextran, Sodium barbital and Triton X-100 were obtained 
from Sigma, toluene and acetic acid from May and Baker and PPO and 
DMPOPOP from Packard Instrument Company. Ethanol 99«8$(v/v) min. 
was purchased from James Burrough Ltd. Chloroform, nitric acid 
(69-72%) and lanthanum chloride were purchased from BDH Ltd.
The Dextran coated charcoal suspension consisted of 9«0g charcoal 
and 0.9g Dextran-20 in 500ml barbital acetate buffer pH8.6.
The scintillant consisted of Triton - 600ml, toluene - 1400 ml, PPO 
- 10g and DMPOPOP - 0.2g.
Vitamin D-deficient serum was originally taken from rats maintained 
for 4 wk on a vitamin D deficient diet. Examination of the bones 
of these animals showed rickets to be present. This serum was used 
as a source of vitamin D binding protein,It was subsequently found 
that animals maintained for only one week on the diet had 
equivalent binding capacity. The serum was stored at -20 0 C and 
diluted 1:10000 for use in barbital-acetate buffer pH8.6, and 
maintained at 4°C.
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Animals
Male and female, weanling, Wistar Albino (COB) rats from Charles 
River, Manston, Kent, were maintained five per cage, in wire bottom 
hanging cages. Food and water were available ad libitum.
Experimental Procedure 
Vitamin D3 Determination
Samples of tail vein blood were taken from male and female rats 
maintained on the following diets for 12 wk - fibre-free (control), 
54% white bread, 54% wholemeal bread, 4.8% bran and 9*6% bran. The 
percentage composition and analysis of the diets is given in 
Appendix 1. The vitamin D content of the diets was approximately
5001.U. vitamin D/kg diet, which represents an adequate intake for 
normal vitamin D metabolism. Extracts of plasma were prepared by 
mixing 0.5ml of plasma with 2ml of ethanol and leaving at 4°C for 
50min. After this time the samples were centrifuged at 15OOrpm,
for 1Omin, in a Mistral 6L centrifuge, and the extract was ready
for use (Belsey et al, 1974)•
Bone Mineral Measurements
Rats maintained on the following diets for 5 months - fibre-free 
(control), 17% white bread, 54% white bread, 17% wholemeal bread, 
54% wholemeal bread, 4.8% bran, 9.6% bran, 8.5% beef suet and 41B 
stock diet, were killed by cervical dislocation and the hind leg 
removed and stored at -20°C until required. The diets contained
adequate levels of all minerals.
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Methods
Measurement of serum 25-hydroxycholecalciferol (Modification of 
Preece et al (1974)).
The incubation mixture consisted of 80pg
26(27)^H-25-hydroxycholecalciferol, plasma extract (45|il), barbital
acetate buffer (500|il) pH8.6 containing 1:10000 dilution of the
o
vitamin D deficient serum. The incubation was carried out at 4 C 
overnight (16 hr). After this time 1Opl of the charcoal suspension 
was added and the tubes left to stand for 15min at 4°C. The tubes 
were then centrifuged at 2650rpm, 4°C, for 15 min using a Mistral 
6L centrifuge. Aliquots of the supernatant (500ul) were put into 
scintillation vials with scintillant (10ml) and water (1OOpl). 
Counts were made for 5min. All samples were measured in 
quadruplicate. Non-specific binding counts were determined by 
omission of the vitamin D deficient serum from the incubation 
mixture. This value was subtracted from all samples. Recoveries 
of plasma extraction were measured by adding 1Opl of tracer to each 
sample. All recoveries were greater than 93%* The standard curve 
was prepared from a serial dilution in 80%' ethanol of 
25-hydroxycholecalciferol to give a total of eight standards with 
concentrations ranging from 0.25ng/ml to 32 ng/ml.
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Measurement of Bone Minerals 
(Turnland et al,1979; Kang et al,1979)
The legs were thawed, the soft tissues removed using scissors and a 
scalpel and the bone weighed. A hole was drilled in each end of 
the bone using a fine drill and the bone reweighed, so that each 
bone could be labelled with a numbered aluminium tag. Chloroform 
extraction was carried out for 24hr using the Soxhlet extraction 
technique, after which the bones were dried in an oven at 100°C for 
24hr or until constant weight was obtained. They were then ashed 
in a muffle furnace at 500°C for 24 hr in acid-washed evaporating 
dishes until they were white and brittle. The ashed bones were 
reweighed. Nitric acid 25% (2ml) was added to the evaporating dish 
containing the bone and the dish and contents were gently warmed 
until the bone had dissolved. The solution was filtered into a 
100ml plastic volumetric flask containing 5% lanthanum chloride 
(4ml). Each dish was washed with 10% nitric acid (25ml) which was 
boiled and added to the volumetric flask. The volume was made up 
to 100ml with deionised water, rinsing and boiling the dish each 
time to ensure complete removal of the contents. The solution was 
then ready for atomic absorption analysis with appropriate 
dilution, using a Perkin Elmer 560 atomic absorption
spectrophotometer (air-acetylene flame)•
Statistical Analyses
These were performed using . . Student's t_ test.
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Results
Measurement of Plasma Vitamin - The quench curve for tritium, 
for which acknowledgements are due to Dr. B. Thewlis, of the 
Flour Milling and Baking Research Association, is shown in Fig. 
5.1. The machine efficiency was found to be 52.6% and the counting 
efficiency varied from 17.4-28.3%. Non-specific binding counts 
were on average 4.87%+ 1.98% of the total counts. Extraction
efficiencies of the plasma samples were on average 98.5%i 5.2%. A 
typical standard curve is shown in Fig. 5.2.
Large variation was found between animals within the same 
dietary groups. Bran, fed either as a supplement or in the form of 
wholemeal bread, was found not to significantly affect plasma 
25-hydroxycholecalciferol concentrations in male or female rats in 
comparison to controls (fibre-free diet). Neither level of bran 
supplementation (4*8 or 9.6%) was found to produce a significant 
effect. Similarly there were no significant differences between 
the male or female rats maintained on the 34% white bread diet when 
compared to the controls (Table. 5*1 )« Female rats were
observed to have lower plasma 25-hydroxycholecalciferol levels than 
the male rats in the same dietary groups, although these 
differences were not significant.
Bone Mineral Measurements - The mineral concentrations are 
expressed in mg/gm dried bone, and mg/gm ashed bone which, refer to 
the bone weight after Soxhlet extraction and the weight after 
ashing respectively. The weights of the femur bones from the 
various diet groups were not significantly different to the control 
group (fibre-free), when expressed as dried or ashed bone weight,
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except for the female rats maintained on the 11% wholemeal bread
diet; the dried bone weights were significantly lower than the
control (Table 5.2).- Plasma concentrations of calcium, magnesium
and phosphorus were measured and no significant differences were
ho
found between any of the diet groups in comparison/the fibre-free 
diet group (Moore,1983)•
No significant differences were observed between the diet 
groups for the bone calcium concentrations when the results were 
related to the dried bone weight in either the male or the female 
groups (Table 5.3 ). When the results were related to ashed bone 
weight the female rats maintained on the white bread diet, 9.6$ 
bran diet, 8.5$ beef suet and 41B stock diet had significantly 
lower calcium concentrations than the fibre-free controls. The 
male rats showed no significant differences to the control group 
for calcium concentrations in relation to the ashed bone weight.
Magnesium concentration was not altered significantly in any 
of the diet groups in comparison to the fibre-free control group in 
either the female or male rats whether related to the dried bone 
weight or to the ashed bone weight (Table 5.4).
Phosphorus concentration was found to be significantly higher 
in the female rats maintained on the 17$ wholemeal bread diet when 
compared to the fibre-free control group and related to dried bone 
weight but not when related to the ashed bone weight. No other 
significant differences were found between the other diet groups
and controls for either the male or female rats when related to 
dried or ashed bone weights (Table 5.5).
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Table 5,1, Measurement of Plasma 25-H.ydroxycholecalciferol 
Concentration in Male and Female rats.
25-Hydroxycholecalciferol concentration 
Cpg/ml plasma)
Dietary
Treatment Male Rats Female Rats
Fibre-free
Control 65 ± 13 46 ± 12
34% White 
bread 57 ± 16 49 ± 13
34% Wholemeal 
bread 63 ± 20 49 ± 17
4.8% Bran 55 ± 13 63 ± 24
9.6% Bran 60 ± 26 41 ± 18
Results are mean — SEM for 5 animals. The rats were maintained 
on the experimental diets for 3 months.
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Table S. 2. Dried and Ashed Weights of Femur Bones in the Rat
Maintained on the Experimental Diets for 3 Months,
Bone Weight (g)
MALE RATS FEMALE RATS
Dietary 
Treatment . Dried Bone Ashed Bone Dried Bone Ashed Bone
Fibre r^ free 
control 0.65±0.02 0.44±0.003 0.47±0.04 0.29±0.03
17% white 
bread 0,6210.03 0,41+0.02 0.42+0.02 0.28+0.01
34% white 
bread 0,62±0,03 0,39+0.02 0. 37±0. 05 0,34±0.03
17% wholemeal 
bread 0,62±0, 04 0.39±0,03 0,41+0.01* 0,27+0.01
34% wholemeal 
bread 0,55±Q. 08 0,36±0.07 0.46±0.01 0. 32±0.02
4,8% bran 0,64±0. 02 0,42±0.02 0.45+0.02 0.29+0.01
B, 6% bran 0,63+0.03 0.42±0.02 0.43±0.02 0,28+0,01
8.5% beef suet 0.63±0. 03 0.41+0.02 0.46±0.07 0.31±0.01
41B Stock Diet 0,67 ±0.03 0,43±0.02 0.45+0.01 0.30+0.01
Results are means ± SEM for 3-5 animals.
Value significantly different from control : *p < 0.02
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Table 5.3, Calcium concentration in Dried and Ashed Femur
Bones of Rata Maintained on the Experimental Diets for 3 Months
mg Calcium/g bone
MALE RATS FEMALE RATS
Dietary
Treatment
Dried Bone Ashed Bone Dried Bone Ashed Bone
Fibre-free
(control) 262+Î5 377+Î5 295±29 482±37
17% white 
bread 233±6 354+7 299+49 469+7!
34% white 
bread 252+4 396+7 25O+Î3 383±18*
17% wholemeal 
bread 245+18 365+lB 292+9 . 422±12
34% wholemeal 
bread 247+Î4 4O9+Î6 262±4 380±31
4.8% bran 249+3 38Î+3 286+2! 399+24
9,6% bran 237±19 355+34 25O+7 385±14*
8.5% beef suet 25Î+9 386+Î4 247±14 365±26*
4IB Stock diet 263+4 4O2+5 245+ÎO 371±15**
Results are mean ± SEM for 4-5 rats.
Value significantly different fron controls: * p < 0.05;
** p < 0.02.
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Table 5,4. Magnesium Concentration in Dried and Ashed Femur
Bones of Rats- Maintained on the Experimental Diets for
3 Months,
mg Magnesium/g bone
Dietary MALE RATS FEMALE RATS
Treatment Dried Bone Ashed Bone Dried Bone Ashed Bone
Fibre-free
Control 4. 7±0,2 6.9±0.4 4.2±0.4 7.010.8
17% white 
bread 4,2±0,3 6,4±0,5 4.1±0,4 6.310.7
34% white 
bread 4.6±0.3 7.2±0.5 5.010.7 7.811.0
17% wholemeal 
bread 4.2±0.4 6.5±0,6 4,110.4 6.310,6
34% wholemeal 
bread 3,8±0.9 5,9±1.2 3.510.4 5.210.8
4,8% bran 4.6±0f 3 7.1±0.4 5.410.5 7.010.5
9.6% bran 4.6±Q,2 6,9±0.3 4.310.2 6.710.7
8.5% beef suet .4,4±0,3 6,7±0,3 4,410.4 6.610.7
4IB Stock diet 3.6±0.6 5.5±1.0 4.310.3 6.510.5
Results are mean ± SEM for 4*5 animals.
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Table 5.5, Phosphorus Concentration in Dried and Ashed Femur Bones
of Rats Maintained on the Experimental Diets for 3 Months.
Dietary mg Phosphorus/g bone
Treatment MALE RATS FEMALE RATS
Dried Bone. Ashed Bone Dried Bone Ashed Bone
Fibre^free
Control 125.±4 Î85+7 109±4 203±26
17% white 
bread 115+12 ÎB9+Î8 ÎÎ6+B Î76+ÎO
34% white 
bread 123±3 Î94+6 137±19 211+32
17% wholemeal 
bread 112±8 Î97+3O 125±5* 230+37
34% wholemeal 
bread 109+15 Î9Î+39 ÎO9+H Î59+Î3
4,8% bran Î29+3 194±4 117±7 169+9
9,6% bran 125±4 Î94+6 116±9 ÎBO+Î5 ’
8.5% beef suet 126+5 191 ±7 116±10 Î69+Î4
4 IB Stock. Diet . 100+10 153+16 125±15 193±26
Results are mean ± SEM for 4-5 animals.
Value significantly different from control : *p < 0,05,
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Discussion
The modifications of the method of Preece et al (1974) were 
the omission of the sample extraction and chromatographic step 
which were replaced by the ethanolic extraction procedure of Belsey 
et al,(1974). The 1:20000(v/v) dilution of the vitamin D-deficient 
serum was replaced with a 1:10000(v/v) dilution, which was found to 
give more consistent results. The om ission of 1 % bovine serum 
albumin was found to be without effect. The volume of sample added 
was 45pl rather than 50pl and the assay was performed in 
quadruplicate rather than triplicate.
The method of Belsey et al (1974) • is a rapid assay 
(incubation time 2hr, 4°C.) for 25-hydroxycholecalciferol in which 
it was shown that the vitamin D-transport protein from vitamin 
D-deficient serum preferentially binds ^H-25-hydroxycholecalciferol 
for which the binding half-time was found to be very low (min), 
contrasting with the binding half-time of J H-cholecalciferol which 
was found to be very high (days). Cholesterol and 
25-hydroxycholesterol produced no displacement of
3j{_25-hydroxy cholecalciferol. Vitamin D analogues which do 
cross-react are at low serum concentration (Belsey et al,1974a). 
The overnight incubation used in the assay now reported would incur 
less than 15% maximum binding attributable to cholecalciferol.
The presence of ethanol in the incubation system solubilises 
the steroids avoiding the need for a lipoprotein carrier which
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requires several days to reach equilibrium (Belsey et al,1971). 
Morris and Peacock (1976) used a level of 10% ethanol extract in 
the incubation system above which plasma proteins are precipitated, 
and below which the ^ H-PS-hydroxycholecalciferol is insufficiently 
solubilised. Haddad and Chyu (1971) used a level of 1% ethanol. 
In the experiment now reported the level of 8.29% ethanol was used, 
a lower level than Preece et al (1974) who used a level of 10.7%.
The results indicate that wheat bran at dietary levels of 4.8 
and 9.6% do not alter the circulating levels of 
25-hydroxycholecalciferol, in male or female rats, compared to a 
fibre-free control diet, and that 54% white bread and 54% wholemeal 
bread are similarly without effect. It can be concluded that wheat 
bran at these levels has no gross effect on absorption and 
subsequent hepatic hydroxylation of dietary cholecalciferol in rats 
receiving an adequate supply of the vitamin.
Work in vitro has shown that lignin, pectin and some types of 
bran bind bile acids and bile salts Eastwood à Hamilton,1968; 
Kritchevsky,1978; Vahouny,1980) whereas cellulose has little 
ability to sequester bile acids (Story and Kritchevsky,1976a; 
Vahouny et al,1978). Eastwood and Hamilton (1968) proposed that 
the nature of the bonding between bile acids or bile salts and 
lignin is hydrophobic constituting partitioning of the bile acids 
and salts between the fibre and the aqueous phases. Lignin has 
also been shown to bind other hydrophobic compounds e.g. phenol 
(Stamm and Millett,1941). Vitamin D is a hydrophobic molecule 
since it has only one oxygen function. Eastwood and Hamilton
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(1968) proposed that the more hydrophobic the molecules the more 
easily they are bound.
Investigations in vivo have shown that bran is ineffective as 
a hypolipidaemic and hypocholesterolaemic agent (Kay and 
Truswell,1977a) so that its ability to bind bile acids and 
cholesterol in vitro bears little relationship to its activity in 
vivo (Calvert and Yeates,1981). Jenkins et al (1975) and Cummings 
et al (1976) have reported increased faecal excretion of steroids 
with increased concentration of dietary wheat fibre. Walters et al 
(1975) conversely reported no effect. The increase in faecal fat 
excretion which accompanies increased consumption of wholewheat 
products is thought not to be significant in terms of the overall 
digestibility and absorption of fat (Cummings,1978). Lowsowsky 
(1978) argues that since the level of faecal fat after the 
consumption of quite high levels of bran is not much greater than 
controls, and bran has a high lipid content - 6.29% (Cummings et 
al,1976), much of the additional faecal fat may be unabsorbed 
material from the bran.
In the light of the action of bran in 'vivo and the results 
observed in the reported experiment it would appear that wheat bran 
does not adversely affect serum 25-hydroxycholecalciferol 
concentration.
Other dietary fibres have been reported to be hypolipidaemic 
in vivo and to have the capacity to bind bile acids and salts in 
vitro. Such fibres may be more likely to produce adverse effects
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on dietary vitamin D absorption. Pectin has been shown to be 
hypocholesterolaemic in rats (Wells and Ershoff,1961 ; Story ejfc 
al,1977), and to increase the excretion of bile acids but not 
sterols in rats fed 1 % cholesterol (Leveille & Sauberlich,1966). 
Guar gum (Chang and Johnson,1976) and carageenan, another vegetable 
gum (Ershoff and Wells,1962; Tsai et al,1976) have been shown to 
decrease cholesterol levels in experimental animals. In man, 
pectin (Keys et al, 1961 ; Jenkins et al, 1975b). has been reported to 
be hypocholesterolaemic whereas Fahrenbach & Riccardi ( 1965) found 
no effect. Guar gum has been reported to lower cholesterol levels 
in man (Fahrenbach & Riccardi,1965? Jenkins et al,1975b).
Dietary fibres associated with hypolipidaemia and 
hypocholesterolaemia may ' exert adverse effects on vitamin D 
absorption. However, man's facility for endogenous synthesis of 
cholecalciferol provides the majority of his requirements. 
Therefore any adverse effect on the availability of dietary vitamin 
D would be of little consequence except where certain groups of the 
population have poor vitamin D status. The recognised groups at 
risk are the indigenous elderly at home (Lawson et al,1979) and 
hospitalised (Corless et al,1975), children and adult women of the 
immigrant Asian population (Holmes et al,1973), and pregnant Asian 
women (Bashmir et al,1981). Lawson et al (1979) found that from 
December to February serum vitamin D levels of some elderly people 
fell to levels associated with osteomalacia, although no clinical 
symptoms were apparent. Ford et al (1972) were the first to report 
lower vitamin D levels in Asian immigrants in the United Kingdom in 
comparison to the indigenous population, which were considered to
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be due to maintainence of their traditional eating habits and dress 
(Preece et al,1975)» Phytate was suggested as a possible cause 
(Dunnigan et al,1975)»
A dietary supply of vitamin D is important where there is a 
low rate of formation in the skin which occurs in house-bound and 
hospitalised elderly people (Lawson,1981) and Asian women wearing 
their traditional costumes in this country. Dietary intakes of 
vitamin D in the United Kingdom are insufficient to maintain plasma 
25-hydroxycholecalciferol at saturated levels in the elderly 
(Lawson,1981). In this situation any adverse effects of dietary 
fibre on vitamin D absorption could exacerbate vitamin D deficiency 
and possibly precipitate osteomalacia. In the elderly, dietary 
fibre may be advised for prophylactic reasons. In the event of 
vitamin D deficiency, increased exposure to sunlight will make good 
any dietary insufficiency. Exposure to artificial ultraviolet 
irradiation has proved to be effective for geriatric patients in 
hospital (Corless et al,1978).
The two ways of expressing the bone mineral concentrations 
relate to the dried calcified organic matrix of the bone with the 
lipid content removed (dried bone), and to the total mineral 
content with all organic components removed (ashed bone). The 
organic matrix consists largely of collagen (90%), glycoproteins, 
phosphoproteins, proteoglycans and peptides. It forms a framework 
for the deposition of hydroxyapatite, the basic structure of bone 
mineral. Other components of bone mineral include amorphous 
calcium phosphate (Eanes and Posner,1970), calcium carbonate,
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magnesium, sodium, fluorine; traces of iron, copper, lead, 
manganese, tin, aluminium, strontium and boron have been detected 
(Eastoe,1961).
Magnesium concentration in the femur bone was found to be 
unaffected by dietary bran supplementation, or the addition of 
wholemeal bread to the diet. Similarly the white bread, beef suet 
and stock diets were without effect on the magnesium concentration. 
About half to two-thirds of the body's magnesium is present in the 
bone of which only 20% is exchangeable (Foster,1968). It resides 
in the hydration shell rather than the hydroxyapatite crystals 
(Neuman and Neuman,1958).
Phosphorus levels were significantly higher in the female 
rats maintained on the 17% wholemeal bread diet when expressed /gm 
dried bone. This effect was probably related to the lighter weight 
of the dried bone observed in this group. Wholemeal bread contains 
approximately four times the amount of phosphorus found in white 
bread. The effect was not seen in the female rats maintained on 
the 54% wholemeal bread diet or in the male rats maintained on the 
wholemeal bread diets. About 88% of the body's phosphorus is 
concentrated in the skeleton, and its homeostatic regulation is 
controlled by the actions of vitamin D, parathyroid hormone and 
calcitonin.
The significant decreases in calcium concentration (ashed 
bone weight) observed in female rats maintained on 54% white bread, 
9*6% bran, 8.5% beef suet and the 41B stock diets do not show any
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changes that are consistent with dietary changes. The 8.5% beef 
suet diet and 54% white bread diet contain less fibre than the
other diets so that these changes are not related to fibre
concentration. Also white bread is fortified with calcium and
would not be expected to produce a decrease in bone calcium
concentration. These changes are representative of a very small 
change in total body calcium since 99% is stored in the skeleton.
It can be concluded that wholemeal bread at levels of 17 and 
54% of the diet and wheat bran at levels of 4.8 and 9*6% of the
diet do not produce any deleterious effects on mineral status in
male and female rats maintained on a well-balanced diet, as
determined by measurement of concentrations of these minerals in 
the femur bone-.
The condition of hypogonadal dwarfism caused by zinc
deficiency, and anaemia caused by iron deficiency in Iran has been 
attributed to the consumption of large amounts of unleavened bread 
(bazari bread), made from high extraction flour (Haghshenass et^  
al,1972). A comparison of the ingestion of bazari and white breads 
has demonstrated the nutritional inferiority of bazari because of 
the poor availability of minerals, shown by increased faecal 
losses, even though bazari bread contains greater quantities of 
zinc, calcium, magnesium and phosphorus than white bread (Reinhold 
etal,1976). Hence the diet of the villagers contained adequate 
zinc, magnesium, iron and calcium but because of poor availability 
deficiency states occurred. Mineral binding is thought to be due 
to phytic acid and uronic acids present in some sources of dietary
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fibre. Purified phytate ingestion in humans is associated with 
increased faecal zinc. Plasma zinc and serum iron were lowered 
initially but returned to normal levels with continued ingestion of 
phytate; calcium and serum phosphate levels were decreased and 
remained at low levels (P.einhold et al, 1975)» The available 
carboxyl groups of the acidic polysaccharides, which represent the 
cation exchange properties of dietary fibre, also bind the dietary 
metal ions. The relative importance of binding by fibre and 
phytate is as yet undetermined. Addition of fibre to the diet has 
also been shown to enhance losses of magnesium, calcium, 
phosphorus, sodium and potassium (Southgate et al,1976; Reinhold 
et al,1976). Sandstead et al, (1977) found no relation between 
dietary fibre and faecal zinc or copper in a metabolic balance 
experiment. The significance of the reported adverse effects of 
dietary fibre on mineral status will be governed by the intake of 
fibre and minerals, and the prevailing mineral status and the 
body's ability to adapt to any decrease in mineral supply. The 
present work shows that dietary wheat bran is without effect on 
bone mineral concentrations in male and female rats consuming 
adequate intakes of minerals.
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Chapter Six
The Effect of Folate Deficiency on 
Microsomal Enzyme Induction
in the Rat.
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Introduction
Long term therapy with anticonvulsant drugs is known to alter 
the metabolism of endogenous substrates and to increase drug 
metabolism probably by induction of liver enzymes, especially 
cytochrome P450. Effects include altered vitamin metabolism
with decreased hepatic hydroxylation to 25-hydroxycholecalciferol 
(Silver et al,1972), which may result in hypocalcaemia (Richens and 
Rowe,1970a) and precipitate rickets or osteomalacia (Dent et^  
al,1970; Stamp,1974); folic acid deficiency (Mannheimer et_ 
al,1952; Richens,1972) which may be associated with megaloblastic 
change and macrocytic anaemia (Reynolds,1972); increased excretion 
of 6p-hydroxycortisol (Werk et al 1964; Brooks et al,1972); 
induction of sex hormone metabolism (Kuntzman,1969); raised serum 
jf-glutamyl transpetidase and liver alkaline phosphatase (Richens 
and Rowe,1970); increased urinary excretion of D-gluconic acid and 
decreased levels of serum bilirubin (Thompson et al,1969)' Effects 
on drug metabolism are increased turnover, causing decreased 
effects of anticoagulants (Macdonald and Robinson,1968), 
antiasthmatics (Brooks et al,1972), antidepressants, contraceptive 
pills (Mumford, 1974) and doxycycline (Penttila et al,1974).
An important consequence of long-term anticonvulsant therapy 
is sudden increased drug sensitivity or toxicity in some patients 
apparently stabilised on anticonvulsants (Davis and 
Labadarios,1976). The metabolic interaction thought to be related 
to this phenomenon is the depression of folic acid levels 
(Labadarios,1975; Fig.1). The mechanisms by which anticonvulsants
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Fig. 6.1. Long-term Effects of Drug Administration on Folate Metabolism 
and Toxic Side Effects of Drugs.
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cause folic acid deficiency are uncertain. The postulated 
mechanisms are inhibition of intestinal conjugase by anticonvulsant 
drugs (Hoffbrand and Nechelles,1968), interference of enterocyte 
uptake of monoglutamate (Dahlke and Mertens-Rosler,1967) and a 
higher dietary requirement due to increased utilisation by enzyme 
induction (Maxwell et al,1972). Some drugs may be acting as folic 
acid antagonists (Hawkins and Meynell,1954; Reynolds,1968). Folic 
acid supplementation (l5-30mg daily) may cause a reversion of 
seizure control (Ghanarin et al,196O), which would support this 
theory. However, it may be explained by decreased serum phenytoin 
concentration, which is caused by repletion of folate (Baylis et 
al,1971 ; Richens,1975)• Borderline intakes of folic acid in 
hospitalised patients have been reported (ibbotson et al,1967; 
Labadarios et al,1978). Hence folic acid deficiency which 
manifests after long-term anticonvulsant therapy could be 
multifactorial, the pertinent causes being inadequate intake, 
reduced absorption and increased utilisation.
Animal experimentation has shown that rats maintained on a 
folate deficient diet containing 500 mg/kg phenobarbitone do not 
exhibit the induced cytochrome P450 levels observed in controls 
(Labadarios,1975)•The control diet contained the same level of 
phenobarbitone and was either folate-supplemented or 
semi-supplemented, the latter being the minimum amount required to 
cure symptoms of folate deficiency, (Asenjo,1948). Labadarios 
proposed that the synthesis of nucleic acids and essential enzyme 
proteins may be decreased in rats maintained on the 
folate-deficient diet, since folic acid is thought to be a
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co-factor in the biosynthesis of purine and pyrimidine nucleotides.
To further investigate this important drug-nutrient 
interaction the study was undertaken of the effect on hepatic 
mixed-function oxidase enzyme activities of administration to 
folate deficient rats of phenobarbitone, an anticonvulsant drug and 
powerful microsomal enzyme inducer, and 3-methylcholanthrene, a 
polycyclic, aromatic hydrocarbon. These two compounds stimulate 
the metabolism of drugs, carcinogens and other substrates of liver 
microsomes by different mechanisms. 3-Methylcholanthrene 
stimulates the metabolism of fewer substrates and induces a
different form of cytochrome P450 to phenobarbitone, namely 
cytochrome P448, which is thought to be involved in the activation 
of carcinogens (Burke and Mayer,1975). Cytochrome P448 differs 
from cytochrome P450 in its molecular weight, terminal amino acid 
composition, antigenicity (with no immunological cross-reactivity)
and substrate specificity___ (Ryan et_al,1979). The microsomal
cytochromes P450 and bg, NADPH cytochrome C reductase and 
mixed-function oxidase enzyme activities were measured to determine 
the effects of any interaction between folate deficiency and enzyme 
induction. Levels of microsomal and total haem were measured to 
determine whether decreased cytochrome P450 synthesis 
(Labadarios,1975) was due to altered haem metabolism, rather than
to effects on the apoprotein moiety of cytochrome P450. Serum and
red cell folate, serum vitamin B}2 levels, haematocrit, haemoglobin 
and red cell counts were measured in order to determine the 
presence and extent of folate deficiency. Hepatic enzymes involved 
in phase II metabolism were also measured, an area not previously 
investigated.
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Experimental /
Materials
Folate, and vitamin determinations were made using a dual
radioassay kit purchased from Amersham International PLC. 
Cyanomethaemoglobin, heparin, Drabkin's reagent, pyridine,
p-nitrophenol, potassium hydroxide and phenbarbitone-sodium were 
obtained from BDH Ltd. 3-Methylcholanthrene and folic acid were 
supplied by Sigma. Benzphetamine was a gift from the Upjohn 
Company, Kalamazoo, Michagan. All other materials were obtained as 
previously reported in Chapter Two.
Diets
Cellulose powder, c o m  starch, corn oil, vitamin- and fat-free
casein and folic acid-free vitamin/mineral premix were supplied by 
Special Diet Services Ltd. Hydrogenated vegetable oil was
purchased from J.Sainsbury's PLC.
Animals
Wistar albino, weanling, male rats, from the University of Surrey 
breeding colony, were housed in wire-bottomed
cages. Food and water were available ad libitum.
Diet composition
The diet was composed as follows : (Thompson et al 1972 ;
Labadarios,1975)
Corn starch........... .
Vitamin- and fat-free casein
46%
20%
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Hydrogenated vegetable oil..............17%
Cellulose powder............ .10%
Corn oil. ...........   ~;...2%
Folic acid-free vitamin/mineral premix... 5%
The folate supplemented diet was prepared by adding 1.Omg 
folic acid in the monoglutamate form /kg diet. Acknowledgements 
are due to Special Diet Services Ltd for the folic acid analyses of 
the diets. The deficient diet was found to contain less than 
0.2mg/kg and the supplemented diet to contain 1.2mg/kg by 
microbiological assay using Lactobacillus casei. The diets were 
stored at 4°C in sealed buckets.
The rats were maintained on the diets for periods of 13 - 18
wk. During the feeding period samples of tail vein blood were 
taken at intervals to determine serum and red . cell, folate levels 
and serum vitamin levels. Animals were weighed and dietary
intakes assessed weekly.
On the morning of the termination of the experiment, between 
9-10.30 a.m., prior to cervical dislocation, each animal was 
anaesthetised with ether and blood was collected by cardiac 
puncture. An aliquot was taken to provide serum for folate and 
vitamin B,^ determinations. The remainder was heparinised and used 
for red blood cell counts, red cell folate, haematocrit and 
haemoglobin determinations. Preparation of liver subfractions was 
as previously described in Chapter Two.
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Dosing Regimes
Phenobarbitone - the low dose was administered in the drinking 
water as a 1% (w/v) solution for 4 days. At the end of the
experiment the animals had been maintained on the diets for 13 wk. 
The high dose was administered by ip injection at 80mg/kg for 14 
days. At the end of the experiment the animals had been maintained 
on the diet for 18 wk.
3-Methylcholanthrene - was dissolved in corn oil and administered 
by ip injection at 25mg/kg for 7 days. Control animals received an 
equivalent volume of corn oil. At the end of the experiment the 
animals had been maintained on the diets for 15 wk.
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Methods
Cytochrome P450, cytochrome hg, NADPH cytochrome C reductase,
7-ethoxyresorufin-o-deethylase, biphenyl 4- and 2-hydroxylases,
1-naphthol glucuronyltransferase and microsomal protein -
determinations were made as previously described in Chapter Two.
Folate and Measurement - The principle of the assay was as    --
follows :
Prior to assay, folate and vitamin ^  were released from their
serum binding proteins by incubation at room temperature, pH
12.8-13.0, with a dénaturation reagent containing potassium
cyanide. The samples were incubated at pH9«5 with folate binding
protein and hog intrinsic factor. Serum folate competes with
.labelled folate for sites on folate binding protein, and serum
vitamin B ^  competes with ^Co-labelled vitamin B ^  for sites on
intrinsic factor. The protein-bound fraction was separated by
adsorption of the free fraction onto coated charcoal, and
precipitated by centrifugation. Counts were made of the free
fraction on a multigamma counter (LKB). The serum folate, vitamin
B,- , and red cell folate concentrations were interpolated from a 
12
standard curve.
Haematocrit - was determined by centrifugation (10 min, MSE 
haematocrit centrifuge) of fresh whole blood drawn into heparinised 
haematocrit tubes and sealed. Determinations were made in 
duplicate.
Haemoglobin - was. determined by the cyanomethaemoglobin method.
(Drabkin & Austin, 1932). Whole blood (20jil) was diluted with 
Drabkin's reagent (4ml) and vortex mixed. The absorbance was
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determined at 540nm against a blank of Drabkin's reagent using an 
SP500 spectrophotometer. The standard, cyanomethaemoglobin, 
contained 57.2mg/l00ml which is equivalent to 11.5mgHb /ml blood. 
Determinations were made in duplicate.
Red Blood Cell Counts - were determined using a Coulter Counter. 
Whole blood was diluted 1:50000 with Isoton. Duplicate counts were 
made, and correction was made for coincidence.
Microsomal Haem (Schenkman et al,1975)
Washed microsomes were prepared and the pellet resuspended in 0.1M 
phosphate buffer pH7«4 at a concentration of 12.5%. Aliquots (3ml) 
were added to pyridine (2ml) and 1M NaOH (1ml) and divided between 
two cuvettes. Formation of the pyridine haemochromogen was 
commenced by the addition of sodium dithionite and recorded as a 
difference spectrum between 550nm and 660nm using an SP18 
spectrophotometer. Haem content was calculated by measuring the 
difference in absorbance between 557nm and 575nni using an 
extinction coefficient of 32.4 mM""*1 cnf1 . The haem content of 1 %
liver homogenate was similarly determined (protein range 0.1-1 .0 
mg).
Benzphetamine-N-demethylase
The method used was identical to that for determination of
ethylmorphine-N-dernethylase except that 0.4 pmol of benzphetamine
were used in the incubation system in place of ethylmorphine
hydrochloride.
p-Nitrophenol glucuronyltransferase
The method measures the rate of disappearance of the substrate. 
The incubation mixture consisted of 0.1 pmol of p-nitrophenol,
0.15-0.25 mg microsomal protein (10000g fraction), 0.6mg Brij, 3
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pnol of UDPGA and 0.125 mmol Tris-EC1 buffer pH 7*4, in a final 
volume of 0.6 ml.
After a 5 min pre-incubation at 57^0, UDPGA was added to initiate 
the reaction. Termination at 4 min was achieved by the addition of 
an aliquot of 0.1M trichloroacetic acid (2.4ml) and plunging the 
tubes into an ice bath. A 20 min centrifugation at 4000 rpm using 
a Beckman J6 centrifuge, precipitated the protein. After addition 
of 10M K0H (0.06ml) the absorbance at 400nm was determined using a 
Cecil 272 Spectrophotometer, against a blank in which the substrate 
was omitted. The standard contained the original concentration of 
p-nitrophenol, achieved by the omission of UDPGA during the 
incubation.
Statistical Analyses
These were performed using Student's t_ test.
Results
The rats fed on the folate deficient diet were consistently 
of lower weight than rats fed on the folate supplemented diet, 
although the results were not statistically significant (Pig 6.2). 
There was no difference in food intake between the two groups.
Red cell folate was observed to decline more rapidly than 
serum concentration (Fig 6.5)* After about 12 wk of feeding, serum 
folate levels were within the same range as those found to be 
associated with lower induced levels of cytochrome P450 
(Labadarios,1975)• Haematocrit, haemoglobin, red blood cell
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counts, mean corpuscular haemoblobin concentration, and mean 
corpuscular volumes in the folate deficient rats were equivalent to 
the controls (Tables 6.1, 6.4, & 6.7), and examination of blood
smears after 12 and 18 wk similarly indicated that megaloblastic 
anaemia was not present. After 13 wk of feeding, the levels of
cytochromes P450 and bg, and NADPH cytochrome C reductase activitiy 
were not altered in the folate deficient group compared to the 
controls (Table 6.2). Microsomal haem was higher in the folate 
deficient group, but this effect was not significant (Table 6.2). 
The activity of biphenyl-4-hydroxylase was found to be 
significantly lower in the folate deficient group, but no changes 
were observed for the other mixed-function oxidase enzymes, or for 
the phase II conjugation enzymes studied (Table 6.3)• After 15 wk 
of feeding there were similarly no changes in cytochrome P450 or 
bg, NADPH cytochrome C reductase activity or microsomal haem 
content (Table 6.8). Biphenyl-4-hydroxylase was decreased in the 
folate deficient group, but the effect was not significant (Table 
6.9). There were no changes in the activities of the other 
mixed-function oxidase enzymes or the glucuronyltransferases.
The administration of phenobarbitone at 1 gm /litre in the 
drinking water for 4 days to rats fed on the folate deficient and 
folate supplemented diets was found to induce cytochrome P450 to an 
equivalent extent in both groups (Table 6.2). Microsomal haem was 
similarly increased in both treated groups (Table 6.2). 
Biphenyl-4-hydroxylase showed a higher level of activity in the 
folate supplemented phenobarbitone group than the folate deficient 
phenobarbitone treated group (Table 6.3)• No differences were
- 152 -
observed for the other mixed-function oxidase enzyme activities or 
glucuronyltransferases (Table 6.3)*
The longer pre-treatment with phenobarbitone, 80 mg/kg ip for 
14 days, to rats maintained on the folate deficient and folate 
supplemented diets produced equivalent levels of induction in both 
groups for cytochromes P450 and bg, NADPH cytochrome C reductase 
activity, microsomal haem (Table 6.5), microsomal oxidase enzyme 
activities and glucuronide-conjugation enzyme activities (Table 
6.6). At the commencement of dosing the control group contained 
three animals, one of which died 3 days prior to the end of the 
experiment.
Treatment with 3-niethylcholanthrene (80mg/kg, for 7 days) was 
found to produce equivalent levels of cytochromes P450 and bg., 
NADPH cytochrome C reductase activity and microsomal haem content 
in the folate deficient and folate supplemented groups (Table 6.8). 
Biphenyl-2-hydroxylase and 7-e thoxyre s o ruf in-0-d ee thyla s e
activities, which are greatly enhanced by 3-methylcholanthrene 
treatment in comparison to phenobarbitone treatment, showed no 
statistically significant differences between the folate 
supplemented and folate deficient groups (Table 6.9)• The other 
mixed-function oxidase enzymes and the glucuronyltransferase 
enzymes similarly showed no statistically significant differences 
in activity (Table 6.9)*
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Table 6.4. Effect of a Longer Phenobarbitone Treatment on Serum
and Red Cell Folate Levelsy and other Blood Parameters 
in the Rat Maintained on a Folate Deficient Diet.
Parameter
Measured
Treatment Group
Folate Supplemented 
8 Omg phenobarbitone/kg
Folate Deficient 
8 Omg phenobarbitone/kg
Serum folate 
(ng/ml)
10.4 ± 0.6 (1 0 0 %) 4.6 ± 0 . 8 (44%)*
Red Cell Folate 
(ng/ml)
793 ± 241 (1 0 0 %) 288 ± 1 1 (36%)**
Serum B 1 2  
(pg/ml)
931 ± 181 (1 0 0 %) 832 ± 6 8 (90%)
Haematocrit (%) .43 ± 7 (1 0 0 %) 42 ± 2 (98%)
Haemoglobin 
(g/1 0 0 ml blood)
12.9 ± 1.7 (1 0 0 %) 13.2 ± 1 , 2 (1 0 2 %)
MCHC (%) - 30.0 ± 0,5 (1 0 0 %) 31.1 ± 2.7 (104%)
RBCC x 106 
(Cells/ mm^)
9.34 ± 2,3 (1 0 0 %) 9.52 ± 1 . 0 (1 0 2 %)
MCV (ym) 46.5 ± 3.8 (1 0 0 %) 44.6 ± 3.2 (96%)
Results are mean ± SEM for two male animals (control) and five 
male animals (deficient) maintained on the diets for 18 weeks. Figures 
in parentheses are percentage value of control group. Phenobarbitone 
was administered at 80mg/kg bodyweight by daily I.P. injection for 14 
days.
MCHC : Mean Corpuscular Haemoglobin Concentration.
RBCC : Red Blood Cell Count.
MCV : Mean Corpuscular Volume.
Value significantly different from control: * p < 0.005
** p < 0 . 0 0 1
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Table 6.5. Effect of a Longer Phenobarbitone Treatment on some
Components of the Hepatic Microsomal Drug Metabolizing 
Enzyme System in the Rat Maintained on a Folate Deficient 
Diet.
Component
Measured
Treatment Group
Folate Supplemented 
8 Omg phenobarbitone/kg 
(Control)
Folate Deficient 
8 Omg phenobarbitone/kg
Cytochrome P450 
(ng/mg protein)
2.80 ± 0,37 (1 0 0 %) 2.16 ± 0.17 (77%)
Cytochrome bg 
(ng/mg protein)
0.65 ± 0.05 (1 0 0 %) 0.58 ± 0 . 0 2 (89%)
NADPH Cytochrome C 
reductase.
(nmol Cytochrome C 
reduced/mg protein/ 
min)
60 ± 1 (1 0 0 %) 64 ± 0.3 (106%)
Microsomal haem 
(Vimol/mg protein)
1.80 ± 0,06 (1 0 0 %) 2 . 0 0 ± 0.14 (1 1 1 %)
Total haem 
(umol/mg liver 
protein)
1.41 ± 0.14 (1 0 0 %) 1.45 ± 0.28 (107%)
Results are Mean ± SEM for 2 male animals (control) and 5 male animals 
(deficient), maintained on the diets for 18 weeks.
Phenobarbitone was.administered at 80mg/kg bodyweight by daily
I,P. injection for 14 days and the animals killed 24 hours after the last
administration. Figures in parentheses are percentage values of control.
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Table 6,6,. Effect of a Longer Phenobarbitone Treatment on Some
Hepatic Drug Metabolizing Enzymes and their Induction 
in thé Rat Maintained on a Folate Deficient Diet,
Treatment Group
Enzyme Folate Supplemented 
Measured BOmg phenobarbitone
....... /kg
Folate Deficient 
8Omg phenobarbitone 
/kg
Biphenyl-4^hydroxylase 
(nmol 4-OH biphenyl/ 
mg protein/hr) 62.4±5,0 (100%) 55.8±2,6 (90%)
Benzphetamine-N- 
demethylase Cymol 
formaldehyde/mg protein/ 
hr) 0.35±0,02 (100%) O’. 33±0.03 (94%)
7-Ethoxyresorufin-o- 
deethylase (nmol resorufin 
/mg protein/hr) 0,035±0.01 (100%) 0.030±0,02 (86%)
1-Naphthol glucuronyl 
transferase (nmol 1- 
naphtholglucuronide/ 
mg protein/min) 48.7+2.8 (100%) 44.6+3.7 (92%)
P-Nitrophenolglucuronyl 
transferase (nmol PNP
used/mg protein/min) 33,5+5 (100%) 33+9 (100%)
Microsomal protein 
(mg/g liver) 39.4+2.2 (100%) 42.6+O.9 (108%)
Results are mean ± SEM for two male animals (control) and five male 
animals (deficient), maintained1 for 18 weeks on the diets* Figures 
in parentheses are percentage values of control groups.
*Phenobarbitone was administered at 80 mg/kg bodyweight by daily IP 
injection for 14 days and the animals killed 24 hr after the last 
administration.
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Discussion
The measurement of circulating serum and red cell folate 
levels were used to judge a state of folate depletion. In the 
experiment now reported the serum and red cell folate levels in the 
folate deficient group had declined to 50$ of the folate 
supplemented group by 12 wk of feeding, and thereafter declined 
more rapidly to approximately 30$ (14 - 15 wk) and then stayed at 
approximately this level. Red cell folate, which is considerably 
higher than serum folate, is less affected by short-term dietary 
changes and is an acurate indication of body folate reserves. 
Decreased blood folate activity indicates a severe depletion of 
tissue stores (Grossowicz et al,1964)» Experimental rats fed a 
folate deficient diet for 20 days were found to have decreased 
liver and kidney folate levels after 10 days, but blood levels were 
not seen to decrease until tissue levels had fallen. Chanarin et_ 
al (1969) have also shown that hepatic levels decline more rapidly 
than serum folate levels in rats maintained on a folate deficient 
diet containing sulphanilamide for 12 wk. Antibiotic may be added 
to experimental diets to speed up and heighten the attainment of 
folate deficiency in the rat since the de novo synthesis of folic 
acid by gut microflora is thought to be a reason for the difficulty 
encountered in inducing folate deficiency in experimental rats 
(Teply et__al,1947). Copfoph.agy is also thought to contribute to 
this problem. It has been reported (Kodicek and Carpenter,1950) 
that 1$ sulphathiazole is haemolytic. Serum from patients 
receiving antibiotics has been shown to inhibit the growth of 
Lactobacillus Casei, the bacteria used for microbiological
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assessment of folic acid (Waters and Mollin, 1961). In the 
experiment now reported the rats were maintained in wire-bottomed ' 
cages. Since drugs were administered to induce enzyme levels, 
antibiotics were not added to the diets, in order to avoid drug 
interactions.
The major circulating form of folic acid in serum is 
5-methyltetrahydrofolic acid. Hence results of radioassay methods 
and microbiological assay using Lactobacillus Casei are directly 
comparable. Red cell values are considerably higher when measured 
by radioassay as this measures total folate,. including the 
peptide-bound fraction which accounts for 86-90$ of the total red 
cell folate,' whereas Lactobacillus Casei does not respond to
polyglutamates or peptide bound derivatives.
The results of this study indicate that a long-term dietary 
deficiency of folic acid in the rat, resulting in low serum and red 
cell folate levels, does not alter the capacity for induction of 
hepatic microsomal cytochromes, or phase I or phase II drug
metabolizing enzymes when compared to a control group of rats with 
normal folate levels.
Labadarios (1975) hypothesised that the lower level of
induced cytochrome P450 in rats maintained on a folate deficient 
diet containing 500 mg/kg phenobarbitone for 12 wk (approximately 
40mg/kg/day for 12 wk), was related to folate deficiency. The 
results now reported with comparable serum folate levels to those 
achieved by Labadarios (1975) indicate that induction of
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cytochromes P450 and b , microsomal haem, biphenyl 4-hydroxylase
5
and 7-ethoxyresorufin-0-deethylase activities is possible. The
differences may be due to the length of time for which the 
experimental rats were exposed to the phenobarbitone - 12 wk where 
decreased induction was reported and periods of 4 days and 2 wk 
where induction was equivalent to induced control values. This 
indicates that there is a further complication resulting from 
long-term administration of phenobarbitone that is causing the 
decreased levels of cytochrome P450 observed by Labadarios (1975) 
in rats receiving phenobarbitone supplemented, folate deficient 
diets.
It is possible that, in the experiment now reported, the
serum folate levels have not reached the critical level at which 
enzyme induction is decreased. However, it was observed that 
individual animals with serum folate levels as low as 1.8 ng/ml 
serum had induced levels of cytochromes P450 and b^, microsomal 
haem, and induced activities of biphenyl hydroxylases, 
7-ethoxyresorufin-0-deethylase and glucuronyl transferases that
were similar to control values. The serum folate value at which 
Labadarios (1975) found decreased levels of of induction was 4*3 
ng/ml serum + 0.2. The average serum folate value of the
phenobarbitone treated group (80 mg/kg, 14 days) and maintained on 
the folate deficient diet was 4«6 ng/ml serum. Long-term exposure 
to anticonvulsant drugs would be associated with long-term 
metabolic disturbances, causing strain on certain metabolic pools, 
especially haem. This may eventually drain the metabolic pools 
whereas with short-term exposure they are adequate for enzyme
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induction to occur.
Folic acid is involved in the biosynthesis of cytochromes 
(Parke,1978a). It is a cofactor in both apocytochrome P450
biosynthesis and haem synthesis (Clement et al, 1981). In the first 
stage of haem synthesis, succinyl CoA and glycine condense to form 
f-aminolaevulinic acid. Conversion of serine to glycine represents 
the most efficient supply of glycine in the body, and this requires 
tetrahydrofolate as coenzyme. A decreased ability of folate 
deficient rats to incorporate labelled formate into serine in vivo 
(Elwyn and Sprinson, 1950) and a lower capacity of tissue
preparations to convert serine to glycine (Vilenkina,1952) have 
been reported. cT-Amino laevulinic acid synthetase has a high Km 
value for glycine and experimental depletion prevents activity of 
the enzyme. In a state of glycine depletion, this will be the rate 
limiting step for haem synthesis (Tephly et al,1975)' Glycine is 
an abundant component of many foods. The amount of amino acid 
coming from the diet, and amino acid turnover and synthesis in the 
tissues represent many times the quantities present free in the 
body at one time, such that pools of free amino acids are small in
relation to the amount of protein in the tissues (Munro and
Portugal,1972).
CytochromeJP450 synthesis in rat liver accounts for 70$ of
_______ I in the liver
haem -synthesisedi/ under normal metabolism. Long-term exposure to
inducing drugs will put a considerable strain on the pathways
involved in its synthesis. Long-term exposure to anticonvulsant
drugs together with a limiting supply of folic acid, may result in
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an inadequate supply of haem, after all the available haem has been 
used up, because of reduced glycine pools. The situation will 
arise where haem synthesis cannot keep pace with requirements.
Clement et al (1981) reported a significant depression of
intestinal haem content in guinea pigs maintained on a folate
deficient diet, and the activity of intestinal
7-ethoxyresorufin-0-deethylase was also significantly decreased.
However the significant depression of NADPH cytochrome C reductase 
activity was suggestive of gut morphological changes.
An activator for uroporphyrinogen I synthetase, which 
catalyses the conversion of porphyrobilinogen to uroporphyrinogen 
III, has been identified (Piper and Van Lier, 1977), which may be a 
pteroylglutamate derivitive. This may regulate the activity of 
uroporphyrinogen I synthetase, which is thought to become the rate 
limiting enzyme if the activity of cf-aminolaevulinic acid is 
increased (Bonkowsky et al,1979). This is another possible 
mechanism by which folic acid deficiency may decrease haem 
synthesis.
Apoprotein synthesis is generally thought to be the primary 
and rate limiting event in the control of cytochrome P450 formation 
(Correia & Mayer,1975)• Under normal conditions, the availability 
of haem is not rate limiting for cytochrome P450 synthesis, or when 
phenobarbitone or 3-niethylcholanthrene are administered (Sardana et 
al,1976). However, if haem synthesis is experimentally inhibited 
during formation and assembly of cytochrome P450, the total 
apocytochrome present on the microsomal membrane is decreased (Bhat
— 169 —
et al,1977). In the event of decreased haem synthesis in the 
folate deficient animals, this will become rate limiting for 
cytochrome P450 formation.
In the experiment now reported, folate depletion was observed 
not to alter hepatic haem levels in rats maintained on a folate 
deficient diet compared to rats maintained on a folate supplemented 
diet, or to decrease the induced levels of hepatic haem in animals 
treated with phenobarbitone or 3-methylcholanthrene. This 
indicates that the effects of short-term drug exposure did not 
affect haem supply indicating that the substrates and coenzymes of 
haem synthesis were adequate for increased synthesis to take place. 
It appears therefore that a longer time of exposure to cytochrome 
P450 inducing agents is necessary for the lesions in the synthetic 
pathway to become apparent. Under conditions of longer exposure 
there is a greater total demand for haem synthesis and a continual 
depletion of substrates which will be in reduced supply because of 
folate deficiency. The decreased supply of haem may then become 
rate limiting for the de novo synthesis of cytochrome P450.
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Chapter Seven
General Discussion
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The Dietary Fibre Hypothesis
It is considered by Southgate (1982) that the original 
dietary fibre hypothesis, which states that a fibre-rich diet is 
protective against the diseases common in affluent Western 
societies,e.g. colon cancer, diverticular disease, diabetes and 
obesity, and that a low fibre diet may be causative in the 
aetiology of such diseases, (Southgate,1982; Trowell,1975; 
Burkitt & Trowell,1975), relates to types of diet. It argues that 
the difference between protective and non-protective diets is 
determined by the amounts of plant cell wall material they provide 
and that the protective agent is, or is derived from, the plant 
cell walls in the diet. As fibre-containing foods are generally of 
low energy density and high bulk, increasing the intake of dietary 
fibre will make it more unlikely that excess energy will be 
consumed, and the percentage contribution to the diet from fat, 
protein and refined carbohydrates is likely to be reduced. Hence 
some of the benefits of a high fibre diet may be attributable to 
the indirect effects of reduced consumption of other dietary 
components. The diets consumed by communities with a low incidence 
of the diseases against which dietary fibre is thought to be 
protective have other characteristics - they are low in fat, 
refined sucrose and salt, and are high in starch (Périsse et 
al,1969),
Studies to test this hypothesis have concentrated on the role 
of dietary fibre. The two main approaches are epidemiological 
studies of the relationship between, intake of dietary fibre and
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incidence of disease, or studies aimed at elucidating the mechanism 
of action of dietary fibre. The latter approach may involve 
feeding a particular fibre or a purified component and measuring a 
biological response or investigating the relationships between the 
biological structures of fibres and their functions.
Problems of Dietary Fibre Studies - Investigation of the mechanisms 
of action of dietary fibre is a slow process requiring longterm and 
carefully controlled experiments.
For the purposes of dietary fibre research it is important to 
study each source of dietary fibre individually. The importance of 
such an approach lies in the necessity to explain the effects in 
terms of individual dietary fibres. Ideally experiments should aim 
to provide nutritionally adequate diets and result in purification 
of the active component of a dietary fibre, detailed physical and 
chemical characterisation of the component and quantitative 
measurement of the effects produced (Lang & Briggs,1976). 
Investigations of individual components of such fibre sources, 
though providing potentially useful information, are fraught with 
difficulties since the purification procedures cause changes in the 
physical properties of the components so that they behave 
differently than when in their natural state in the plant cell 
wall. Similarly such procedures as drying, grinding, freeze-drying 
and cooking influence the behaviour of fibres in the 
gastro-intestinal tract. As dietary fibre is associated with other 
nutrients, any change in dietary fibre content from one source will 
encompass changes in other nutrients so that it will be difficult
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to identify the causal factor of any observed effects. Hence
purification studies have inherent problems and fibre in its
natural state contains other nutritional components, so that it is 
difficult to identify the causal agent of any observed effect.
Ideally, experiments would be designed to determine the effect of 
each individual fibre component in a natural fibre source, but this 
approach is non-physiological. However it may give some 
indications of effects of the various dietary fibre components.
The Rat as an Animal Model for Dietary Fibre Studies - There are
species differences in the extent of digestion of a dietary fibre
source and these variations may cause difficulties when
s u, fibre
extrapolating from rat to man. In The rat / is generally poory
f  ----------
digested (Cummings,1981 a), whereasl man most fibres are digested
to a greater extent. However, because of the high cellulose 
md lignin content of wheat bran it is poorly digested ‘in man. Digestion of 
wheat bran in the rat includes epidermal disruption, interior cross 
tube and aleurone cell distortion, and hydrolysis of protein 
substances between internal tissues. Little other digestion occurs 
apart from bacterial degradation of endosperm remnants (George et. 
al,1979). Most studies indicate that cellulose is not digested ia 
the rat to any appreciable extent, which justifies the description 
of cellulose as a non-nutritive fibre and non-nutritive bulk (Lang 
& Briggs,1976).
Mixed-Function Oxidases and Toxicity - The mixed-function oxidase 
enzyme system is responsible for the metabolism of foreign 
compounds (Parke,1968). Such reactions generally lead to the
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deactivation of drugs and detoxication of environmental chemicals 
by producing metabolites with greater polarity and lower lipid 
solubility than the parent compound. However, microsomal 
oxygenation in some cases leads to the formation of reactive 
intermediates (Gelboin,1969; Oesch et al,1972) which have similar 
or greater lipid solubility than the parent compound, are 
electrophilic and may attack the nucleophilic centres of DNA and 
other biological macromolecules (Miller & Miller,1969)• This forms 
the basis of mutagenicity and carcinogenicity of such metabolites. 
Microsomal enzyme activities mediated by cytochrome P448 are 
believed to be involved in the formation of such reactive 
intermediates (Burke & Mayer,1975; Parke & loannides,1982).
It is now generally accepted that metabolites ultimately 
responsible for toxicity are often reactive intermediates. They 
may be only minor metabolites, but are more important 
toxicologically than the major metabolites (Hawkins,1981). Hence, 
induction of cytochrome P450 and increased rates of mixed-function 
oxidations which result from exposure to certain drugs, 
environmental chemicals and dietary anutrients, may be beneficial 
if the foreign compound is rendered inactive by such metabolism, 
but harmful if toxic reactive metabolites are produced.
Apart from the mixed-function oxidase enzyme system which 
metabolises xenobiotics, a number of other enzymes in the cell e.g. 
glucuronyltransferases, epoxide hydratase,
glutathione-s-transferase, which further detoxify foreign 
compounds, exert a. significant influence on the fate of foreign
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compounds in an organism. These enzymes convert mutagenic, 
electrophilic intermediates into non-toxic substances that do not 
react with biological macromolecules• If phase II metabolism is 
greater than the rate of conversion of a carcinogen to its reactive 
intermediates by phase I metabolism then the toxic effects will be 
prevented.
Diet and Carcinogenesis - The evidence that a substantial 
proportion of human cancers is related to diet (Miller et al, 1980) 
has come from epidemiological studies. These include studies of 
migrants, correlational studies of various dietary factors with the 
incidence . of cancers and case-control studies in various 
populations. Carcinogenesis is a multistage process, the 
successive stages of which may involve qualitatively different 
events that can be enhanced or inhibited by different types of 
environmental factors (Weinstein et al,1980). The probability that 
these events will occur is influenced by factors in the host which 
.are independent of the carcinogenic stimuli i.e. age, sex, genetic 
constitution, present and past environment, nutritional status, 
endocrine activity, immunological function and function of 
carcinogen-metabolizing enzymes, DNA repair enzymes and cell growth 
control processes. Modification of these factors may eventually be 
important in reducing the risk of cancer. The natural history of 
neoplastic development can be divided into initiation, which 
encompasses interaction of a genotoxic agent with DNA to yield 
abnormal genetic material and promotion, where epigenetic agents 
increase the development of lesions initiated by genotoxic 
carcinogens; progression to invasion of adjacent tissues and
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metastasis in distant tissues may subsequently occur. Actual and 
potential regulation of these processes is at the stage of 
promotion. Promoting agents exhibit both threshold and maximal 
activity and their action is reversible (Pitot,1982). Hence the 
identification of promoting agents in the environment is important 
in understanding the nature and prevention of development of human 
cancer. That nutrition plays a role in tumour promotion was 
reported by Rusch et al (1945), and Boutwell et al (1949)*
Tryptophan has been shown to be an effective promoting agent in 
chemically-induced bladder carcinogenesis in the rat (Cohen et 
al, 1979), but its administration actually inhibits 
hepatocarcinogenesis initiated by azo dyes and
N-nitrosodiethylamine (Evarts & Brown,1977). Fatty * acids,
predominantly unsaturated, have been indicated as promoting agents 
in the genesis of experimental neoplasia of the liver, mammary 
gland and forestomach (Diamond et al,1980; Carroll &
Hopkins,1979). Bile acids have been implicated as promoting agents 
in experimental colonic cancer in the rat; a variety of 
halogenated aromatic compounds and several synthetic chemicals 
including saccharin, butylated hydroxytoluene and cyclamate, have 
exhibited promoting activity in bladder and liver carcinogenesis 
(Diamond et al,1980). Identification of the many promoting agents 
to which man is exposed from the environment is of great
importance, since they undoubtedly play a significant role in the 
development of human cancers. It is probable that all humans 
possess some initiated cells, from birth or earlier, due to ambient 
environmental factors, such as background radiation, diet and 
therapeutic intervention. Promotion may therefore be one of the
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major factors in the genesis of clinical cancers and nutrition may 
he a major influence on its extent.
Diet and Colon Cancer - Examination of the environmental factors 
that possibly contribute to the occurrence of colonic cancer 
indicates that diet plays a major role (Armstrong & Doll,1975; 
Graham & Mettlin,1979)• The active species is most likely to be 
generated in the colon or colonic tissue from substrates present in 
a high risk diet (Thompson & Hill,1982). Examination of luminal 
contents has not yet revealed any potentially active substrate; 
the substrates investigated include nitrosamines (Yenitt,1981), 
tryptophan and tyrosine (Hill,1980; Bone,1976), neutral steroids 
(Wynder & Reddy,1978) and bile acids (Hill,1977a). The presence of 
faecal mutagens has been demonstrated by various investigators. 
Bruce et al (1977) have 'shown the faeces of humans consuming a high 
fat diet to contain compounds causing direct mutagenesis of TA98 
and TA100 in the Ames test, and have demonstrated that increased 
dietary fibre, ef-tocopherol or vitamin C consumption reduced faecal 
mutagens. Kuhnlein et al (1981) demonstrated that vegetarians have 
lower levels of faecal mutagens than non-vegetarians. Certain 
compounds have been reported to be non-carcinogenic or 
non-mutagenic alone, but to enhance the tumo rigenic or mutagenic 
properties of carcinogens (Reddy et al,1980).
The protective effect of dietary fibre against colonic 
cancers may be due to adsorption, dilution or altered metabolism of 
co-carcinogens, promoters or as yet unidentified carcinogens 
Cummings etal,1979a). Different types of non-nutritive fibres
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possess specific binding properties and different bulking and 
diluting effects. However, by modifying the luminal environment 
dietary fibres may protectively influence the action of genotoxic 
and epigenetic carcinogens, thus feasibly reducing the risk of 
colon cancer.
Mucus and Gastro-intestinal Disease - The mucous barrier can be 
considered as a protective layer to the underlying delicate mucosa 
against insult from foreign toxic compounds. If the normal 
physiological functions of the mucus are altered, its protective 
effect on the epithelium may be changed either to the benefit or 
detriment of the organism. Mucus is believed to contribute to the 
thickness of the unstirred layer in the intestine (Nimmerfall & 
Rosenthaler,1980), which may in greater quantities reduce the 
absorption rate especially of lipid soluble compounds 
(Thompson,1978a). The methodology used in the present work was 
possibly inadequately sensitive to detect any changes caused by 
bran in mucus production, and more specific determinations are 
required to elucidate further the effect of bran on changes in 
mucus production and composition. If bran were to increase mucus 
production, this would be beneficial by increasing the protection 
of the underlying epithelium against toxic •chemicals and 
carcinogenic metabolites. This effect would be especially 
beneficial in the colon where a carcinogen activating ■ cytochrome 
P450 system has been detected (Strobel et al,1980). It is possible 
that a carcinogen-detoxifying system is also present in the colonic 
wall, and since bacterial metabolism may produce carcinogenic 
metabolites, a mucus layer offering maximal protection to the colon
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wall would be beneficial.
Nutritional status and Drug-Nutrient Interactions - The response of 
an organism to a toxic substance will vary widely depending on many 
factors e.g. the species, the toxic substance, the dose, the route 
of administration, the presence of synergists or antagonists, and 
many other factors. Nutritional well-being is required for normal 
functioning of the metabolic detoxifying system of foreign
compounds. The choice of a well-balanced diet containing a variety 
of foods should supply adequate nutrients and also limit the intake 
of undesirable substances. An adequate diet will provide full 
stores of all materials required for growth and repair
(Bender,1980). If the intake falls below the needs of an
individual, the body stores will be depleted. At first there will 
be no effect on health and only biochemical examination would 
detect this. Eventually normal functioning of organs and tissues 
will be impaired, again only shown biochemically, and with no
visible signs of ill-health. This situation is termed sub-clinical 
malnutrition. Clinical signs will appear only when the deficiency 
is sufficiently severe to cause damage to body tissues. Related to 
the ill-defined area of sub-clinical malnutrition is covert 
malnutrition (Bender,1975), where a given level of a nutrient 
appears adequate but is revealed not to be when the individual is 
stressed. Covert malnutrition can thus be defined theoretically 
but its presence will not be determined in an individual prior to 
an event. Exposure to foreign compounds may cause stress to an 
individual. Response to continued exposure may involve adaptation 
of metabolic responses, a situation where stores of nutrients and
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metabolic intermediates may determine the limitations of such 
adaptation. An adequate diet is thus important when long-term 
exposure to drugs occurs. Since organisms are continually exposed 
to many toxic and foreign compounds, an adequate diet may offset 
adverse reactions.
In addition to interactions between foods and foreign 
compounds which may alter the potential toxic effect of a foreign 
compound, nutritional status is important in determining the 
activity of the biochemical defence systems. Adverse effects of 
dietary fibre on the balance of some minerals has been reported. 
The prevailing mineral status will affect the outcome of any such 
adverse effect of dietary fibre.
However, the nutrient requirements of individuals are not 
known. The recommended daily intakes of nutrients are based on the 
measured average requirements of small numbers of individual 
subjects with a large safety factor added on. Similarly, the 
nutrient intakes of individuals are not known (Bender,1980). The 
recommended daily intake of dietary fibre is more difficult to 
determine than other nutrients, especially as it is composed of a 
variety of different substances, the importance of the relative 
amounts of which is unknown.
The Importance of Nutrition in Toxicological Studies - The major 
importance of nutritional status as one of the many factors 
influencing the biological effects of foreign compounds is 
well-recognised even though the mechanisms by which dietary factors
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influence the toxicology of a compound are not well-understood. 
Conventional experimental studies designed to evaluate the toxicity 
of a compounds, such as drugs, food additives, and environmental 
chemicals, are generally conducted with animals maintained on a 
nutritionally balanced diet. Although data generated from these 
studies provides valuable information on the toxicity of the test 
compounds under such conditions, their relevance for man is limited 
because of the wide variation in nutritional status and dietary 
intakes of the human population.
Conclusions of the present study - The role of
diet in causation of disease is now the subject of intensive
scientific investigation. Much scientific research has been 
stimulated by the hypothesis of Burkitt (1971) that a lack of 
dietary fibre in the diet, especially bran, is central to the mode 
of causation of many of the diseases of affluence including
colo-rectal cancer, atherosclerosis, diverticular disease, 
diabetes, obesity and ulcerative colitis. Despite vastly 
increasing our understanding of the composition, chemical, physical 
and physiological effects of dietary fibre, no conclusive
biochemical evidence has been elucidated which substantiates this 
theory. The long-term health effects of increasing dietary fibre 
content are not fully established (Talbot,1980).
It can be concluded from the present study that wheat bran 
does not induce components of the hepatic or intestinal 
mixed-functional oxidase enzyme system in the rat. This indicates 
that the postulated protective effect of bran against the diseases
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of affluence is not mediated by altering the direction of 
metabolism or substrates of the mixed-function oxidase enzyme 
system which generally detoxifies foreign compounds but is also 
responsible for the production of toxic and carcinogenic 
metabolites. Similarly a high fat diet did not induce components 
of the hepatic mixed-function oxidase system. A lack of effect of 
wheat bran on bone mineral stores of calcium, magnesium and 
phosphorus was shown in the rat receiving adequate dietary supplies 
of these minerals. It can be concluded that the reported adverse 
effects of dietary fibre on mineral status were not substantiated 
in this experiment under conditions of adequate nutrition. Studies 
of the effect of wheat bran on gastro-intestinal mucus production 
were generally inconclusive. Conclusions from the further 
investigation of the drug-nutrient interaction between folic acid 
deficiency and anticonvuls ant treatment resulting in eventual drug 
toxicity, suggest that reduced cytochrome P450 induction is not 
related to short-term folic acid deficiency but may be determined 
by prolonged deficiency of to some further complication resulting 
from long-term ingestion of these drugs.
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Appendix I (ii): to chapters 2 and 5
Composition of the Experimental Diets by Analysis
Analyses of diets adjusted to 12% moisture basis
Diet Moisture
%
Ash % Nitrogen
%
Fat % NDF %
Fibre
Free 9.6±0.9 3.9+O.3 2.7±0.2 4.610.3 0.0710.04
17% White 
Bread 1 0 .0 ±0 .7 4.2+O.3 2.7+O.Î 4.610.4 0.5 10.1
34% White 
Bread 1 0 .2 +1 . 0 4.3±0.3 2.7+O.1 5.010.5 0.8 10.3
17%
Wholemeal
Bread 9.9±0, 8 4.2±0,3 2 ,7+0. 2 4.910.5 1.9 10.2
34%
Wholemeal
Bread 10.3±1.2 4.5±0.2 2 .8 ±0 . 1 5.010.4 3.7 ±0.4
4.8%
Bran 9.8±0. 8 4.1±0.2 2 .7+0.1 4.610.4 2.1 10.3
9.6%
Bran 9.9±0. 8 4.4+0.3 2.7±0.1 4.710.4 4.2 10.5
8.5% Beef 
Suet 8,8±0.7 3.8±0.2 2.610.1 ' 11.411.6 0.15±0.14
4IB Stock 
Diet 1 2 .6 ±0 .7 ’ 6 . 0± 1 . 0 2.410.2 4.010.5 17.610.25
NDF ~ Neutral Detergent Fibre
Values are mean ± SD of 21 batches of diet.
Acknowledgements are due to the Flour Milling and Baking Research 
Association for Supplying this data.
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Appendix II: to chapter 2
Bodyweight and Liver Weight Data
DIET GROUP
Feeding
Period
Fibre-
Free
(Control)
4.8%
Bran
9.6%
Bran
8.5%
Beefsuet
41B
Stock diet
4 weeks - Mean - SEM for four Male rats
Initial body 
weight (g) 69 ±4 7O+3.3 7014.6
Final body 
weight Cg) 240±4 231 ±5 23614
Weight gain Cg) 171 ±3 161 ±4 16615
Liver weight 
Cg) 9 . 0 ±0 .3 8 .5+0.2 9.7+0. 6
Relative 
liver weight 
Cg/100g body 
weight) 3.75+0. 1 3. 6 8 ±0 . 1 4.H+O.3
7 weeks ^ Mean ± SEM for six Male rats
Initial body 
weight (g) 64±4 70±3 61±1 59±2
Final body 
weight (g) 300±15 316-10 307 ± 8 285-12
Weight gain (g) 236±12 246+9 211136 226112
Liver weight
Cg) 12.5+0.6 13 ±0 . 6 12.730.6 11.730.8
Relative Liver 
weight (g/1 0 0 g 
bodyweight 4 .2 +O. 2 4.130.2 4.130.1 4. 1 30. 2
12 weeks - Mean ± SEM for five Male rats
Initial body 
weight Cg) 50+3 54 32 44 32 ,5034
Final body 
weight (g) 375321 400±13 401124 357115
Weight gain (g) 325+Î9 3463:13 357+23 307+25
Liver weight 
Cg)
14.4±2,4 14.912.1 14.811.5 12.8+0.9
Relative liver 
weight Cg/100g 
bodyweight)
3.8±0.4 3.710.3 3.710.1 3.610.1
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Appendix II: to chapter 2 Contd ,,.
Bodyweight and Liver Weight Data
DIET GROUP
Feeding
Period
Fibred-
Free
(Control)
9.6%
Bran
85 >%
B.eei
Suet
4 IB
Stock Uiet
12 weeks - Mean ± SEM for five female rats
. 1 
i
Initial body 
weight ( g ) 44-0.4* 44^0.4* 44-0.4*
J l
44-0.4*
Final body 
weight ( 9) 248±8 25215 262115 27618
Weight gain
(g)
Liver weight
(g)
204 2 0 8 2 1 8 2 3 2
7.610.6 7.710,5 7,610.5 8.810.6
Relative 
liver weight 3. 1± 3.11 2,91 3.21
!
18 months Mean ± SEM for five male rats
Initial body 
weight ( g )
4 9 -0 .4 * 4 9 -0 .4 4 9 -0 .4 *
i
4 9 -0 .4
Final body 
weight (g) 
Weight gain (g) 
Liver weig^ vt^
652136
603
20.510,5
682143
635
20.511.5
767147
718
2 1 .0 1 1 . 8
659134
610
21.318.6
Relative 
liver weight 3.1710.13 3,0510.28 2.7410.18 3.1510.17
* Mean and SEM for batches of rats on delivery to FMBRA 
(based on total deliveries of 750 of each sex in the 
batches used to supply the above experiments).
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A p p e n d i x  I I I  ; t o  c h a p t e r  6
B o d y w e i g h t  a n d  L i v e r w e i g h t  D a t a
Treatment Group
Induction
Treatment
Folate
Supplemented
Folate
Deficient
Folate
Supplemented
with
Induction
Treatment
Folate 
Deficient 
with • 
Induction 
Treatment
Phenobarbitone 0.1% Cw/v) in drinking water for 4 days
Final
Bodyweight Cg) 429±7 424±25 473±13
4O6+Î3
Liver­
weight (g) 14.4±0.5 14,3±0.9* 22.0±1.1
18.2±0.9
Relative Liver 
weight (g/100g 
bodyweight) 3.35+0.1 3.36±0.4 4.Ô3+O.Î
4.48±0.2
Phenobarbitone 80 mg/kg for 14 days Cl.P. )
Final
Bodyweight (g) 52Î+32 (2)
473118
Liver­
weight Cg) 2O.9+Î.4 (2)
18.8±1.0
Relative Liver 
weight Cg/100g 
bodyweight) , 4.05+0,05 (2)
4.0210.2
3,-Me fhvi, nho 1 anthr ene 25 mg/kg bodyweight for 7 days (I.P .)
Final
Bodyweight Cg) 474±8 471+10 497+23
447122
Liver­
weight (g) 12.9±0,3 13.2+0.4 18.8+1.2
16.7+0.7
Relative Liver 
weight (g/100g 
bodyweight) 2.74±0.06 2.81±0.10 3.77+O.O9
3.7410.10
Results are means and SEM of five male animals (unless otherwise 
indicated)
Value significantly different from Control: * p < 0.02
STARCH AND DIETARY FIBRE 
COMPOSITION OF THE "2nd.tails" BRAN FROM HEYGATE1S TRING MILL
/cw/w
Moisture 11*0
Starch 14»1
Hemicelluloses 27*3
hexoses 5*5
pentoses 20* 9
uronic acids . 0* 85
Cellulose 9*45
hexoses 8* 23
pentoses O* 41
uronic acids O* 82
Lignin 4* 8
Total DF 41* 6
A c k n o w l e u y e n i e n  t are due to FMBRA for supplying tais data-.
